UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-K

FORM 10-K

[X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended December 31 2018, 2021

or

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission file number 0-15746000-15746

VIRTUAL CRYPTO TECHNOLOGIES,VIEWBIX INC.

(Exact Name Ofof Registrant As Specified In Its Charter)

Delaware68-0080601
(State of Incorporation)

(I.R.S. Employer

Identification No.)

11 Ha’amalDerech Menachem Begin Street Rosh Ha’Ayin, , Ramat Gan, Israel48091745268104
(Address of Principal Executive Offices)(ZIP Code)

Registrant’s Telephone Number, Including Area Code: (212) 400-7198+9729-774-1505

Securities Registered Pursuantregistered pursuant to Section 12(g)12(b) of Thethe Act: Common Stock, $0.0001

Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, Par Value $0.0001VBIXOTCQB

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☐ No

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐ No

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes [X] No [  ]

Indicate by check mark if disclosure of delinquent filerswhether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to ItemRule 405 of Regulation S-K is not contained herein, and will not be contained, to the best of the registrant’s knowledge, in the definitive proxy or information statements incorporated by reference in Part IIIS-T (§ 232.405 of this Form 10-K or any amendment to this Form 10-K. [  ]

On June 30, 2018,chapter) during the aggregate market value of the 13,605,672 shares of common stock held by non-affiliates ofpreceding 12 months (or for such shorter period that the registrant was approximately $2,027,245 based on the closing price of $0.149 of the Registrant’s common stock on June 29, 2018, the last trading day in June 2018. On March 28, 2019, the Registrant had 110,749,643 shares of common stock outstanding.required to submit such files). Yes ☐ No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, (as defineda smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act) or a smaller reporting company.Act.

Large accelerated filer[  ]Accelerated filer[  ]Non-Accelerated filer[  ]Smaller reporting company[X]
Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Yes ☐ No ☒

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. Yes ☐ No

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes [  ] No [X]

The aggregate market value of the registrant’s common stock held by non-affiliates of the registrant was $815,277 as of June 30, 2021, based upon the closing price of the common stock on that date, which was $0.0401.

As of March 17, 2022, there were 34,753,669 shares of common stock, par value $0.0001 per share (“Common Stock”) outstanding.

 

 

 

TABLE OF CONTENTS

ItemDescriptionPage
PART I
ITEM 1.DESCRIPTION OF BUSINESS4
ITEM 1A.RISK FACTORS67
ITEM 1B.UNRESOLVED STAFF COMMENTS1618
ITEM 2.PROPERTIES1618
ITEM 3.LEGAL PROCEEDINGS1618
ITEM 4.MINE SAFETY DISCLOSURES1618
PART II
ITEM 5.MARKET FOR REGISTRANT’S COMMON EQUITY RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASE OF EQUITY1718
ITEM 6.SELECTED FINANCIAL DATA20
ITEM 7.MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITIONS AND RESULTSPLAN OF OPERATIONSOPERATION20
ITEM 7A.QUANTITATIVE AND QUALITATIVE DISCLOSURE ABOUT MARKET RISK2624
ITEM 8.CONSOLIDATED FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA27F-1
ITEM 9.CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE5125
ITEM 9A.CONTROLS AND PROCEDURES5125
ITEM 9B.OTHER INFORMATION5126
PART III
ITEM 10.DIRECTORS EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE5227
ITEM 11.EXECUTIVE COMPENSATION5328
ITEM 12.SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED SHAREHOLDER MATTERS5529
ITEM 13.CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS AND DIRECTOR INDEPENDENCE5530
ITEM 14.PRINCIPAL ACCOUNTING FEES AND SERVICES5530
PART IV
ITEM 15.EXHIBITS AND CONSOLIDATED FINANCIAL STATEMENT SCHEDULES5631

Cautionary Statement regarding Forward-Looking Statements

This Annual Report on Form 10-K includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The Registrant has based these forward-looking statements on its current expectations and projections about future events. These forward-looking statements are subject to known and unknown risks, uncertainties and assumptions about the Registrant that may cause its actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “may,” “will,” “should,” “could,” “would,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” “continue,”“may”, “will”, “should”, “could”, “would”, “expect”, “plan”, “anticipate”, “believe”, “estimate”, “continue”, or the negative of such terms or other similar expressions. Factors that might cause or contribute to such a discrepancy include, but are not limited to, those described in this Annual Report on Form 10-K and in the Registrant’s other Securities and Exchange Commission filings.

PART I

ITEM 1. DESCRIPTION OF BUSINESS

Overview and backgroundrecent developments

On January 17, 2018,Viewbix Inc. (f/k/a Virtual Crypto Technologies, Inc., f/k/a Emerald Medical Technologies,Applications Corp.) (the “Registrant”, “Viewbix” or the “Company”) was incorporated in the State of Ohio in 1989 under a predecessor name, Zaxis International, Inc. (the “Registrant” or “Company”(“Zaxis”). On August 25, 1995, Zaxis merged with a subsidiary of The InFerGene Company, a Delaware corporation, which entity changed its name to Zaxis International, Inc. and the Company was reincorporated in Delaware under the name of Zaxis International, Inc. On December 30, 2014, Zaxis entered into an agreement with Emerald Medical Applications Ltd., a private limited liability company organized under the laws of the State of Israel (“Emerald Israel”).

On March 16, 2015, Zaxis and Emerald Israel executed a share exchange agreement, which closed on July 14, 2015, and Emerald Israel became the Company’s wholly-owned subsidiary. Emerald Israel was engaged in the business of developing Emerald Israel’s DermaCompare technology and the development, sale and service of imaging solutions utilizing its DermaCompare software for use in derma imaging and analytics for the detection of skin cancer. On January 29, 2018, the Company ceased the DermaCompare operations of its former subsidiary.

On January 17, 2018, the Company formed Virtual Crypto Technologies Ltd as a new wholly-owned subsidiary under the laws of the State of Israel, (“Virtual Crypto Technologies Ltd. (the “VCT Israel”) and appointed Mr. Alon Dayan, who has served as the Registrant’s Chief Executive Officer since June 30, 2018 and has been a member of the Company’s Board of Directors since March 14, 2018, as CEO of Virtual Crypto Israel. Virtual Crypto Israel was formed, to develop and market software and hardware products facilitating allowing and supporting the purchase and/or sale of cryptocurrencies through ATMs, tablets, PCspersonal computers (“PCs”) and/or mobile devices (the “Products”).

devices. On January 29,February 12, 2018,pursuant to resolution of the Registrant’s Board of Directors,the Registrant transferred the management shares of the Registrant’s former Israeli subsidiary, Emerald Medical Applications Ltd. (“Emerald IL”) to Attorney Eviatar Knoller, Esq., with offices inTel Aviv-Jaffa, Israel, as trustee (the “Trustee”) for the purpose of enabling the Trustee to liquidate the management shares and/or the assets of Emerald IL to satisfy its debts.

The Company filed a Current Report on Form 8-K on January 24, 2018, with the United States Securities and Exchange Commission (the “SEC”), reporting that Virtual Crypto Israel had entered into a binding term sheet (the “Chiron Term Sheet”) with Chiron Refineries Ltd. (“Chiron”), a public company listed on the Tel-Aviv Stock Exchange (TASE: CHR). Pursuant to the Chiron Term Sheet: (i) Virtual Crypto Israel agreed to appoint a wholly-owned subsidiary of Chiron, to be organized under the laws of the Turkish Republic of Northern Cyprus (the “Distributor”), as the exclusive distributor of Virtual Crypto Israel’s Products in Turkey, including the territory of Turkish Republic of Northern Cyprus (collectively, the “Territory”); and (ii) the Distributor shall have the right to appoint sub-distributors within the Territory. The appointment of the Distributor was subject to the payment by the distributor to Virtual Crypto Israel of $250,000 as an appointment fee, of which $150,000 was to be deemed an advance payment by the distributor made on account of future purchases of the Company’s Products.

The Company further granted the Distributor an option, exercisable by the Distributor within 12 months from the date on which the ATM Product, including the related software and hardware, was fully tested and ready for installation and operation, to be appointed as an exclusive distributor of the Products for the Federal Republic of Nigeria. If the option was exercised, the Distributor was required to pay Virtual Crypto Israel an appointment fee not more than $250,000. In November 2018, Chiron reported that it had encountered financial difficulties and as such the Company will no longer pursue the transactions contemplated by the Chiron Term Sheet.

To date, $100,000 was paid by the Distributor to Virtual Crypto Israel, which has been recognized as revenues for the year ended December 31, 2018.

The Registrant filed a Definitive Information Statement on February 12, 2018definitive information statement to change its name from Emerald Medical Applications Corp. to Virtual Crypto Technologies, Inc. to reflect its new operations and business focus, and, effective onas of March 7, 2018, FINRAthe Financial Industry Regulatory Authority (“FINRA”) approved the Registrant’s name change and its trading symbol was changed from MRLA“MRLA” to VRCP“VRCP” on the OTCQB.

The disclosure in this annual report relates to our business activities during the fiscal year ended December 31, 2018. Additional disclosure has been included in this annual report related to recent developments and subsequent events that occurred after the fiscal year ended December 31, 2018. Reference is made to the disclosure in Note 10-Subsequent Events, to the Notes to Consolidated financial Statements.Transaction with Gix Internet Ltd.

During the period commencing January 16, 2018 through March 23, 2018, the Registrant raised $1.9 million in equity capital (the “Equity Raise”) through the offering of units (the “Unit Offering”) at a price of $0.07 per Unit, each Unit consisting of: (i) one (1) share of the Company’s common stock (the “Shares”); (ii) one (1) common stock purchase warrant exercisable for a period of twelve months to purchase one additional Share at an exercise price of $0.14 per Share (the “Class F Warrants”); and (iii) one (1) common stock purchase warrant exercisable for a period of twelve months to purchase one additional Share at an exercise price of $0.28 per Share (the “Class G Warrants”).The proceeds of the Equity Raise are being utilized by the Registrant to fund the operations of Virtual Crypto Israel including, but not limited to the costs associated with the development of the Products. Reference is made to the disclosure under Item 5. “Market For Registrant’s Common Stock, Related Stockholder Matters And Issuer Purchase Of Equity” and under the subcaption “Sale of Unregistered Securities in 2018” with respect to the Equity Raise from the sale of units in 2018.

The Unit Offering was made by the Registrant: (i) principally pursuant to the exemption provided by Regulation S promulgated by the United States Securities and Exchange Commission (the “SEC”) under the Securities Act of 1933, as amended (the “Act”); and (ii) to a lesser extent pursuant to Regulation D promulgated by the SEC under the Act; and (iii) and only to “accredited investors” as that term is defined in Rule 501 of Regulation D promulgated by the SEC under the Act. With respect to the Unit Offering made pursuant to Regulation S, the Units were offered in offshore transactions to persons who are not “U.S. Persons” as that term is defined in Rule 902 of Regulation S promulgated by the SEC under the Act.

Recent Developments

Share Exchange Agreement

The operations of Virtual Crypto Israel only generated revenues of $100,000 during the year end December 31, 2018 from one customer, Chiron, who has encountered financial difficulties. During 2018, we spent $790,413 in order to develop our systems in an industry that has experienced significant difficulties over the last 18 months. We believe that this has led to a decrease in the anticipated demand for Virtual Crypto Israel’s products and services. Therefore, onOn February 7, 2019, we filed a Form 8-K reporting that the Registrant entered into a share exchange agreement (the “Share Exchange Agreement”) with Gix Internet Ltd., formerly known as Algomizer Ltd. (TASE:GIX), an Israeli Corporationa company organized under the laws of the State of Israel (“Algomizer”Gix Internet” or “Parent Company”), pursuant to which Algomizer will assign, transferon July 25, 2019 (the “Closing Date”) Gix Internet assigned, transferred and deliverdelivered its 99.83% holdings in Viewbix Ltd., an Israeli corporation, (“Viewbix Israel”) to usthe Company in exchange for shares of restricted common stock ofCommon Stock, representing 65% of the issued and outstanding share capital of the Company on a fully diluted basis onas of the closing date,Closing Date, following the conversion of certain convertible notes of the Company and excluding certain warrants to purchase shares of common stock, which will expirethe Common Stock expiring in 2020 and with an exercise price representing a valuation equal to $30,000,000 (“Fullyadditional warrants as further described below (the “Fully Diluted Share Capital”). In addition, upon the earlier of: (a) the launch of a live video product to an American consumer in the U.SUnited States by Viewbix Ltd.,Israel, or (b) the launch of an interactive television product to an American consumer in the U.S.,United States by Viewbix Ltd., weIsrael, the Company will issue Algomizerto Gix Internet an additional 1,642,193 shares of restricted common stockCommon Stock of the Company representing 5% of the Fully Diluted Share Capital.Capital immediately following the Closing Date.

Furthermore,On July 24, 2019, the Company filed a Certificate of Amendment to its Certificate of Incorporation with the Secretary of State of Delaware reflecting its name change from Virtual Crypto Technologies, Inc. to Viewbix Inc. to reflect its new operations and business focus and, effective on August 7, 2019, FINRA approved the Registrant’s name change and its trading symbol was changed from “VRCP” to “VBIX” on the closing date, we will issue Algomizer:OTCQB.

On the Closing Date, (i) the Company issued 20,281,085 shares of its Common Stock to Gix Internet in exchange for consideration consisting of 99.83% holdings in Viewbix Israel, and (ii) convertible notes representing 3,434,889 shares of Common Stock then currently issued to holders were converted. The shares of Common Stock were issued under Regulation S. The Company also issued a total of 7,298,636 warrants to Gix Internet to purchase shares of restricted common stockCommon Stock, whereby (i) 3,649,318 of such warrants were issued with an exercise price representing a valuation for the Company of $15,000,000 on Fully Diluted Share Capital basis, which will represent 10% of the Fully Diluted Share Capital immediately following the closing, which warrants will be exercisable for a period of ten years,$0.48, and (ii) 3,649,318 of such warrants to purchase shares of restricted common stockwere issued with an exercise price representingof $0.80.

Following the Closing Date, Viewbix Israel became a valuationsubsidiary of the Registrant. Viewbix Israel was incorporated in February 2006 in Israel.

On January 27, 2020, VCT Israel was sold to a third party for NIS 50,000 ($14,459).

Merger with Gix Media Ltd.

On December 5, 2021, the Company entered into a certain Agreement and Plan of $25,000,000 on Fully Diluted Share Capital basis, which will represent 10%Merger (the “Merger Agreement”) with Gix Media Ltd., an Israeli company and the majority-owned subsidiary of Gix Internet, in the field of MarTech (Marketing Technology) solutions, primarily search and content monetization (“Gix Media”) and Vmedia Merger Sub Ltd., an Israeli company and wholly-owned subsidiary of the Fully Diluted Share CapitalCompany (“Merger Sub”), pursuant to which, following the Merger (as defined herein), and upon satisfaction of additional closing conditions, Merger Sub will merge with and into Gix Media, with Gix Media being the surviving entity and wholly-owned subsidiary of the Company (the “Gix Merger”).

Subject to the terms and conditions of the Merger Agreement, at the Merger Effective Date (as defined in the Merger Agreement) all outstanding ordinary shares of Gix Media, having no par value (the “Gix Media Shares”) will be converted into shares of Common Stock, such that immediately following the closing, which latter warrantsGix Merger, holders of Gix Media Shares will hold 90% of the Company’s capital stock on a fully diluted basis. The Merger Agreement also contains customary representations, warranties and covenants made by each of the Company, Gix Media and Merger Sub.

Following the Gix Merger, the board of directors of the Company is expected to consist of six (6) directors and will be exercisable for a periodcomprised of ten years.four (4) new directors to be appointed by Gix Media, who will join the Company’s two currently-serving directors, Amihay Hadad and Alon Dayan.

The closingOn December 21, 2021, the shareholders of each of Gix Media and Merger Sub approved the Merger Agreement. Consummation of the Share Exchange AgreementGix Merger is conditioned upon ussubject to certain additional closing conditions, including, among other things, (i) the Company filing an amendment to ourits certificate of incorporation to change the Company’s name to ViewBix“Gix Media, Inc., effecting a reverse split(ii) obtaining approval from certain third parties, including the approval of ourBank Leumi due to certain liens registered in its favor against ordinary shares of common stock at a ratio of 1:15, which we intend to effect whether or not the transactions under the Share Exchange Agreement will consummate,Gix Media; (iii) conversion of ourthe Company’s outstanding convertible notesinstruments into restricted shares of restricted common stockCommon Stock and Algomizer(iv) obtaining a tax pre-ruling from the Israeli Tax Authority relating to the Share Exchange Agreement.

ViewBix Ltd., through its ViewBix Studio, provides its clientsIn connection with a video engagement platform designed to add enhanced branding and interactive elements – from call-to-action buttons to email captures – to digital videos. ViewBix Studio is simple, intuitive and requires no coding experience, thereby enabling clients to enhance videos and publish them across any platform, for any device in just minutes. Videos enhanced by Viewbix are compatible with existing ad serving, measurement and analytics platforms and easily work within existing agency or client processes for launching advertising campaigns. Beyond adding interactions to video, Viewbix uses second-by-second measurement of engagements to uncover contextual insights as to what, when and how users are engaging or responding to brand messaging.

5

Reverse Stock Split

OnGix Merger, on February 26, 2019, stockholders holding a13, 2022, the requisite majority of our outstanding shares of common stockthe Company’s stockholders approved an amendmentcertain amendments to ourthe Company’s certificate of incorporation, in orderincluding, but not limited to affect(i) a name change from “Viewbix Inc.” to “Gix Media, Inc.”, (ii) a reverse stock split of the Company’s common Stock at a ratio of 1-for-28 (the “Planned Reverse Split”), (iii) a staggered board structure, and (iv) certain other provisions therein. The Company intends to effect the foregoing amended and restated certificate of incorporation upon the closing of the Gix Merger. Additionally, on February 25, 2022, the Company filed a Schedule 14C Information Statement with the SEC, whereby it reported the foregoing approvals by the requisite majority of the Company’s stockholders.

Viewbix Business Overview

Viewbix is an interactive video technology and data platform that provides its client with deep insights into their video marketing performance as well as the effectiveness of its messaging. Viewbix allows companies to add a layer of interactive content on top of a video that allows viewers to engage and interact with the video. The platform measures exactly when a viewer takes an action while watching a video and collects and reports the results to the client.

Viewbix developed the interactive video platform based on a Software as a Service (“SaaS”) business model with interactive elements, and the ability to collect and analyze information about each interactive action performed during the viewing of the video clip. The interactive elements and information gathered allows the client to analyze user viewing habits and optimize in real-time throughout the campaign, while increasing the effectiveness of online and live video marketing.

Viewbix has adapted its technology platform to work on most nonproprietary platforms on the Internet, including, but not limited to, online video campaigns, brand and image videos, online tutorials, live and real-time video streaming (e.g. music concerts and sporting events), video presentations, and more. Using the Viewbix platform, video creators can integrate advances features into their videos, specifically the inclusion of “click” buttons that trigger a particular action, into a given video, like the insertion of a smart form for retrieving the contact information of the viewer. Viewbix then collects all the data around the cross section of the viewing data and engagement data and offers its clients the opportunity to download and analyze the results. Viewbix also offers a full service option where the Viewbix account managers will analyze the data and report results and suggestions to its clients.

Notwithstanding the foregoing, the Company initiated certain cost reduction measures during fiscal year-ended December 31, 2020. On January 1, 2020, each of the Company’s former Chief Executive Officer and Chief Operating Officer tendered their resignations from their respective positions. Moreover, due to the Company’s failure to meet predetermined sales targets set forth in the Share Exchange Agreement, the Company determined to reduce the size of its sales team and, likewise, the R&D team was replaced with a more cost-effective consultant. These decisions, and future decisions related to cost-reduction measures, may impact the Company’s ability to sell and support its products in the future and, accordingly, may materially impact the Company’s business operations.

Industry Overview

Video marketing remains one of the fastest growing industries, and, accordingly is increasingly crowded with competition. According to a study published by Cisco, by 2022 online videos will represent 82% of online consumer traffic. Globally, three trillion minutes (or five million years) of video content will cross the Internet each month by 2022, which is the equivalent of 1.1 million minutes of video streamed or downloaded every second.

According to an additional study published by Statista, ad spending is expected to show an annual growth rate of 11%, resulting in a projected market volume of $162,242 million by 2026. In the video advertising segment, it is expected that $136,486 million will be generated through mobile in 2026.

Competition

While there are many companies that offer hosting and streaming services, Viewbix focuses on providing expanded value to its clients that reaches beyond the hosting and streaming platforms. Viewbix has several direct competitors, including Hapyak, which operates primarily via websites, and Innovid, which focuses on advertisements. Additionally, video hosting companies, such as Wistia and Vidyard, both offer certain interactive elements similar to Viewbix. However, Viewbix’s proprietary component is its focus on interactivity and deep data, whose results can thereafter be analyzed and applied.

Intellectual Property and Other Proprietary Rights

Our commercial success depends, in part, on obtaining and maintaining patent and other intellectual property protection, in the United States and internationally, for the technologies used in our products. We cannot be sure that any of our common stockpatents will be commercially useful in protecting our technology. Our commercial success also depends in part on a 1-for-15 basis. our non-infringement of the patents or proprietary rights of third parties. The patent positions can be highly uncertain and involve complex and evolving legal and factual questions.

We intendhave four patents that have been granted to effect such reverse stock split once all approvalsus in the U.S. which we consider material to our business and operating success, including the following:

U.S. Patent No. 10,467,684: the granted patent relates to novel techniques implemented by Viewbix which enables businesses to configure their video players to incorporate interactivity functions, such as call-to-actions, into their video publishing and delivery workflows;
U.S. Patent No. 8,706,562: the granted patent relates to video e-commerce networking, modules and methods used to configure a video or playlist that is delivered to viewers where the content displayed in the video player is dynamic and can be automatically customized based on the publisher site;
U.S. Patent No. 8,706,558: the granted patent relates video e-commerce networking, modules and methods to display a video or playlist that is delivered to a viewer where the content displayed in the video player is dynamic and automatically customized based on the publisher site; and
U.S. Patent No. 9,792,645: the granted patent provides a unique method to facilitate video interactions between a publisher and end users, and measures the data produced through that interaction.

We also protect our proprietary technology and processes, in part, by confidentiality and invention assignment agreements with our employees, consultants, scientific advisors and other contractors. These agreements may be breached, and we may not have adequate remedies for such actions are obtained.

Pursuantany breach. We also rely on trade secrets to protect our product candidates. However, our trade secrets may otherwise become known or be independently discovered by competitors. To the extent that our employees, consultants, scientific advisors or other contractors use intellectual property owned by others in their work for us, disputes may arise as to the Reverse stock split,rights in related or resulting know-how and inventions.

Product Development

Viewbix focuses its R&D efforts on the expansion of its interactive live capabilities by collecting the engagement data for each fifteen (15) sharessession and relating back to a live stream, which is aimed to enhance clients’ feedback on its stream for both real time and future stream optimizations.

Employees

As of our common stock will be automatically converted, without any further action by our stockholders, into one shareDecember 31, 2021, Viewbix has two employees in management and finance in Israel. Additionally, Viewbix retains the services of common stock. No fractional shares will be issued as the result of the reverse stock split. Instead, each stockholder will be entitled to receive one share of common stock in lieu of the fractional share that would have resulted from the reverse stock split.two R&D service providers.

ITEM 1A. RISK FACTORS

The shares of our Common Stock are highly speculative in nature, involve a high degree of risk and should be purchased only by persons who can afford to lose their entire amount invested in the Common Stock. Accordingly, prospective investors should carefully consider, along with other matters referred to herein, the following risk factors in evaluating our business before purchasing any shares of Common Stocks.Stock. If any of the following risks actually occurs, our business, financial condition or operating results could be materially adversely affected. In such case, you may lose all or part of your investment. You should carefully consider the risks described below and the other information in this Prospectus before investing in our Common Stock. Prospective investors should also carefully consider

Summary Risk Factors

Our business is subject to numerous risks and uncertainties, including those highlighted in the fact that several ofsection titled “Risk Factors” immediately following this prospectus summary. These risks include, among others, the risk factors related to our former business are no longer applicable and that there are new risk factors applicable to our new business operations.following:

We initiated certain cost-reduction measures during the previous fiscal year, which could have long-term adverse effects on our business and we may not realize the operational or financial benefits from such actions;
The COVID-19 pandemic may adversely affect our business, financial condition, liquidity and results of operations;
Our success depends, in part, upon the continued demand of video as an integral part of corporate marketing and internal communications plans and the continued growth and acceptance of videos as effective alternatives to traditional online and offline marketing products and services;
Due to our evolving business model and rapid changes in the Internet and the nature of services, it is difficult to accurately predict our future performance and may be difficult to increase revenue or profitability;
Our customers may reduce or terminate their business relationship with us at any time. If customers representing a significant portion of our revenue reduce or terminate their relationship with us, it could have a material adverse effect on our business, results of operations and financial condition;
Large and established internet and technology companies, such as Google and Facebook, play a substantial role in the digital advertising market and may significantly impair our ability to operate in this industry;
The advertising/marketing industry is highly competitive. If we cannot compete effectively in this market, our revenues are likely to decline;

If we cannot enforce and protect our intellectual property rights, our business could be adversely affected;
We may in the future be, subject to claims of intellectual property infringement that could adversely affect our business;
Patent terms may be inadequate to protect our competitive position for an adequate amount of time;
We may not be able to protect our systems, technology and infrastructure from cyberattacks;
Our business depends on our ability to collect and use data, and any limitation on the collection and use of this data could significantly diminish the value of our platform and cause us to lose customers and revenue;
Shares of Common Stock issuable upon the conversion of warrants may substantially increase the number of shares of Common Stock available for sale in the public market and depress the price of our Common Stock;
 Our Planned Reverse Split may not result in a proportional increase in the per share price of our Common Stock;
We are subject to compliance with securities law, which exposes us to potential liabilities, including potential rescission rights;
The availability of a large number of authorized but unissued shares of Common Stock may, upon their issuance, lead to dilution of existing stockholders;
We have never paid cash dividends and do not anticipate doing so in the foreseeable future;
Our Common Stock is subject to the “Penny Stock” rules of the SEC and the trading market in our stock is limited, which makes transactions in our stock cumbersome and may reduce the value of an investment;
Since our Common Stock is thinly traded, sale of your holding may take a considerable amount of time;
Shares of Common Stock eligible for future sale may adversely affect the market;
If we fail to maintain effective internal controls over financial reporting, the price of our Common Stock may be adversely affected;
We are required to comply with certain provisions of Section 404 of the Sarbanes-Oxley Act of 2002 and if we fail to comply in a timely manner, our business could be harmed and our stock price could decline;
Our annual and quarterly results may fluctuate, which may cause substantial fluctuations in our Common Stock price;
Delaware law contains provisions that could discourage, delay or prevent a change in control of our company, prevent attempts to replace or remove current management and reduce the market price of our stock;
Political, economic and military instability in Israel may impede our ability to operate and harm our financial results; and
Exchange rate fluctuations between foreign currencies and the U.S. Dollar may negatively affect our earnings.

Risks Associated with Our Business and Industry

We initiated certain cost-reduction measures during the previous fiscal year, which could have long-term adverse effects on our business and we may not realize the operational or financial benefits from such actions.

We initiated certain cost-reduction measures during the previous fiscal year, and we may engage in similar activities in the future. This decision may distract management, could slow improvements in our platform and limit our ability to attract customers. It remains unclear how and to what extent this decision will impact our future business and operating success.

The COVID-19 pandemic may negatively impact the global economy in a significant manner for an extended period of time, and also adversely affect our business and operating results.

The COVID-19 pandemic has resulted in a widespread health crisis that has adversely affected businesses, economies and financial markets worldwide, placed constraints on the operations of businesses, decreased consumer mobility and activity, and caused significant economic volatility in the United States, Israel and international capital markets. The COVID-19 pandemic has caused an economic recession, high unemployment rates and other disruptions, both in the United States, Israel and the rest of the world. The COVID-19 pandemic has not yet currently adversely affected our business, however, any of these impacts, including the prolonged continuation of these impacts, could in the future, adversely affect our business and operating results and heighten many of the other risks described in these “Risk Factors.”

Our former DermaCompare operation never achieved marketsuccess depends, in part, upon the continued demand of video as an integral part of corporate marketing and internal communications plans and the continued growth and acceptance nor were any revenues ever generated. The failure of such acceptance caused usvideos as effective alternatives to cease our DermaCompare operationtraditional online and divest our DermaCompare subsidiary in January 2018.offline marketing products and services.

We provide a platform that allows companies to understand what messages are resonating with their video viewers and how to leverage that data to enrich and empower a more effective video experience. Our revenues were expected to comeare derived from the sale of the DermaCompare product. As a result, we continued to incur operating losses until our new management and Board of Directors determined to divest the DermaCompare subsidiary. We are now dependent upon our ability to successfully manufacture, via third-party agreements, to develop and market our planned Products implementing software and hardware facilitating, allowing and supporting the purchase and/or sale of cryptocurrencies through ATMs, tablets, PCs and/or mobile devices (collectively, our “Products”)

We only commenced operations in March 2018, following the equity raise, in the business of developing and marketing software and hardware products facilitating, for the purpose of allowing and supporting purchase and/or sale of cryptocurrencies through ATMs, tablets, PCs and/or mobile devices and, as a result, have no history of operations in such business.

On January 17, 2018, we organized Virtual Crypto Israel as a new, wholly-owned Israeli subsidiary to develop and market software and hardware products facilitating, allowing and supporting purchase and/or sale of cryptocurrencies through ATMs, tablets, PCs and/or mobile devices (the “Products”). To date, these efforts have not produced any significant revenues from our new business activities and we have virtually no history of operations in developing and marketing the Products.

Our historical financial information does not reflect our new business activities nor our recent agreement to distribute our Products.

As a result, our historic operations do not provide any basis for an evaluation of our business or our current business operations or focus. Our prospects must be considered in light of the uncertainties, risks, expenses, and difficulties frequently encountered by companies in their early stages of operations in new and developing fields such manufacturing and marketing Products for the purchase and sale of cryptocurrencies through ATMs, tablets, PCs and mobile devices. We may expect to incur additional net losses over the next several years as we seek to develop our operations in the field of supporting the purchase and sale of cryptocurrencies using our Products. The amount of future losses and when, if ever, we will achieve profitability are uncertain.platform. If we are unsuccessful at executing on our business plan, our business, prospects, and results of operations may be materially adversely affected.

We have an evolving business model.

As blockchain technologies and cryptocurrencies become more widely available and utilized in early 2018, we expected the services and products associated with them to evolve and, as a result, our Products would have to continue to evolve. Very recently, the Securities and Exchange Commission (the “SEC”) issued a Report that promoters that use initial coin offerings or token sales to raise capital may be engaged in the offer and sale of securities in violation of the Securities Act of 1933, as amended (the “Act”) and the Securities Exchange Act of 1934 (the “Exchange Act”). While we are not involved, nor will we engage in the business of initial coin offerings or token sales, any adverse impact on the cryptocurrency industry that may occur as a result of the recent SEC Report or other potential regulatory actions may adversely impact our ability to successfully market our Products. From time to time we may modify aspects of our business model rand our Products and there can be no assurance that these or any other modifications will be successful or will not result in harm to the business. We will continue, however, to try and develop Products with in anticipation of any positive change or improvement in the regulatory environments for blockchain technologies and cryptocurrencies, of which there can be no assurance. Notwithstanding the foregoing, we fully intend to maintain the existence and operations of Virtual Crypto Israel and at December 31, 2018, we had approximately $500,000 in cash available for our Virtual Crypto Israel operations

Our management team has limited experience in the field of manufacturing and marketing our new Products, which are still in development, to support the cryptocurrency market.

The Registrant’s management only determined in or about January 2018 to shift our primary corporate focus towards the manufacture and sale of software and hardware Products facilitating, allowing and supporting purchase and/or sale of cryptocurrencies through ATMs, tablets, PCs and/or mobile devices. Our management and that of Virtual Crypto Israel has relatively limited experience in supporting purchase and/or sale of cryptocurrencies and the blockchain technology industry generally. While we intend to expand our management team and staff as market conditions justify with individuals with more experience in this industry and will closely scrutinize any individuals we engage, we cannot assure you that well-qualified individuals will be available to us or that our assessment of individuals we retain will prove to be correct, if and when we determine to engage new personnel, of which there can be no assurance. These individuals may be unfamiliar with the requirements of being involved in a public company which could cause us to have to expend time and resources helping them become familiar with such requirements. This could be expensive and time-consuming and could lead to various regulatory issues which may adversely affect our operations.

The further development and acceptance of cryptocurrency trading, of which there can be no assurance, represents a new and rapidly changing industry.

If an when the market conditions and regulatory environment for our Products improve, of which there can be no assurance, we will be dependent upon our ability to manufacture and market our Products in a timely manner if we hope to succeed in serving this new and developing industry. We will be subject to a variety of factors that are difficult to evaluate. Further slowing or stopping of the development or acceptance of cryptocurrencies and our ability to manufacture Products in a timely manner and within the limits of our capital resources may adversely affect an investment in our common stock.

The use of our Products to purchase and sell cryptocurrencies to, among other things, buy and sell goods and services and/or the acquisition of cryptocurrencies as an investment, is part of a new and evolving industry that has confronted certain adverse regulatory pressure, particularly from the SEC. There can be no assurance that our Products will be accepted by this new and likely demanding market that employs the use of a computer-generated mathematical and/or cryptographic protocol. The growth of this industry, in general, is subject to a high degree of uncertainty. The factors affecting the further development of this industry, include, but are not limited to:

continued worldwide growth in the adoption and use of cryptocurrencies and the acceptance of our Products;

changes in consumer demographics and public tastes and preferences that can limit demand for our Products, compounded by continuing regulatory uncertainty;

the maintenance and development of hardware and software for our Products;
the availability and popularity of other forms or methods of buying and selling cryptocurrencies;
general economic conditions and the regulatory environment relating to cryptocurrencies; and
negative consumer perception of cryptocurrencies specifically and cryptocurrencies generally.

A decline in the popularity or acceptance of cryptocurrencies caused by regulatory uncertainty, among other reasons, would harm our ability to market our Products and, as a result, could adversely impact our ability to generate revenues and profits, if any.

Currently, there is relatively small use of cryptocurrencies in the retail and commercial marketplace in comparison to relatively large use by speculators; as a result, we expect that the market for our Products may develop slowly, if at all.

Cryptocurrencies have only recently become accepted as a means of payment for goods and services by certain major retail and commercial outlets and use of cryptocurrencies by consumers to pay such retail and commercial outlets remains limited. As a result, the demand for our Products may be expectedvideo advertising does not continue to develop slowly, if at all. As a result, we reasonably anticipate that we will not generate positive cash flow from operations for the foreseeable and there can be no assurance that we will ever generate profits.

If wegrow or customers do not keep pace with technological changes,embrace our Products, if and when developed, may not become competitive and/or our competitors may develop and market similar products that receive greater market acceptance.

The market for blockchain technology is characterized by rapid technological change, frequent product and service innovation and evolving industry standards. As a result, our Products must be able to keep pace withplatform, this rapidly developing and competitive marketplace and at the same time deal with continuing regulatory uncertainty. There can be no assurance that we will be able to manufacture our Products successfully or, if we can manufacture Products that achieve market acceptance, that we will be able to fulfill demand if such demand exceeds our production capabilities. In fact, there can be no assurance that demand for our Products will ever develop. We expect that we will be dependent on third party manufacturers for the foreseeable future but at present have no firm arrangements for the manufacture of our Products. If we are unable to provide enhancements and new features for our Products and any future product offerings that achieve market acceptance or that keep pace with these technological developments, our business could be adversely affected.

It may be illegal now, or in the future, to acquire, own, hold, sell or use cryptocurrencies and, as a result, the potential use and demand for our Products could be materially adversely affected.

Although currently cryptocurrencies generally are not regulated or are lightly regulated in most countries, including the United States, one or more countries may take regulatory actions in the future that could severely restrict the right to acquire, own, hold, sell or use cryptocurrencies which would adversely impact demand for our Products and/or limit their acceptance by potential users, including locations where we expect to place our Products. Such restrictions may adversely affect the Company. Such circumstances would have a material adverse effect on the ability of the Company to continue as a going concern or to pursue this segment at all, which would have a material adverse effectour business and financial condition.

Our success also depends, in part, on the business, prospects or operations of the Company and potentially the value of any cryptocurrencies the Company holds or expects to acquire for its own account and harm investors.

We will be dependent upon our ability to compete for a share of available video advertising/marketing expenditures as more traditional offline and emerging media companies continue to raise equityenter the online advertising/marketing market, as well as on the continued growth and acceptance of online advertising generally. If for any reason online advertising is not perceived as effective (relative to traditional advertising), web browsers, software programs and/or debt financing at acceptable termsother applications that limit or prevent advertising from being displayed become commonplace and/or the industry fails to effectively manage click fraud, the market for online advertising will be negatively impacted. Any lack of growth in the market for online advertising/marketing (particularly for paid listings) could adversely affect our business, financial condition and results of operations.

Due to our evolving business model and rapid changes in the Internet and the nature of services, it is difficult to accurately predict our future performance and may be difficult to increase revenue or profitability..

We believe thatdeveloped our platform based on a SaaS business model. We do not have an extensive history of ongoing operations in orderusing our business model from which to continue as a going concern, includingpredict our future performance, and making such predictions, particularly with regard to the costs of being a public company, we will need approximately $60,000 per year simply to cover the administrative, legal and accounting fees. We have funded these losses primarily through the sale of restricted shareseffect of our Common Stockefforts to aggressively increase the distribution and the issuance of convertible notes, which have subsequently been converted into restricted shares of Common Stock.

We generated revenues of $100,000 for the year ended December 31, 2018, all of which came from one customer with whom we are no longer doing business,profitability is very complex and no revenues for the ended December 31, 2017.

Notwithstanding our capital raise from the sale of our equity securities primarily during the period from January 2018 through March 2018, following the formation of Virtual Crypto Israel, there can be no assurance that we will have adequate capital resources or be able to continue to raise equity and/or debt capital to fund planned operations or that any additional funds will be available to us when needed or at all, or, if available, will be available on favorable terms or in amounts required by us.challenging. If we are unable to obtain adequate capital resourcescontinuously improve our platform, this could have a negative effect on our competitiveness and ability to fund operations,service and attract customers. If we are unsuccessful in doing so in a timely fashion, we may not be requiredable to delay, scale backachieve revenue growth or eliminate someincrease our profitability.

Our customers may reduce or allterminate their business relationship with us at any time. If customers representing a significant portion of our plan of operations, which mayrevenue reduce or terminate their relationship with us, it could have a material adverse effect on our business, results of operations and abilityfinancial condition.

We generally engage with two types of customers: small companies who change from time to operate astime and a going concern.

Our new Products will be dependent upon software still in development; Software failures, breakdowns innumber of large companies with whom the operationsengagement is for shorter periods of time. We do not enter into long-term contracts with our serverscustomers, and communications systems or the failure to implement system enhancements could harm our business.

Our success dependssuch customers do business with us on the efficient and uninterrupted operation of our servers and communications system, all of which are still in early stages of development. A failure of our network or data gathering procedures could impede the processing of data, delivery of databases and services, client data and day-to-day management ofa non-exclusive basis. Accordingly, our business is highly vulnerable to adverse economic conditions, market evolution and development of new or more compelling offerings by our competitors, which could resulteither lead to reduced advertising spend generally or motivate our current or potential customers to migrate to our competitors. Any reduction in the corruptionspending by, or loss of, data. While we plan that allexisting or potential customers would negatively impact our revenue and operating results.

Furthermore, the discretionary, non-exclusive nature of our operations will have disaster recovery plans in place, such plans, when in place, might not adequately protectrelationships with customers subjects us and any failure could irreparably damage any efforts for establishing a successful market presence. In addition, any failure by our computer environment to provide our required data communications capacity could result in interruptions in our service, which could be expected to prevent us from achieving any market acceptance for our new Products.

Additionally, significant delays in the planned delivery of system enhancements, improvements and inadequate performance of the systems once they are completed could damage our reputation and harm our business. Long-term disruptions in the infrastructure caused by events such as natural disasters, the outbreak of war, the escalation of hostilities and acts of terrorism, particularly involving cities in which we have offices, could adversely affect our businesses.increased pricing pressure. Although we planbelieve our rates are competitive, our competitors may be able to carry property and business interruption insurance for our business operations, our coverage might not be adequate to compensate us for all losses that may occur.

We face risks related to the storage of customers’ and their end users’ confidential and proprietary information.

Our Products are being designed to maintain the confidentiality and security of our customers’ and their end users’ confidential and proprietary data that are stored on our server systems, which may include sensitive personal data. However, any accidental or willful security breachesoffer more favorable pricing or other unauthorized access to these data could expose us to liability for the loss of such information, time-consuming and expensive litigation and other possible liabilities as well as negative publicity. Techniques used to obtain unauthorized access or to sabotage systems change frequently and generally are difficult to recognize and react to. We may be unable to anticipate these techniques or implement adequate preventative or reactionary measures.

Compliance with changing regulations concerning corporate governance and public disclosure may result in additional expenses.

In recent years, there have been several changes in laws, rules, regulations and standards relating to corporate governance and public disclosure, including the Dodd-Frank Wall Street Reform and Consumer Protection Act (the “Dodd-Frank Act”), the Sarbanes-Oxley Act of 2002 (“Sarbanes-Oxley”) and various other new regulations promulgated by the SEC and rules promulgated by the national securities exchanges.

The Dodd-Frank Act, enacted in July 2010, expands federal regulation of corporate governance matters and imposes requirements on publicly-held companies, including us, to, among other things, provide stockholders with a periodic advisory vote on executive compensation and also adds compensation committee reforms and enhanced pay-for-performance disclosures. While some provisions of the Dodd-Frank Act were effective upon enactment, others will be implemented upon the SEC’s adoption of related rules and regulations. The scope and timing of the adoption of such rules and regulations is uncertain and accordingly, the cost of compliance with the Dodd-Frank Act is also uncertain.

In addition, Sarbanes-Oxley specifically requires, among other things, that we maintain effective internal control over financial reporting and disclosure of controls and procedures. In particular, we must perform system and process evaluation and testing of our internal control over financial reporting to allow management to report on the effectiveness of our internal control over financial reporting, as required by Section 404 of Sarbanes-Oxley Act (“Section 404”), and our independent registered public accounting firm is required to attest to our internal control over financial reporting.

Our testing, or the subsequent testing by our independent registered public accounting firm may reveal deficiencies in our internal control over financial reporting that are deemed to be material weaknesses. Our compliance with Section 404 will require that we incur substantial accounting expenses and expend significant management efforts. We currently have limited internal audit capabilities and will need to hire additional accounting and financial staff with appropriate public company experience and technical accounting knowledge. Moreover, if we are not able to comply with the requirements of Section 404 in a timely manner, or if we or our independent registered public accounting firm identifies deficiencies in our internal control over financial reporting that are deemed to be material weaknesses, the market price of our stock could decline, and we could be subject to sanctions or investigations by the SEC or other regulatory authorities, which would require additional financial and management resources.

These and other new or changed laws, rules, regulations and standards are, or will be, subject to varying interpretations in many cases due to their lack of specificity. As a result, their application in practice may evolve over time as new guidance is provided by regulatory and governing bodies, which could result in continuing uncertainty regarding compliance matters and higher costs necessitated by ongoing revisions to disclosure and governance practices. Our efforts to comply with evolving laws, regulations and standards are likely to continue to result in increased general and administrative expenses and a diversion of management time and attention from revenue-generating activities to compliance activities. Further, compliance with new and existing laws, rules, regulations and standards may make it more difficult and expensive for us to maintain director and officer liability insurance, and we may be required to accept reduced coverage or incur substantially higher costs to obtain coverage. Members of our board of directors and our principal executive officer and principal financial officer could face an increased risk of personal liability in connection with the performance of their duties.advantageous terms. As a result, we may be compelled to reduce our rates or offer other incentives in order to maintain our current customers and attract new customers. If a significant number of customers are able to compel us to charge lower rates or provide rate concessions or incentives, there is no assurance that we would be able to compensate for such price reductions or conserve our profit margins.

Risks Related to our Competition

Large and established internet and technology companies, such as Google and Facebook, play a substantial role in the digital advertising market and may significantly impair our ability to operate in this industry.

Google is a substantial player in the digital advertising market along with other players such as Microsoft. In addition, a small number of social network companies, such as Facebook, account for a large portion of digital advertising budgets. The high concentration of power among Google, Facebook and some other large market participants causes us to be subject to any unilateral changes they may make with respect to advertising on their respective platforms, which may be more lucrative than alternative methods of advertising or partnerships with other publishers that are not subject to such changes. Furthermore, we could have difficulty attractinglimited ability to respond to, and retaining qualified directorsadjust for, changes implemented by large market participants.

These companies, along with other large and executive officers,established Internet and technology companies, may also leverage their power to make changes to their web browsers, operating systems, platforms, networks or other products or services in a way that impacts the entire digital advertising marketplace.

The advertising/marketing industry is highly competitive. If we cannot compete effectively in this market, our revenues are likely to decline.

We face intense competition in the marketplace. We operate in a dynamic market that is subject to rapid development and introduction of new technologies, products and solutions, changing branding objectives, evolving customer demands and industry guidelines, all of which affect our ability to remain competitive. There are a large number of companies and advertising technology companies that offer products or services similar to ours and that compete with us for finite advertising budgets. There is also a large number of niche companies that are competitive with us, as they provide a subset of the services that we provide. Some of our existing and potential competitors may be better established, benefit from greater name recognition, may offer solutions and technologies that we do not offer or that are more evolved than ours, and may have significantly more financial, technical, sales and marketing resources than we do. In addition, some competitors, particularly those with a larger and more diversified revenue base and a broader offering, may have greater flexibility than we do to compete aggressively on the basis of price and other contract terms as well as respond to market changes. Additionally, companies that do not currently compete with us in this space may change their services to be competitive if there is a revenue opportunity, and new or stronger competitors may emerge through consolidations or acquisitions. If our platform is not perceived as competitively differentiated or we fail to develop adequately to meet market evolution, we could lose customers and market share or be compelled to reduce our prices and harm our operational results.

10 

Risks Related to our Intellectual Property

If we cannot enforce and protect our intellectual property rights, our business could be adversely affected.

We rely on patents, copyright, trademark, domain name and trade secret laws in the United States and similar laws in other countries, as well as licenses and other agreements with our employees, and other parties, to establish and maintain our intellectual property rights in the technology, products and services used in our operations. These laws and agreements may not guarantee that our intellectual property rights will be protected and our intellectual property rights could be challenged or invalidated. Amendments to or interpretations of U.S. patent laws or new rulings around U.S. patent laws may adversely impact our ability to protect our new technologies, content, products and services and to defend against claims of patent infringement. In addition, such intellectual property rights may not be sufficient to permit us to take advantage of current industry trends or otherwise to provide competitive advantages, which could harmresult in costly redesign efforts, discontinuance of offerings, decreased traffic and associated revenue or otherwise adversely affect our business. We continually evaluate and monitor regulatory developments and cannot estimate the timing or magnitude of additional costs we may incur as a result.

We may needin the future be, subject to increase the sizeclaims of our organization and may experience difficulties in managing growth, if any.

At present, we are a small company. If and when the regulatory market permits and the market for blockchain and crypto-currencies stabilize, of which there can be no assurance, we expect to experience a period of expansion in infrastructure and overhead and anticipateintellectual property infringement that further expansion will be required to address potential growth and market opportunities. Future growth will impose significant added responsibilities on members of management, including the need to identify, recruit, maintain and integrate new managers. Our future financial performance and its ability to compete effectively will depend, in part, on its ability to manage any future growth effectively.

The loss of key personnel could adversely affect our business. We

Many companies (including patent holding companies) and individuals own patents, copyrights, trademarks, and trade secrets and frequently enter into litigation based on allegations of infringement or other violations of intellectual property rights. As we develop and offer our platform through various distribution channels we may experience an increase in the number of intellectual property claims against us. These claims, whether meritorious or not, may result in litigation, may be abletime-consuming and costly to hireresolve, and retain qualified personnelmay require expensive changes in our methods of doing business. These intellectual property infringement claims may require us to supportenter into royalty or licensing agreements on unfavorable terms or to incur substantial monetary liability. Additionally, these claims may result in our growth.being enjoined preliminarily or permanently from further use of certain intellectual property or may require us to cease or significantly alter certain of our operations.

The Company’s success dependsSome of our commercial agreements may require us to indemnify third parties against intellectual property infringement claims, which may require us to use substantial resources to defend against or settle such claims or, potentially, to pay damages. These third parties may also discontinue the use of our platform, as a significant extent upon the effortsresult of its CEO, and other key senior employees and other key personnel. Theinjunctions or otherwise, which could result in loss of revenues and adversely impact our business. Additionally, we may be exposed to liability or substantially increased costs if a commercial partner does not honor its contractual obligation to indemnify us for intellectual property infringement claims made by third parties or if any amounts received are not adequate to cover our liabilities or the servicescosts associated with defense of such personnelclaims. The occurrence of any of these events could adversely affect our business andbusiness.

Patent terms may be inadequate to protect our ability to implement our growth plan. We cannot assure you thatcompetitive position for an adequate amount of time.

Patents have a limited lifespan. In the servicesUnited States, if all maintenance fees are timely paid, the natural expiration of the members of our management team will continue toa patent is generally 20 years from its earliest U.S. non-provisional or international patent application filing date. Various extensions may be available, to us, or that we will be able to findbut the life of a suitable replacement for any of them. We do not have key man insurance on any members ofpatent, and the protection it affords, is limited. Even if patents covering our management team. If any member of our management team were to die and weproducts are unable to replace either or both of them for a prolonged period of time,obtained, once the patent life has expired, we may be unableopen to carry outcompetition from competitive products, including generics. As a result, our long-term business planpatent portfolio may not provide us with sufficient rights to exclude others from commercializing products similar or identical to ours.

Risks Related to Cyber and our future prospect for growth, and our business, may be harmed.Data Collection

Our success is dependent upon our ability to attract, train, manage and retain sales, marketing and other qualified personnel. There is substantial competition for qualified personnel, and an inability to recruit or retain qualified personnel may impact our ability to implement our strategy to grow our business.

If we are unable to adopt, implement and maintain equity compensation arrangements that provide sufficient incentives, we may be unable to hire and retain employees and attract qualified candidates in the future. If we are unable to hire and retain employees, including qualified technical personnel, and attract additional qualified candidates, our business and results of operations could be adversely affected.

We may not be able to successfully expandprotect our business through acquisitions.systems, technology and infrastructure from cyberattacks.

We review corporatemay be under attack by perpetrators of malicious technology-related events, such as the use of botnets, malware or other destructive or disruptive software, distributed denial of service attacks, phishing, attempts to misappropriate user information and product line acquisition candidatesother similar malicious activities. The incidence of events of this nature (or any combination thereof) is on the rise worldwide. While we continuously develop and maintain systems designed to detect and prevent events of this nature from impacting our platform, we have invested (and continue to invest) heavily in these efforts. These efforts are costly and require ongoing monitoring and updating as a parttechnologies change and efforts to overcome preventative security measures become more sophisticated.

Any event of this nature that we experience could damage our systems, technology and infrastructure, prevent us from providing our services, compromise the integrity of our growth strategy. If we decidedservices, damage our reputation and/or be costly to undertake an acquisition, we may not be ableremedy, as well as subject us to successfully integrate itinvestigations by regulatory authorities, fines and/or litigation that could result in orderliability to realize the full benefit of such acquisition. Factors which may affectthird parties.

11 

Our business depends on our ability to grow successfully through acquisitions include:collect and use data, and any limitation on the collection and use of this data could significantly diminish the value of our platform and cause us to lose customers and revenue.

inability to identify suitable targets given the relatively narrow scope of our business;
inability to obtain acquisition or additional working capital financing due to our financial condition;
difficulties and expenses in connection with integrating the acquired companies and achieving the expected benefits;
diversion of management’s attention from current operations;
the possibility that we may be adversely affected by risk factors facing the acquired companies;
acquisitions could be dilutive to earnings, or in the event of acquisitions made through the issuance of our common shares to the shareholders of the acquired company, dilutive to our existing shareholders;
potential losses resulting from undiscovered liabilities of acquired companies not covered by the indemnification we may obtain from the seller; and
loss of key employees of the acquired companies.

Our platform receives, collects, stores, processes, transfers and uses certain data about how viewers engaged with videos and helps companies to leverage that data to become a better story teller and optimize the videos. Our ability to access and utilize such data is crucial.

Our ability to either collect or use data could be restricted by new laws or regulations. We are subject to numerous federal, state, local, and international laws, directives and regulations regarding privacy, data protection, and data security and the collection, storing, sharing, use, processing, transfer, disclosure and protection of personal information and other data, the scope of which are changing, subject to differing interpretations, and may be inconsistent among jurisdictions or conflict with other legal and regulatory requirements. We are also subject to certain contractual obligations to third parties related to privacy, data protection and data security. We strive to comply with our applicable policies and applicable laws, regulations, contractual obligations and other legal obligations relating to privacy, data protection and data security to the extent possible. However, the regulatory framework for privacy, data protection and data security worldwide is, and is likely to remain for the foreseeable future, uncertain and complex, and it is possible that these or other actual or alleged obligations may be interpreted and applied in a manner that we do not anticipate or that is inconsistent from one jurisdiction to another and may conflict with other legal obligations or our practices. Further, any significant change to applicable laws, regulations or industry practices regarding the collection, use, retention, security or disclosure of data, or their interpretation, or any changes regarding the manner in which the consent of users or other data subjects for the collection, use, retention or disclosure of such data must be obtained, could increase our costs and require us to modify our services and features, possibly in a material manner, which we may be unable to integrate ViewBix Ltd.’scomplete, and may limit our ability to store and process user data or develop new services and features.

If we were found in violation of any applicable laws or regulations relating to privacy, data protection or security, our business may be materially and technology successfullyadversely affected and we would likely have to change our business practices and potentially the services and features available through our platform. In addition, these laws and regulations could impose significant costs on us and could constrain our ability to use and process data in manners that may be commercially desirable. In addition, if a breach of data security were to occur or achieveto be alleged to have occurred, if any violation of laws and regulations relating to privacy, data protection or data security were to be alleged, or if we had any actual or alleged defect in our safeguards or practices relating to privacy, data protection, or data security, our solutions may be perceived as less desirable and our business, prospects, financial condition and results of operations could be materially and adversely affected.

We also expect that there will continue to be new laws, regulations and industry standards concerning privacy, data protection and information security proposed and enacted in various jurisdictions. For example, the European Union’s (“EU”), data protection landscape is currently unstable, resulting in possible significant operational costs for internal compliance and risks to our business. The EU has adopted the General Data Protection Regulation (“GDPR”), which became effective in May 2018, and contains numerous requirements and changes from previously existing EU laws, including more robust obligations on data processors and heavier documentation requirements for data protection compliance programs by companies. Among other requirements, the GDPR regulates the transfer of personal data subject to the GDPR to third countries that have not been found to provide adequate protection to such personal data, including the United States. Failure to comply with the GDPR could result in penalties for noncompliance.

In addition to the GDPR, the European Commission has another draft regulation in the approval process that focuses on a person’s right to conduct a private life. The proposed legislation, known as the Regulation of Privacy and Electronic Communications (“ePrivacy Regulation”), would replace the current the current ePrivacy Directive. Originally planned to be adopted and implemented at the same time as the GDPR, the ePrivacy Regulation is still being negotiated.

12 

Additionally, in June 2018, California passed the California Consumer Privacy Act (“CCPA”), which provides new data privacy rights for consumers and new operational requirements for companies. Specifically, the CCPA provides that covered companies must provide new disclosures to California consumers and afford such consumers new abilities to opt-out of certain sales of personal information. The CCPA became operative January 1, 2020. The CCPA provides for civil penalties for violations, as well as a private right of action for data breaches that is expected benefitsto increase data breach litigation. We cannot fully predict the impact of such acquisition.the CCPA on our business or operations, but it may require us to modify our data practices and policies and to incur substantial costs and expenses in an effort to comply. Some observers have noted the CCPA could mark the beginning of a trend toward more stringent privacy legislation in the United States, which could increase our potential liability and adversely affect our business. Further in March 2017, the United Kingdom (“U.K.”) formally notified the European Council of its intention to leave the EU pursuant to Article 50 of the Treaty on European Union (“Brexit”). The U.K. ceased to be an EU Member State on January 31, 2020, but enacted, a Data Protection Act substantially implementing the GDPR, effective in May 2018, which was further amended to align more substantially with the GDPR following Brexit. It is unclear how U.K. data protection laws or regulations will develop in the medium to longer term and how data transfers to and from the U.K. will be regulated. In addition, some countries are considering or have enacted legislation requiring local storage and processing of data that could increase the cost and complexity of delivering our services.

As partIn addition, failure to comply with the Israeli Privacy Protection Law 1981, and its regulations as well as the guidelines of the Israeli Privacy Protection Authority, may expose us to administrative fines, civil claims (including class actions) and in certain cases criminal liability. Current pending legislation may result in a change of the current enforcement measures and sanctions.

Any failure or perceived failure by us to comply with our posted privacy policies, our privacy-related obligations to users or other third parties, or any other legal obligations or regulatory requirements relating to privacy, data protection or data security may result in governmental investigations or enforcement actions, litigation, claims or public statements against us by consumer advocacy groups or others and could result in significant liability, cause our users to lose trust in us, and otherwise materially and adversely affect our reputation and business. Furthermore, the costs of compliance with, and other burdens imposed by, the laws, regulations, other obligations and policies that are applicable to the businesses of our users may limit the adoption and use of, and reduce the overall demand for, our platform. Additionally, if third parties we work with violate applicable laws, regulations or contractual obligations, such violations may put our users’ data at risk, could result in governmental investigations or enforcement actions, fines, litigation, claims, or public statements against us by consumer advocacy groups or others and could result in significant liability, cause our users to lose trust in us and otherwise materially and adversely affect our reputation and business. Further, public scrutiny of, or complaints about, technology companies or their data handling or data protection practices, even if unrelated to our business, strategy, on February 7, 2019, we entered into a Share Exchange Agreement with Algomizer Ltd., an Israeli corporation, pursuantindustry or operations, may lead to which Algomizer will assign, transfer and deliver its 99.83% holdings in Viewbix Ltd., an Israeli corporation, to us in exchange for sharesincreased scrutiny of restricted common stock as further detailed in “Item 1. Description of Business” above. The Share Exchange Agreement is subject to certain closing conditionstechnology companies, including us, filing an amendmentand may cause government agencies to enact additional regulatory requirements, or to modify their enforcement or investigation activities, which may increase our certificate of incorporation to change the Company’s name to ViewBix Inc., effecting a reverse split of our shares of common stock at a ratio of 1:15, conversion of our outstanding convertible notes into shares of restricted common stockcosts and Algomizer obtaining a tax pre-ruling from the Israeli Tax Authority relating to the Share Exchange Agreement. If these conditions are not satisfied or waived, the acquisition will not be consummated. There can be no assurance that we will complete the acquisition on the time frame that we anticipate or under the terms set forth in the Share Exchange Agreement, or at all. Failure to complete the acquisition of ViewBix Ltd. or any delays in completing the acquisition could have an adverse impact on our future business and operations. In addition, we will have incurred significant acquisition-related expenses without realizing the expected benefits.risks.

In addition, even if the acquisition of ViewBix Ltd. under the Share Exchange Agreement is consummated, we may encounter difficulties integrating the business, technology, products, personnel or operations of ViewBix Ltd., particularly if the key personnel of ViewBix Ltd. choose not to work for us or we have difficulty retaining the customers or partners of ViewBix Ltd. due to changes in management or otherwise. Moreover, the anticipated benefits of the acquisition of ViewBix Ltd. may not be realized or we may be exposed to unknown liabilities.

Risks Related to Our Common Stock

Shares of Common Stock issuable upon the conversion of warrants may substantially increase the number of Sharesshares of Common Stock available for sale in the public market and depress the price of our stock.Common Stock.

As of December 31, 2018,2021, we had outstanding: (i) Class FJ Warrants exercisable to purchase 27,697,855 Shares,3,649,318 shares of Common Stock at an exercise price of $0.28$0.48 per Share.;share of Common Stock; and (ii) Class GK Warrants exercisable to purchase 27,697,855 Shares,3,649,318 shares of Common Stock, at an exercise price of $0.14$0.80 per Share; (iii) Class H Warrants exercisable to purchase 1,321,429 Shares, at an exercise priceshare of $0.14 per Share; and (iv) Class I Warrants exercisable to purchase 571,429 Shares, at an exercise price of $0.14 per Share .Common Stock.

In addition, upon the closing of the Share Exchange Agreement, of which there can be no assurance, we will issue to Algomizer: (i) warrants to purchase shares of restricted common stock with an exercise price representing a valuation for the Company of $15,000,000 on Fully Diluted Share Capital basis, which will represent 10% of the Fully Diluted Share Capital immediately following the closing, which warrants will be exercisable for a period of ten years, and (ii) warrants to purchase shares of restricted common stock with an exercise price representing a valuation for the Company of $25,000,000 on Fully Diluted Share Capital basis, which will represent 10% of the Fully Diluted Share Capital immediately following the closing, which latter warrants will be exercisable for a period of ten years.

To the extent any of these Warrantswarrants are exercised and any additional warrants are grantedissued and subsequently exercised, there will be further dilution to our stockholders. Until the warrants expire, these warrant holders will have an opportunity to profit from any increase in the market price of our SharesCommon Stock without assuming the risks of ownership. Holders of options and warrants may exercise these securities at a time when we could obtain additional capital on terms more favorable.

The exercise price of the warrants will dilute the voting interest of the owners of presently outstanding shares of Common Stock by adding a substantial number of additional Sharesshares of our Common Stock. We have reserved Sharesshares of Common Stock for issuance upon the exercise of the warrants and may increase the Sharesshares reserved for these purposes in the future.

The Sharesshares of our Common Stock, which are issuable upon the exercise of any outstanding warrants may be sold in the public market pursuant to Rule 144, if applicable. The sale of our common stockCommon Stock issued or issuable upon the exercise of the warrants and options described above, or the perception that such sales could occur, may adversely affect the market price of our common stock.Common Stock. 

 

13 

Our Planned Reverse Split may not result in a proportional increase in the per share price of our Common Stock.

We intend to effect the Planned Reverse Split with the primary intent of increasing the price of our Common Stock in order to meet the initial listing requirements of the Nasdaq Capital Market. The effect of the Planned Reverse Split on the market price for our Common Stock cannot be accurately predicted. In particular, we cannot assure you that the proportionate increase in the price of our common stock immediately after the Planned Reverse Split from the price for shares of our Common Stock immediately before the Planned Reverse Split will be maintained for us to meet the initial listing requirements of the Nasdaq Capital Market or that the such market prices will be maintained for a substantial period of time. It is not uncommon for the market price of a company’s common stock to decline in the period following a reverse stock split. If the market price of our Common Stock declines following the Planned Reverse Split, the percentage decline may be greater than would occur in the absence of the Planned Reverse Split. The market price of our Common Stock may also be affected by other factors which may be unrelated to the Planned Reverse Split or the number of shares outstanding.

Moreover, because some investors may view the Planned Reverse Split negatively, we cannot assure you that the Planned Reverse Split will not adversely impact the market price of our Common Stock. Accordingly, our total market capitalization after the Planned Reverse Split may be lower than the market capitalization before the Planned Reverse Split.

We are subject to compliance with securities law, which exposes us to potential liabilities, including potential rescission rights.

We have offered and sold restricted shares ofour Common Stock and other restricted securities to investors pursuant to certain exemptions from the registration requirements of the Securities Act of 1933, as amended (the “Act”), as well as those of various state securities laws, including the exemptions provided under Regulation S and Regulation D promulgated by the SEC under the Act.laws. The basis for relying on such exemptions is factual; that is, the applicability of such exemptions depends upon our conduct and that of those persons contacting prospective investors and making the offering. We have not received a legal opinion to the effect that any of our prior offerings were exempt from registration under any federal or state law. Instead, we have relied upon the operative facts as the basis for such exemptions, including information provided by investors themselves.

If any prior offering did not qualify for such exemption, an investor would have the right to rescind its purchase of the securities if it so desired. It is possible that if an investor should seek rescission, such investor would succeed. A similar situation prevails under state law in those states where the securities may be offered without registration in reliance on the partial preemption from the registration or qualification provisions of such state statutes. If investors were successful in seeking rescission, we would face severe financial demands that could adversely affect our business and operations. Additionally, if we did not in fact qualify for the exemptions upon which it has relied, we may become subject to significant fines and penalties imposed by the SECU.S. Securities and Exchange Commission (the “SEC”) and state securities agencies.

The availability of a large number of authorized but unissued shares of Common Stock may, upon their issuance, lead to dilution of existing stockholders.

We are authorized to issue 490,000,000 shares of Common Stock, $0.0001 par value per share, of which, as of March 28, 2019, 110,749,643December 31, 2021, 34,753,669 shares of Common Stock were outstanding. Additional shares of Common Stock may be issued by our board of directors without further stockholder approval. The issuance of large numbers of shares, possibly at below market prices, is likely to result in substantial dilution to the interests of other stockholders. In addition, issuances of large numbers of shares of Common Stock may adversely affect the market price of our Common Stock. Reference is made to the disclosure under Item 1 “Description of Business” and under the subcaption “Recent Development” with respect to the issuance of shares: (i) on the conversion of convertible notes; (ii) representing 65% of the issued and outstanding share capital of the Company on a fully diluted basis on the closing date of the Share Exchange Agreement; and (iii) of up to 5,000,000 restricted shares of the Company’s common stock, as well as the issuance of Class T cashless warrants to purchase up to 3,000,000 restricted shares of the Company’s common stock, exercisable within 36 months at an exercise price of $0.01 per restricted shares, as compensation for services rendered by directors, employees and consultants. Such restricted shares and warrants shall be allocated among the relevant existing personnel at the discretion of the Company’s chief executive officer and chief financial officer. As of the date of this Form 10-K, no restricted shares nor Class T warrants were issued by the Company.

Our Certificate of Incorporation authorizes 10,000,000 shares of preferred stock, $0.0001 par value $0.0001 per share of which none were issued and outstanding as of the date of this registration statement.December 31, 2021. The board of directors is authorized to provide for the issuance of these unissued shares of preferred stock in one or more series, and to fix the number of shares and to determine the rights, preferences and privileges thereof. Accordingly, the board of directors may issue preferred stock which may convert into large numbers of shares of Common Stockcommon stock and consequently lead to further dilution of other shareholders.stockholders.

14 

We have never paid cash dividends and do not anticipate doing so in the foreseeable future.

We have never declared or paid cash dividends on our common shares.Common Shares. We currently plan to retain any earnings to finance the growth of our business rather than to pay cash dividends. Payments of any cash dividends in the future will depend on our financial condition, results of operations and capital requirements, as well as other factors deemed relevant by our board of directors.

Our Common Stock is subject to the “Penny Stock” rules of the SEC and the trading market in our stock is limited, which makes transactions in our stock cumbersome and may reduce the value of an investment.

The Securities and Exchange CommissionSEC has adopted Rule 15g-9 which establishes the definition of a “penny stock,” for the purposes relevant to us, as any equity security that has a market price of less than $5.00 per share or with an exercise price of less than $5.00 per share, subject to certain exceptions. For any transaction involving a penny stock, unless exempt, the rules require:

That a broker or dealer approve a person’s account for transactions in penny stocks; and
The broker or dealer receives from the investor a written agreement to the transaction, setting forth the identity and quantity of the penny stock to be purchased.

In order to approve a person’s account for transactions in penny stocks, the broker or dealer must:

Obtain financial information and investment experience objectives of the person; and
Make a reasonable determination that the transactions in penny stocks are suitable for that person and the person has sufficient knowledge and experience in financial matters to be capable of evaluating the risks of transactions in penny stocks.

The broker or dealer must also deliver, prior to any transaction in a penny stock, a disclosure schedule prescribed by the CommissionSEC relating to the penny stock market, which, in highlight form:

Sets forth the basis on which the broker or dealer made the suitability determination; and
That the broker or dealer received a signed, written agreement from the investor prior to the transaction.

Generally, brokers may be less willing to execute transactions in securities subject to the “penny stock” rules. This may make it more difficult for investors to dispose of our Common Stock and cause a decline in the market value of our stock.Common Stock.

Disclosure also has to be made about the risks of investing in penny stocks in both public offerings and in secondary trading and about the commissions payable to both the broker-dealer and the registered representative, current quotations for the securities and the rights and remedies available to an investor in cases of fraud in penny stock transactions. Finally, monthly statements have to be sent disclosing recent price information for the penny stock held in the account and information on the limited market in penny stocks.

Financial Industry Regulatory Authority, Inc. (“FINRA”) sales practice requirements may limit a shareholder’s ability to buy and sellSince our Common Stock.

In addition to the “penny stock” rules described above, FINRA has adopted rules that require that in recommending an investment to a customer, a broker-dealer must have reasonable grounds for believing that the investment is suitable for that customer. Prior to recommending speculative low-priced securities to their non-institutional customers, broker-dealers must make reasonable efforts to obtain information about the customer’s financial status, tax status, investment objectives and other information. Under interpretations of these rules, FINRA believes that there is a high probability that speculative low-priced securities will not be suitable for at least some customers. FINRA requirements make it more difficult for broker-dealers to recommend that their customers buy our Common Stock which may limit your ability to buy and sell our stock and have an adverse effect on the market for our shares.

Our stock is thinly traded, sale of your holding may take a considerable amount of time.

The shares of our Common Stock are thinly-traded on the OTCQB Market, meaning that the number of persons interested in purchasing our Common Stock at or near bid prices at any given time may be relatively small or non-existent. As a consequence, there may be periods of several days or more when trading activity in our shares is minimal or non-existent, as compared to a seasoned issuer which has a large and steady volume of trading activity that will generally support continuous sales without an adverse effect on share price. We cannot give you any assurance that a broader or more active public trading market for our Common Stock will develop or be sustained, or that current trading levels will be sustained. Due to these conditions, we can give you no assurance that you will be able to sell your shares at or near bid prices or at all if you need money or otherwise desire to liquidate your shares.

15 

 

Shares of Common Stock eligible for future sale may adversely affect the market.

From time to time, certain of our stockholders may be eligible to sell all or some of their shares of Common Stock by means of ordinary brokerage transactions in the open market pursuant to Rule 144 promulgated under the Securities Act, subject to certain limitations. In general, pursuant to amended Rule 144, non-affiliate stockholders may sell freely after six months, subject only to the current public information requirement. Affiliates may sell after six months, subject to the Rule 144 volume, manner of sale (for equity securities), current public information and notice requirements. Any substantial sales of our Common Stockcommon stock pursuant to Rule 144 may have a material adverse effect on the market price of our Common Stock. Reference is made to the disclosure under the Risk Factor “The availability of a large number of authorized but unissued shares of Common Stock may, upon their issuance, lead to dilution of existing stockholders” above.

If we fail to maintain effective internal controls over financial reporting, the price of our Common Stock may be adversely affected.

We identified a material weakness in our period and our financial reporting process. Our internal control over financial reporting may have material weaknesses and conditions that could require correction or remediation, the disclosure of which may have an adverse impact on the price of our Common Stock. We are required to establish and maintain appropriate internal controls over financial reporting. Failure to establish those controls, or any failure of those controls once established, could adversely affect our public disclosures regarding our business, prospects, financial condition or results of operations. In addition, management’s assessment of internal controls over financial reporting may identify material weaknesses and conditions that need to be addressed in our internal controls over financial reporting or other matters that may raise concerns for investors. Any actual or perceived weaknesses and conditions that need to be addressed in our internal control over financial reporting or disclosure of management’s assessment of our internal controls over financial reporting may have an adverse impact on the price of our Common Stock.

We are required to comply with certain provisions of Section 404 of the Sarbanes-Oxley Act of 2002 and if we fail to comply in a timely manner, our business could be harmed and our stock price could decline.

Rules adopted by the SEC pursuant to Section 404 of the Sarbanes-Oxley Act of 2002 require an annual assessment of internal controls over financial reporting, and for certain issuers an attestation of this assessment by the issuer’s independent registered public accounting firm. The standards that must be met for management to assess the internal controls over financial reporting as effective are evolving and complex, and require significant documentation, testing, and possible remediation to meet the detailed standards.

We expect to incur expenses and to devote resources to Section 404 compliance on an ongoing basis. It is difficult for us to predict how long it will take or costly it will be to complete the assessment of the effectiveness of our internal control over financial reporting for each year and to remediate any deficiencies in our internal control over financial reporting. As a result, we may not be able to complete the assessment and remediation process on a timely basis. In addition, although attestation requirements by our independent registered public accounting firm are not presently applicable to us, we could become subject to these requirements in the future and we may encounter problems or delays in completing the implementation of any resulting changes to internal controls over financial reporting. In the event that our Chief Executive Officer orand Chief Financial Officer, determinewhich currently is the same individual, determines that our internal control over financial reporting is not effective as defined under Section 404, we cannot predict how the market prices of our shares of Common Stock will be affected; however, we believe that there is a risk that investor confidence and share value may be negatively affected.

Our share price could be volatile, and our trading volume may fluctuate substantially.

The price of our common shares has been and may in the future continue to be extremely volatile, with the sale price fluctuating from a low of $0.1 to a high of $2.24 since 2012. Many factors could have a significant impact on the future price of our common shares, including:

our inability to raise additional capital to fund our operations;
our failure to successfully implement our business objectives and strategic growth plans;
compliance with ongoing regulatory requirements;
market acceptance of our product;
changes in government regulations;
general economic conditions and other external factors; and
actual or anticipated fluctuations in our quarterly financial and operating results; and the degree of trading liquidity in our common shares.

Our annual and quarterly results may fluctuate, which may cause substantial fluctuations in our common stockCommon Stock price.

Our annual and quarterly operating results may in the future fluctuate significantly depending on factors including the timing of purchase orders, new product releases by us and other companies, gain or loss of significant customers, price discounting of our product, the timing of expenditures, product delivery requirements and economic conditions. Revenues related to our product are required to be recognized upon satisfaction of all applicable revenue recognition criteria. The recognition of revenues from our product is dependent on a number of factors, including, but not limited to, the terms of any license agreement and the timing of implementation of our products by our customers.

16 

Any unfavorable change in these or other factors could have a material adverse effect on our operating results for a particular quarter or year, which may cause downward pressure on our common stock price. We expect quarterly and annual fluctuations to continue for the foreseeable future.

Delaware law contains provisions that could discourage, delay or prevent a change in control of our company, prevent attempts to replace or remove current management and reduce the market price of our stock.

Provisions in our certificate of incorporation and bylaws may discourage, delay or prevent a merger or acquisition involving us that our stockholders may consider favorable. For example, our certificate of incorporation authorizes our board of directors to issue up to ten million shares of “blank check” preferred stock. As a result, without further stockholder approval, the board of directors has the authority to attach special rights, including voting and dividend rights, to this preferred stock. With these rights, preferred stockholders could make it more difficult for a third party to acquire us.

We are also subject to the anti-takeover provisions of the DGCL.Delaware General Corporation Law (the “DGCL”). Under these provisions, if anyone becomes an “interested stockholder,” we may not enter into a “business combination” with that person for three years without special approval, which could discourage a third party from making a takeover offer and could delay or prevent a change in control of us. An “interested stockholder” is, generally, a stockholder who owns 15% or more of our outstanding voting stock or an affiliate of ours who has owned 15% or more of our outstanding voting stock during the past three years, subject to certain exceptions as described in the DGCL.

Risks Related to our Operations in Israel

Political, economic and military instability in Israel may impede our ability to operate and harm our financial results.

Our offices and management team are located in the Tel-Aviv metropolitan area, Israel. Accordingly, political, economic, and military conditions in Israel and the surrounding region may directly affect our business and operations. In recent years, Israel has been engaged in sporadic armed conflicts with Hamas, an Islamist terrorist group that controls the Gaza Strip, with Hezbollah, an Islamist terrorist group that controls large portions of southern Lebanon, and with Iranian-backed military forces in Syria. In addition, Iran has threatened to attack Israel and may be developing nuclear weapons. Some of these hostilities were accompanied by missiles being fired from the Gaza Strip against civilian targets in various parts of Israel, including areas in which our employees and some of our consultants are located, and negatively affected business conditions in Israel. Any hostilities involving Israel or the interruption or curtailment of trade between Israel and its trading partners could adversely affect our operations and results of operations Our commercial insurance does not cover losses that may occur as a result of events associated with war and terrorism. Although the Israeli government currently covers the reinstatement value of direct damages that are caused by terrorist attacks or acts of war, we cannot assure you that this government coverage will be maintained or that it will sufficiently cover our potential damages. Any losses or damages incurred by us could have a material adverse effect on our business. Any armed conflicts or political instability in the region would likely negatively affect business conditions and could harm our results of operations.

Further, in the past, the State of Israel and Israeli companies have been subjected to economic boycotts. Several countries still restrict business with the State of Israel and with Israeli companies. These restrictive laws and policies may have an adverse impact on our operating results, financial condition or the expansion of our business. A campaign of boycotts, divestment and sanctions has been undertaken against Israel, which could also adversely impact our business.

In addition, many Israeli citizens are obligated to perform several days, and in some cases more, of annual military reserve duty each year until they reach the age of 40 (or older, for reservists who are military officers or who have certain occupations) and, in the event of a military conflict, may be called to active duty. In response to increases in terrorist activity, there have been periods of significant call-ups of military reservists. It is possible that there will be military reserve duty call-ups in the future. Our operations could be disrupted by such call-ups, which may include the call-up of members of our management. Such disruption could materially adversely affect our business, prospects, financial condition and results of operations.

17 

Exchange rate fluctuations between foreign currencies and the U.S. Dollar may negatively affect our earnings.

Our reporting and functional currency is the U.S. dollar. Our revenues are currently primarily payable in U.S. dollars and we expect our future revenues to be denominated primarily in U.S. dollars and Euros. However, certain amount of our expenses are in NIS and as a result, we are exposed to the currency fluctuation risks relating to the recording of our expenses in U.S. dollars. We may, in the future, decide to enter into currency hedging transactions. These measures, however, may not adequately protect us from material adverse effects.

ITEM 1B. UNRESOLVED STAFF COMMENTS

None.

ITEM 2. PROPERTIES

After the year-ended December 31, 2018: (i) the Registrant’s subsidiary, Virtual Crypto IL, leased offices facilities from an unaffiliated third-party at 10 Ha’amal Street, Rosh Ha’ayin, Israel 4809234 consisting of approximately 50 square feet of office space, for $800 per month. The Registrant believes that its present facilities are sufficient for the foreseeable future.None.

ITEM 3. LEGAL PROCEEDING

We are currently not involved in any litigation that we believe could have a material adverse effect on our financial condition or results of operations, except as set forth below. There is no action, suit, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the executive officers of the Company, threatened against or affecting the Company, our Common Stock, our officers or directors in their capacities as such, in which an adverse decision could have a material adverse effect, other than as set forth below.

In AprilJune 2017, a lawsuit was filed with the Regional Labor Court in Tel Aviv court by Mr. Wayn(the “Tel Aviv Court”) against Emerald Israel, and other defendants, claiming certain damages toin the total amount of $100,000,approximately $225,000, under the assertion of wrongful dismissaltermination by the Registrant and Emerald IL. The Registrant believes these claims to be unsubstantiated and wholly without merit and intends to defend itself against these claims. The Company believes that he will not be successful in his claim. Nevertheless, the outcome of the proceeding will not materially affect the Registrant.

In December 2017, a liquidation request wasIsrael. We filed our response with the Tel Aviv District Court in October of 2017. The dispute was initially heard by the Tel Aviv Court on February 13, 2020. In a groupsupplemental hearing on February 11, 2021, the plaintiff provided a certified confirmation of former employeespayment of Emerald IL, underapproximately $14,668 by the assertionNational Insurance Institute of delayIsrael for one month’s prior notice of paytermination, redemption of 16.8 days of vacation and insolvency.severance pay. On December 20, 2017, at a hearing beforeJune 3, 2021, and after the court, it was ordered that the Emerald IL shall settle its pension debts to the former employees under applicable Israeli law within 21 days and settle its other debts to them in 60 days, the failure of which would result in a winding-up order (the equivalent of a liquidation) could be given. Based on the collaboration of Emerald IL and its former employeesplaintiff and the fact thatdefendants filed their summaries, the Companylawsuit against Emerald Israel was in negotiation with third-parties for the infusion of equity capital and has started negotiating the sale of certain assets, the Company’s legal advisors believe that the liquidation claim will be dismissed by the court. The amounts being claimed by the former employees was less than $96,000 and are included in current liabilities at December 31, 2018.dismissed.

On January 29, 2018, the “Registrant”) transferred the ordinary shares of the Registrant’s former Israeli subsidiary, Emerald IL to Attorney Eviatar Knoller, Esq., with offices at20 Lincoln, Tel Aviv-Jaffa 6713412, as trustee (the “Trustee”). The purpose of the transfer of the management shares to the Trustee, pursuant to resolution of the Registrant’s Board of Directors, was to enable the Trustee to liquidate the management shares and/or the assets of Emerald IL to satisfy its debtsand satisfy its financial obligations to former employees. As a result, the former employees of Emerald IL commenced an action in a court of competent jurisdiction in Israel to liquidate Emerald IL and use any assets to satisfy the debts owed to the former employees.

ITEM 4. MINE SAFETY DISCLOSURES

None.

16

PART II

ITEM 5. MARKET FOR REGISTRANT’S COMMON STOCK, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASE OF EQUITY

Market Information

Our common stockCommon Stock is currently quoted on the OTCQB market under the symbol VCRP. ForVBIX. We plan to effect the periods indicated, the following table sets forth the highPlanned Reverse Split, and, low bid pricesaccordingly, share amounts, per share data, share prices, exercise prices or conversion rates in this annual report on Form 10-K are subject to change following the effectiveness of the Planned Reverse Split. The Planned Reverse Split will not change the authorized number of shares or the par value of our common stock. The below prices represent inter-dealer quotations without retail markup, markdown, or commission and may not necessarily represent actual transactions.

  Fiscal 2018  Fiscal 2017  Fiscal 2016 
  High  Low  High  Low  High  Low 
First Quarter ended March 31 $0.38  $0.04  $0.51  $0.07  $1.75  $0.55 
Second Quarter ended June 30 $0.24  $0.15  $0.28  $0.04  $0.77  $0.55 
Third Quarter ended September 30 $0.2  $0.05  $0.07  $0.01  $0.74  $0.30 
Fourth Quarter ended December 31 $0.08  $0.03  $0.07  $0.02  $0.40  $0.16 
18 

Holders of Common Stock

As of December 31, 2021, there were approximately 2,692 stockholders of record of our Common Stock and 34,753,669 shares of our Common Stock outstanding.

Our transfer agent is Transfer Online, 512 SE Salmon Street, Portland, OR 97214-3444, Phone: (503) 227-2950.

Dividends

Holders of common stockCommon Stock are entitled to dividends if declared by the Boardour board of Directors,directors, out of funds legally available therefore. We have never declared cash dividends on our common stockCommon Stock and our Boardboard of Directorsdirectors does not anticipate paying cash dividends in the foreseeable future as it intends to retain future earnings to finance the growth of our businesses.

Rule 144 Shares

As of the date of this Registration Statement, we do not have any significant number of shares of our Common Stock that are currently available for sale to the public in accordance with the volume and trading limitations of Rule 144.

Outstanding Warrants

As described in Note 3. Convertible Nots, the Company’s 6,334,626 Class A Warrants and 5,400,478 Class B Warrants were cancelled during the first quarter of 2018, in connection with the change in terms of the convertible notes.

As described above in this Note 4. Stockholders’ Equity, the Company issued 27,697,855 Class F and 27,697,855, Class G Warrants in connection with the $0.07 Unit Offering.

On January 26, 2018, the Company signed a two-year consulting agreement with Maz Partners, pursuant to which it will to provide investment and corporate finance advice to the Company in consideration for 200,000 Class H Warrants. Each Class H Warrant is exercisable through to January 2020 to purchase one (1) Share at an exercise price of $0.14 per Share. The fair value of these Class H Warrants at the issuance date was $39,845 and was charged to General and administration expenses in the Statement of Comprehensive Loss with a corresponding credit to Additional Paid-in Capital in the Statement of Changes in Stockholders’ Deficit.

The following table summarizes information of outstanding warrants as of December 31, 2018:2021:

  Warrants  Warrant Term Exercise Price  Exercisable 
            
Class J Warrants  3,649,318  July 2029 $0.48   3,649,318 
Class K Warrants  3,649,318  July 2029 $0.80   3,649,318 

  Warrants  Warrant Term Exercise Price  Exercisable 
Investors – Class F Warrants  27,697,855  January 2019 -April 2019 $0.14   27,697,855 
Investors – Class G Warrants  27,697,855  January 2019 -April 2019 $0.28   27,697,855 
Investors - Class H Warrants  1,321,429  January 2019 -March 2020 $0.14   1,321,429 
Investors - Class I Warrants  571,429  January 2020 $0.14   571,429 

In connection with the Share Exchange Agreement, upon the earlier of: (a) the launch of a live video product to an American consumer in the United States by Viewbix Israel, or (b) the launch of an interactive television product to an American consumer in the United States by Viewbix Israel, we will issue to Gix Internet an additional 1,642,193 shares of restricted Common Stock of the Company.

Securities Authorized for Issuance Under Equity Compensation Plans

The following table summarizes information of outstanding options as of December 31, 2018:2021:

  Number of securities to be issued upon exercise of outstanding options, warrants and rights  

Weighted-

average exercise price of outstanding options, warrants and rights

  

Number of securities remaining

available for

future issuance

 
Plan Category            
Equity compensation plans approved by security holders 2014 Equity Incentive Plan  5,076,483  $       0.2         - 

Sale of Unregistered Securities

During the last three years, the Registrant issued the following restricted shares which were not registered under the Act

Sale of Unregistered Securities in 2016:

Name of Issuee DateNumber of Issuance
securities to be
issued upon
exercise of
outstanding
options, warrants
and rights
Weighted-average exercise price of outstanding
options, warrants
and rights
  Number of Shares
securities
remaining
available for future
issuance
 ConsiderationBases for Issuance
Yair Fudim02/18/2016482,000Valued at $0.9995 per shareServices
Estery Giloz Ran02/18/2016482,000Valued at $0.9995 per shareServices
Baruch Kfir02/18/2016231,000Valued at $0.9995 per shareServices
Legend Securities Inc03/17/201650,000Valued at $0.65per shareServices
JFS Investments PR LLC01/26/2016125,000Valued at $1.75 per shareServices
Garden state securities Inc05/04/2016150,000Valued at $0.70 per shareServices
JFS Investments PR LLC05/10/201641,667Valued at $0.71 per shareServices
Kodiak Capital Group LLC05/18/2016150,000Valued at $0.68 per shareServices
Alpha Capital Anstalt06/26/2016125,000Valued at $0.70 per shareServices
Legend Securities Inc06/28/201650,000Valued at $0.70 per shareServices
JFS Investments PR LLC06/30/2016333,333Valued at $0.68 per shareServices
VAR Growth Corporation07/01/2016300,000Valued at $0.71 per shareServices
David Treves07/27/20166,767Valued at $0.53 per shareServices
Firstfire Global Opportunities Fund LLC08/04/201631,250Valued at $0.49 per shareServices
Guy Shalom10/11/2016119,000$0.40 per shareInvestment
Total Shares IssuedPlan Category     2,677,017       
Equity compensation plans approved by security holders 2017 Employee Incentive Plan               -               -133,333

During 2016,

Recent Sales of Unregistered Securities

On December 18, 2020, we entered into a Stock Subscription Agreement (the “Subscription”) with certain investors (the “Investors”) in connection with the Registrant issued Class A Warrantssale and Class B Unit Warrantsissuance of an aggregate of 3,000,000 shares of Common Stock, at a purchase price of US$0.01 per share, and for an aggregate purchase price of US$30,000. In addition, and on the same date, we entered into a Loan Agreement (the “Loan Agreement”) with the Investors, pursuant to which the Investors lent an aggregate of $69,000 (the “Principal Amount”). In accordance with the terms of the Loan Agreement, we repaid the interest on the Principal Amount (8% compounded annually) to the following entities for bona fide servicesInvestors in the form of an issuance of an aggregate of 552,000 shares of Common Stock, at a price per share of $0.01. The shares of Common Stock were issued to the Registrant. The issuances of these Warrants were in consideration for convertible note payable and was made without registration under the Act in reliance upon the exemptions provided in Section 4(2) of the Act and Reg S.

Name of Subscriber Bases for Issuance Date of Issuance  Price Per Unit  

Class A Warrant

Issued

  

Class B Warrant

Issued

 
Ilan Malca Subscription Agreement  05/24/2016  $0.40   100,000   - 
Alpha Capital Anstalt Subscription Agreement  05/30/2016  $0.40   1,000,000   1,000,000 
Maz Partners LP Subscription Agreement  03/31/2016  $0.40   200,000   - 
Chi Squared Capital Inc Subscription Agreement  05/30/2016  $0.40   100,000   100,000 
Firstfire Global Opportunities Fund LLC Subscription Agreement  07/07/2016  $0.40   250,000   250,000 
Guy Shalom Investment Agreement  10/11/2016  $0.40   119,000   - 
Total Warrants Issued            1,769,000   1,350,000 

Sale of Unregistered Securities in 2017:

On February 24, 2017, Publicis Groupe 90 (“Publicis 90”) invested 500,000 Euros or approximately U$526,000 and the Registrant accepted a RegInvestors pursuant to Regulation S Subscription Agreement from Publicis 90 in consideration for the issuance to Publicis 90 of 1,315,563 restricted shares of the Registrant’s common stock at a subscription price of $0.40 per share. The issuance was made in reliance upon the exemptions provided in Section 4(2) of the Securities Act of 1933, as amended (the “Act”) and Regulation S promulgated byamended. In January 2022, the SEC underInvestors expressed their intention to convert the Act.

On April 25, 2017, a holder of a convertible note in the principal amount of $100,000 converted $10,400 into 74,572, shares based on an adjusted conversion price of $0.14. The conversion price was adjusted on March 22, 2017 pursuant to the provisionsremaining sum of the 2016 Secured Convertible Note Agreement.

On June 12, 2017, certain warrant holders holding 1,100,000 Class A Warrants and 1,100,000 Class B Warrants, electedPrincipal Amount to exercise certain warrants on a cashless basis. In accordance with the 2016 Secured Convertible Note Agreement the Class A warrants and Class B warrants were increased to 5,665,626 each, based on an adjusted share price of $0.14 per share and 3,451,490 Class B Warrants were converted to 1,096,395 shares at $0.14 per share. The exercise price and number of shares issued were adjusted on March 22, 2017.

On June 12, 2017, the Company completed the issuance of 125,000 shares of our Common Stock and accordingly, we agreed to extend the Company’s common stock to Alpha Anstalt Capital (“Alpha”) pursuant to the Company’s agreement with Alpha in the prior year.repayment date.

In July and August 2017, the Company issued 571,429 units to two accredited investors for $0.14 per unit in total amount of $80,000. Each unit consist (i) 571,429 restricted shares at a price of $0.14 per share, (ii) 571,429 warrants exercisable for a one-year period in exercise price of $0.14, and (iii) 571,429 warrants exercisable for a two-year. As of December 31, 2017, the Company had not issued the shares to the accredited investors.

Sale of Unregistered Securities in 2018:

During the first quarter of 2018, the Company received the aggregate amount of $1,940,950 from certain “accredited investors” in consideration for the issuance of 27,697,855 of the Company’s units at an offering price of $0.07 per Unit, defined as the “$0.07 Unit Offering” discussed above, each consisting of: (i) one Share; (ii) one Class F Warrant exercisable for a period of twelve months to purchase one additional Share at an exercise price of $0.14 per Share; and (iii) one Class G Warrant exercisable for a period of twelve months to purchase one additional Share at an exercise price of $0.28 per Share. The offer and sale of these Units, without registration under the Securities Act of 1933, as amended (the “Act”), was made in reliance upon the exemption provided by Section 4(2) of the Act and/or Regulation S and Regulation D promulgated thereunder.

On February 8, 2018, in connection with the August 2017 Unit Offering discussed above, the Company issued 571,429 units of the Company’s securities to two accredited investors for consideration of $80,000 which was received in August 2017. Each Unit in the August 2017 Unit financing consisted of: (i) one Share; (ii) one Class H Warrant exercisable for twelve months to purchase one additional Share at a price of $0.14 per Share; and (iii) one Class I Warrant exercisable for twenty-four months to purchase one additional Share at a price of $0.14 per Share.

On March 12, 2018, the Company issued a total of 3,629,999 restricted Shares to certain consultants in consideration for services rendered during the first quarter of 2018, which Shares were valued at $892,300, based on the closing share price on the day prior to the date of issuance. The above-mentioned amount was recorded as a charge to the Company’s Statement of Comprehensive Loss, with a corresponding credit to Additional Paid in Capital in the Company’s Statement of Changes in Stockholders’ Equity.

On March 20, 2018, the Company issued a total of 62,500 restricted Shares pursuant to the exercise of a stock option at an exercise price of $0.01 per Share, which option was granted in connection of certain services rendered in October 2016.

On March 9, 2018, the Company signed a consulting agreement with Ayin, Nun, Chaf, Yeuzt Ltd, pursuant to which it will to provide professional legal advice to the Company in consideration for 550,000 Class H Warrants. Each Class H Warrant is exercisable through to March 2020 to purchase one (1) Share at an exercise price of $0.14 per Share.

On April 20, 2018, the Company issued a total of 700,000 restricted Shares to certain consultants in connection with services rendered during the second quarter of 2018, which Shares were valued at $112,000, based on the closing share price on the day prior to the date of issuance. The above-mentioned amount was recorded as a charge to the Company’s Statements of Operations and Comprehensive Loss, with a corresponding credit to Additional Paid in Capital in the Company’s Statement of Changes in Stockholders’ Deficit.

During the year ended December 31, 2018 the Company issued a total of 54,621,800 Shares in connection with the conversion of convertible note in amount of $546,218.

19 

ITEM 6. SELECTED FINANCIAL DATA

None.Not required for smaller reporting companies.

ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITIONS AND PLAN OF OPERATION

Overview

The following plan of operation provides information which management believes is relevant to an assessment and understanding of our results of operations and financial condition. The discussion should be read along with our consolidated financial statements and notes thereto. This section includes a number of forward-looking statements that reflect our current views with respect to future events and financial performance. Forward-looking statements are often identified by words like believe, expect, estimate, anticipate, intend, project and similar expressions, or words which refer to future events. These forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from our predictions.

PlanOrganizational Background

The Registrant was incorporated in the State of Operations

Ohio in 1989 under a predecessor name, Zaxis International, Inc. On January 23, 2018,August 25, 1995, Zaxis International, Inc. merged with a subsidiary of The InFerGene Company, a Delaware corporation, which entity changed its name to Zaxis International, Inc. and the Registrant, through its newly organized, wholly-owned Israeli subsidiary, Virtual Crypto Technologies Ltd. (the “Subsidiary” or “Virtual Crypto Israel”),Company was reincorporated in Delaware under the name of Zaxis International, Inc. On December 30, 2014, Zaxis entered into a binding term sheet (the “Term Sheet”)an agreement with Chiron RefineriesEmerald Medical Applications Ltd. (“Chiron”), a publicprivate limited liability company listed on the Tel-Aviv Stock Exchange (TASE: CHR). Pursuant to the Term Sheet, the Registrant’s Subsidiary agreed to: (i) appoint a wholly-owned subsidiary of Chiron, under incorporationorganized under the laws of the Turkish RepublicState of Northern Cyprus, asIsrael.

Emerald Medical Applications Ltd.

On March 16, 2015, Zaxis and Emerald Israel executed a share exchange agreement, which closed on July 14, 2015, and Emerald Israel became the exclusive distributor (the “Distributor”) of our Subsidiary’s products (as defined below)Company’s wholly-owned subsidiary. Emerald Israel was engaged in the territorybusiness of developing Emerald Israel’s DermaCompare technology and the Republicdevelopment, sale and service of Turkey, includingimaging solutions utilizing its DermaCompare software for use in derma imaging and analytics for the territorydetection of Turkish Republicskin cancer. On January 29, 2018, the Company ceased the DermaCompare operations of Northern Cyprus (the “Territory”);its former subsidiary.

On January 29, 2018, the Company ceased the DermaCompare operations of Emerald Israel and (ii)on May 2, 2018, the Distributor shall have the rightDistrict Court of Lod, Israel issued a winding-up order for Emerald Israel and appointed an Israeli attorney to appoint sub-distributors within the Territory.serve as special executor for Emerald Israel.

Virtual Crypto Technologies Ltd. was formed on

On January 17, 2018, the Company formed VCT Israel to develop and market software and hardware products facilitating, allowing and supporting purchase and/or sale of cryptocurrencies through ATMs, tablets, PCspersonal computers (“PCs”) and/or mobile devices (the “Products”).

devices. On January 29, 2018,27, 2020, VCT Israel was sold to a third party for NIS 50,000 ($14,459).

Transaction with Gix (the “Recapitalization Transaction”)

On February 7, 2019, the Company entered into the Share Exchange Agreement with Gix Internet, pursuant to which on Closing Date, Gix Internet assigned, transferred and delivered its 99.83% holdings in Viewbix Israel to the Company in exchange for Common Stock representing 65% of the issued and outstanding share capital of the Company on a fully diluted basis as of the Closing Date, following the conversion of certain convertible notes of the Company and excluding certain warrants to purchase shares of Common Stock expiring in 2020 and additional warrants as further described below (the “Fully Diluted Share Capital”). In addition, upon the earlier of: (a) the launch of a live video product to an American consumer in the United States by Viewbix Israel, or (b) the launch of an interactive television product to an American consumer in the United States by Viewbix Israel, the Company agreed to issue to Gix Internet an additional 1,642,193 shares of restricted Common Stock representing 5% of the Fully Diluted Share Capital immediately following the Closing Date.

20 

On July 24, 2019, and in connection with the Share Exchange Agreement, the Company filed a Certificate of Amendment to its Certificate of Incorporation with the Secretary of State of Delaware reflecting its name change from Virtual Crypto Technologies, Inc., f/k/a Emerald Medical Applications Corp. (the “Registrant”) transferred to Viewbix Inc. to reflect its new operations and business focus. On August 7, 2019, FINRA approved the managementRegistrant’s name change and its trading symbol was changed from “VRCP” to “VBIX” on the OTCQB.

On the Closing Date, (i) the Company issued 20,281,085 shares of Common Stock to Gix Internet in exchange for consideration consisting of 99.83% holdings in Viewbix Israel, and (ii) convertible notes representing 3,434,889 shares of Common Stock then currently issued to holders were converted. The shares of Common Stock were issued under Regulation S. The Company also issued a total of 7,298,636 warrants to purchase shares of Common Stock to Gix Internet, whereby (a) 3,649,318 of such warrants to purchase shares of Common Stock were issued with an exercise price of $0.48, and (b) 3,649,318 of such warrants to purchase shares of Common Stock were issued with an exercise price of $0.80.

Following the Registrant’s former IsraeliClosing Date, Viewbix Israel became a subsidiary Emerald Medical Applications Ltd. (“Emerald IL”) owned by the Registrant to Attorney Eviatar Knoller, Esq., with offices at20 Lincoln, Tel Aviv-Jaffa 6713412, as trustee (the “Trustee”). The purpose of the transferRegistrant. Viewbix Israel was incorporated in February 2006 in Israel.

On June 6, 2020, Algomizer Ltd. changed its name to Gix Internet Ltd.

On January 1, 2020, the Company announced certain cost reduction measures due the Company not achieving certain revenues goals. In connection with these cost reduction measures, on January 1, 2020, Mr. Jonathan Stefansky, the Company’s then chief executive officer and member of the management sharesCompany’s board of directors, tendered his resignation from the Board, and on the same date the sides reached a mutual understanding whereby Mr. Stefansky would step down as chief executive officer, effective March 1, 2020. On the same date, the Company and Mr. Hillel Scheinfeld, the Company’s then chief operating officer, reached a similar mutual understanding and agreed he would step down, also effective March 1, 2020. Mr. Amihay Hadad, the Company’s chief financial officer, was appointed to the Trustee, pursuant to resolutionCompany’s board of directors on January 1, 2020, and, effective as of March 1, 2020, he was also appointed as the Registrant’s Board of Directors dated January 29, 2018, was to enable the Trustee to liquidate the management shares and/or the assets of Emerald IL to satisfy its debts.Company’s chief executive officer as well.

The operations of its former subsidiary never generated any revenues and was unable to raise capital to fund its ongoing operations and satisfy its financial obligations to former employees. As a result, the former employees of Emerald IL commenced an action in a court of competent jurisdiction in Israel to liquidate Emerald IL and use any assets to satisfy the debts owed to the former employees. Effective March 8, 2018, Emerald IL ceased to be a wholly-owned subsidiary and a part of the Registrant.

On January 17, 2018,27, 2020, the Registrant formedCompany entered into an agreement with a third-party to sell Virtual Crypto Technologies Ltd as a new wholly-owned subsidiary under the laws of the State of Israel (“Virtual Crypto Israel”).Ltd. for NIS 50,000 ($14, 459), which transaction was consummated on February 12, 2020.

Our Business Operations during 2018

We were a digital health startup company engaged in the development, sale and service of imaging solutions utilizing our proprietary DermaCompare software that we developed for use in derma imaging and analytics (our “DermaCompare” or “Product”). We believed that the DermaCompare software represents an advancement in skin cancer screening that should enable physicians to more readily identify and monitor changes in their patients’ skin characteristics. As discussed above, we determined in January 2018 to terminate the business of our DermaCompare subsidiary, Emerald IL, and transferred the assets of that subsidiary to the Trustee for liquidation.

Results of Operations during the year ended December 31, 20182021 as compared to the year ended December 31, 20172020

We generated revenues of $100,000Revenues for the year ended December 31, 2018, all of which were generated from our Chiron term sheet agreement. We are no longer pursuing our business relationship with Chiron or its subsidiary. We generated no revenues2021 was $41 thousand as compared to $96 thousand for the year end December 31, 2020. The reason for the decrease during the fiscal year ended December 31, 2017 during which fiscal year we were still trying2021 is due to commercially exploit our DermaCompare technology, to no avail. We had operating expenses related to research and development and general and administrative expensesthe Company’s cost-reduction measures implemented beginning on January 1, 2021.

DuringCost of revenues for the year ended December 31, 2018, we incurred $25,006,486 in net loss due2021 was $0 which is a slight decrease to $790,413 in research$5 thousand for the year end December 31, 2020.

Research and development expenses and $1,773,839 in general and administrative expenses, $22,542,234 in financing expenses.

Duringcosts for the year ended December 31, 2017, we incurred $1,573,906 in net loss2021 was $64 thousand as compared to $108 thousand for the year end December 31, 2020. The reason for the decrease during the fiscal year ended December 31, 2021 is due to $557,300the Company’s cost-reduction measures implemented beginning on January 1, 2020, though despite these measures, the Company hired the services of an R&D team during the fiscal year ended December 31, 2021.

Sales and marketing expenses for the year ended December 31, 2021 was $2 thousand as compared to $8 thousand for the year end December 31, 2020. The reason for the decrease during the year ended December 31, 2021 is due to the Company’s cost-reduction measures implemented beginning on January 1, 2020.

21 

General and Administration expenses for the year ended December 31, 2021 was $304 thousand as compared to $437 thousand for the year end December 31, 2020. The reason for the decrease in general and administrative expenses and $307,516 in financing expenses and $709,090 Loss from discontinued operations available2021 is due to shareholderscertain cost reduction measures initiated by the Company as of the company.beginning of January 2020.

Our net financial expense was $30 thousand for the year ended December 31, 2021, compared to net financial income of $13 thousand for the year end December 31, 2020. The reason for the increase in financial expenses in 2021 is due to the loan agreement with Pure Capital and other lenders entered into on December 18, 2020, which interest expenses were recognized in the year ended December 31, 2021.

Our taxes on income was $2 thousand for the year ended December 31, 2021 and for the year ended December 31, 2020.

Liquidity and Capital Resources

OnAs of December 31, 2018,2021, we have had current assets of $558,677$156 thousand consisting of $499,919$74 thousand in cash and cash equivalents, $8 thousand in trade receivables, $30 thousand in other accounts receivables and, $44 thousand in prepaid expenses.

As of $41,516 and marketable securities of $17,242. WeDecember 31, 2021, we had $975,153$2,436 thousand in current liabilities consisting of $13,115$9 in trade payables, $242 in other accounts payable and accrued liabilities, $69 Short term loan, and $2,116 payable to our Parent Company.

As of December 31, 2020, we had current assets of $225 thousand consisting of $148 thousand in cash and cash equivalents and restricted cash, $15 thousand in trade receivables, $20 thousand in other receivables and $42 thousand in prepaid expenses. We had $2,303 thousand in current liabilities, which consisted of $177 in accounts payable and accrued liabilities $7,064 employeeand $22 trade payable, $50 Short term loan, and short-term portion of convertible notes of $485,449 and liabilities held of sale in respect of$2,054 payable to our discontinued operations of $469,525.Parent Company.

On December 31, 2017, we have had current assets of $15,181 consisting of $2,959 in cash and other receivables of $12,222. We had fixed assets, net of $14,290. We had $1,011,941 in current liabilities consisting of $445,653 in accounts payable and accrued liabilities, $82,331 in accounts payable to related party, $98,476 employee payable, and short-term portion of convertible notes of $385,481.

We hada negative working capital of $416,476$2,280 thousand and $996,760$2,078 thousand as of December 31, 20182021 and December 31, 2017,2020, respectively. The Company is assessing a number of options to increase its working capital to better sustain its operations. During the first quarter of 2018 we raised $1.9 million through the issuances of convertible loans and addition equity financings.

Our total liabilities as of December 31, 20182021 were $975,153$2,436 thousand compared to $1,618,106 at$2,303 thousand as of December 31, 2017.2020.

During the fiscal year ended December 31, 2018,2021, we had negative cash flow from operations of $1,544,054$74 thousand which was mainly the result of a net loss of $25,006,486, depreciation expense of $14,290, increase in provision for settlements of convertible loan of $21,472,897, $1,150,675 worth of shares and warrants issued for services, $1,040,838 amortization of debt discount, $50,000 decreased of deferred revenues, and loss from marketable securities of $32,758,$386 thousand, offset by decrease in working capital of $199,026.$312 thousand.

During the fiscal year ended December 31, 2017,2020, we had negative cash flow from operations of $630,015$53 thousand which was mainly the result of a net loss of $1,573,906, $2,866 increase in other receivables, $40,339 increase in amounts due from related party and$443 thousand, depreciation expense of $5 thousand, offset by $189,461 increasegains from the sale of a subsidiary and decrease in accounts payable and accrued liabilities and $350,208 interest and amortizationworking capital of discount on convertible debt.$385 thousand.

During the fiscal year ended December 31, 2021, we had no cash flow from investing activities as compared to a positive cash flow effect from investing activities of $13 thousand as during the year ended December 31, 2018,2020.

During the fiscal year ended December 31, 2021, we had no cash flow effect from investing activities.

During the year ended December 31, 2017, we had negative investingfinancing activities resulted from decrease in restricted cash $11,866.

During the year ended December 31, 2018, we hadas compared to a positive cash flow from financing activities of $2,041,014,$99 thousand during the fiscal year ended December 31, 2020, which related to the Loan Agreement and issuance of shares we have made during the fiscal year ended December 31, 2020. In January 2022, the repayment date under the Loan Agreement was extended per the resultInvestors’ request. The Investors also expressed their intention to convert the remaining sum of proceedsthe Principal Amount to shares of $1,940,951 receivedour Common Stock, however, if we are required to repay the Principal Amount in cash, we will be able to receive cash flow for the repayment from saleour Parent Company. The Gix Loan along with any accrued interest is due on December 31, 2022, unless extended upon mutual consent of common stockthe Company and related warrants (netGix Internet.

There are no limitations in the Company’s Certificate of issuance expenses), $100,000 received fromIncorporation on the Company’s ability to borrow funds or raise funds through the issuance of short-term convertible notes,shares of its common stock to affect a business combination. The Company’s limited resources and $63 fromlack of having cash-generating business operations may make it difficult to borrow funds or raise capital. The Company’s limitations to borrow funds or raise funds through the exerciseissuance of options. Basedrestricted capital stock required to effect or facilitate a business combination may have a material adverse effect on the receiptCompany’s financial condition and future prospects, including the ability to complete a business combination.

22 

Until such time as the Company can generate substantial revenues, the Company expects to finance its cash needs through a combination of the sale of its equity and/or convertible debt securities, debt financing and strategic alliances, collaborations, and funds from its Parent Company. To the extent that the Company raises additional capital through the sale of its equity and/or convertible debt securities, the ownership interest of its shareholders will be diluted, and the terms of these securities may include liquidation or other preferences that adversely affect the rights of our common shareholders. Debt financing, if available, may involve agreements that include covenants limiting or restricting our ability to take specific actions, such as incurring additional debt, making capital expenditures or declaring dividends. To the extent that debt financing ultimately proves to be available, any borrowing will subject us to various risks traditionally associated with indebtedness, including the risks of interest rate fluctuations and insufficiency of cash flow to pay principal and interest, including debt of an acquired business. If the Company raises funds through additional collaborations or strategic alliances with third parties, we believe wemay have adequate capital to operate pursuantrelinquish valuable rights to our future revenue streams and/or distribution arrangements. No assurance can be given that any future financing will be available or, if available, that it will be on terms that are satisfactory to the Company. If the Company is unable to raise additional funds through equity and/or debt financings when needed or on attractive terms, the Company may be required to delay, limit, reduce or terminate the operations of some or all of its business plan through December 2019.segments.

During

Going Concern

The Company has incurred $386 thousand in net losses for the year ended December 31, 2017, we had positive2021, has $2,280 thousand shareholders’ deficit as of December 31, 2021 and $2,078 thousand in total shareholders’ deficit as of December 31, 2020 and $74 thousand negative cash flowflows from financing activitiesoperations for the year ended December 31, 2021, and $53 thousand negative cash flows from operations for the year ended December 31, 2020. Management expects the Company to continue to generate substantial operating losses and to continue to fund its operations primarily through utilization of $606,342 which wasits current financial resources and through additional raises of capital.

Such conditions raise substantial doubts about the resultCompany’s ability to continue as a going concern. Management’s plan includes raising funds from outside potential investors. However, there is no assurance such funding will be available to the Company or that it will be obtained on terms favorable to the Company or will provide the Company with sufficient funds to meet its objectives. These financial statements do not include any adjustments relating to the recoverability and classification of proceedsassets, carrying amounts or the amount and classification of $526,342 received from sale of common stock and related warrants (net of issuance expenses), and $80,000 fromliabilities that may be required should the Receipt on account of stock. Based on the receipt of these funds, we believe we have adequate capitalCompany be unable to operate pursuant to our business plan through December 2019continue as a going concern.

 

Availability of Additional Capital

Our potential financing transactions may include the issuance of equity and/or debt securities including convertible debt, obtaining credit facilities, or other financing mechanisms. In the event that we seek to raise funds through additional private placements of equity or convertible debt, the trading price of our common stock could be adversely affected. Further, any adverse conditions in the financial markets could make it more difficult to obtain future financing through the issuance of equity or debt securities when and if needed. Even if we are able to raise a sufficient amount of funds that may be required, it is possible that we could incur unexpected costs and expenses or experience unexpected cash requirements that would force us to seek additional and/or alternative financing. Further, if we issue additional equity or debt securities, stockholders may experience additional dilution or the new equity securities may have rights, preferences or privileges senior to those of existing holders of our common stock. If additional financing is not available or is not available on acceptable terms, we may have to curtail our plan of operations.

The Company has only limited capital. Additional financing is necessary for the Company to continue as a going concern. Our independent auditors have issued an unqualified audit opinion for the year ended December 31, 20182021 with an explanatory paragraph on going concern.

23 

In view of these matters, realization of a major portion of the assets in the accompanying balance sheet is dependent upon continued operations of the Company. Management believes that actions presently being taken to obtain additional equity financing will provide the opportunity to continue as a going concern.

Off-Balance Sheet Arrangements

As of December 31, 2018, and 2017, we did not have any off-balance sheet arrangements as defined in Item 303(a)(4)(ii) of Regulation S-K promulgated under the Securities Act of 1934.

Contractual Obligations and Commitments

As of December 31, 2018,2021, and 2017,2020, we did not have any contractual obligations.

Critical Accounting Policies

This Management’s Discussion and Analysis of Financial Condition and Results of Operations discuss ourOur consolidated financial statements which have beenare prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). In connection with theThe preparation of our consolidated financial statements we are requiredand disclosures requires us to make assumptionsjudgments, estimates, and estimates about future events, and apply judgmentsassumptions that affect the reported amounts of assets and liabilities revenue, expenses and the related disclosures.disclosure of contingent assets and liabilities at the date of the financial statements as well as the reported revenue and expenses during the reporting periods. We base our assumptions, estimates and judgments on historical experience, currentknown trends and events and various other factors that management believeswe believe to be relevant atreasonable under the timecircumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. We evaluate our consolidated financial statements are prepared. On a regular basis, management reviews the accounting policies, assumptions, estimates and judgments to ensure that our financial statements are presented fairly and in accordance with U.S. GAAP. However, because future events and their effects cannot be determined with certainty, actual results could differ from our assumptions and estimates, and such differences could be material. As applicable to the consolidated financial statements included elsewhere in this report, the most significant estimates and assumptions relate to (i) the going concernon an ongoing basis. Our actual results may differ from these estimates under different assumptions (iv) measurement of Convertible Note.and conditions.

Our significant accounting policies are discusseddescribed in Note 2, Summary of Significant Accounting Policies, ofmore detail in the Notesnotes to Consolidated Financial Statements includedour audited consolidated financial statements appearing elsewhere in this report. Our management believes that, as for the financial statements for the periods included in this report, the going concern assessment is a critical accounting policy. However, due to the early stage of operations of the Company, there are no other accounting policies that are considered to be critical accounting policies by management.Annual Report on Form 10-K.

Going Concern Uncertainty

The development and commercialization of our product will require substantial expenditures. We have not yet generated any material revenues and have incurred substantial accumulated deficit and negative operating cash flows. We currently have no sources of recurring revenue and are therefore dependent upon external sources for financing our operations. There can be no assurance that we will succeed in obtaining the necessary financing to continue our operations. As a result, our independent registered public accounting firm has expressed substantial doubt about our ability to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Recently issued accounting pronouncements

1.Accounting Standard Update 2014-09, “Revenue from Contracts with Customers”

Commencing January 1, 2018, the Company adopted Accounting Standard Update 2014-09, Revenue from Contracts with Customers (Topic 606) (“ASU 2014-09”).

ASU 2014-09 outlines a single comprehensive model to use in accounting for revenue arising from contracts with customers and supersedes most current revenue recognition guidance, including industry-specific guidance. ASU 2014-09 also requires entities to disclose sufficient information, both quantitative and qualitative, to enable users of financial statements to understand the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers.

An entity should apply the amendments in ASU 2014-09 using one of the following two methods:

1. Retrospectively to each prior reporting period presented with a possibility to elect certain practical expedients, or,

2. Retrospectively with the cumulative effect of initially applying ASU 2014-09 recognized at the date of initial application. If an entity elects the latter transition method, it also should provide certain additional disclosures.

During 2016, the FASB issued several Accounting Standard Updates (“ASUs”) that focus on certain implementation issues of the new revenue recognition guidance including Narrow-Scope Improvements, Practical Expedients and technical corrections.
In accordance with an amendment to ASU 2014-09, introduced by Accounting Standard 2015-14, “Revenue from contracts with Customers – Deferral of the Effective Date”, for a public entity, the amendments in ASU 2014-09 became effective for annual reporting periods beginning after December 15, 2017, including interim periods within that reporting period (the first quarter of fiscal year 2018 for the Company).
The adoption of ASU 2014-09 did not have a significant impact on its consolidated financial statements.

2.Accounting Standard Update (ASU) No. 2017-11, “Earnings Per Share”
In July 2017, the FASB issued ASU No. 2017-11, Earnings Per Share (Topic 260); Distinguishing Liabilities from Equity (Topic 480); Derivatives and Hedging (Topic 815): (Part I) Accounting for Certain Financial Instruments with Down Round Features, (Part II) Replacement of the Indefinite Deferral for Mandatorily Redeemable Financial Instruments of Certain Nonpublic Entities and Certain Mandatorily Redeemable Noncontrolling Interests with a Scope Exception (“ASU 2017-11”).
Among others, Part I of ASU 2017-11 simplifies the accounting for certain financial instruments with down round features, which is a provision in an equity-linked financial instrument (or embedded feature) that provides a downward adjustment of the current exercise price based on the price of future equity offerings. Current accounting guidance creates cost and complexity for organizations that issue financial instruments with down round features by requiring, on an ongoing basis, fair value measurement of the entire instrument or conversion option.

ASU 2017-11 require companies to disregard the down round feature when assessing whether the instrument is indexed to its own stock, for purposes of determining liability or equity classification. Companies that provide earnings per share (EPS) data will adjust their basic EPS calculation for the effect of the feature when triggered (i.e., when the exercise price of the related equity-linked financial instrument is adjusted downward because of the down round feature) and will also recognize the effect of the trigger within equity.

ASU 2017-11 also addresses navigational concerns within the FASB Accounting Standards Codification related to an indefinite deferral available to private companies.
The provisions of the new ASU related to down rounds are effective for public business entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018 (fiscal 2019 for the Company). Early adoption is permitted for all entities.
The adoption of ASU 2017-11 did not have a significant impact on its consolidated financial statements

3.Accounting Standard Update 2018-07, Compensation—Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting
In June 2018, the FASB issued Accounting Standard Update 2018-07, Compensation—Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting (ASU 2018-07). ASU 2018-07 aligns the measurement and classification guidance for share-based payments to nonemployees with the guidance for share-based payments to employees, with certain exceptions.
Consistent with the accounting requirement for employee share-based payment awards, nonemployee share-based payment awards within the scope of Topic 718 will be measured at grant-date fair value of the equity instruments that an entity is obligated to issue when the goods has been delivered or the service has been rendered and any other conditions necessary to earn the right to benefit from the instruments have been satisfied. Equity-classified nonemployee share-based payment awards will be measured at the grant date.
With respect to awards with performance conditions, ASU 2018-07 concludes that, consistent with the accounting for employee share-based payment awards, an entity will consider the probability of satisfying performance conditions when nonemployee share-based payment awards contain such conditions.
ASU 2018-07 also requires that the classification of equity classified nonemployee share-based payment awards will continue to be subject to the requirements of Topic 718 unless the award was modified after the goods has been delivered, the service has been rendered, any other conditions necessary to earn the right to benefit from the instruments have been satisfied, and the nonemployee is no longer providing goods or services. This eliminates the requirement to reassess classification of such awards upon vesting.
In addition, ASU 2018-07 includes certain Non-public Entity-Specific Amendments.
ASU 2018-07 is effective for Public entities in annual periods beginning after 15 December 2018, and interim periods within those years (first quarter of 2019 for the Company). Early adoption is permitted, including in an interim period, but not before an entity adopts the new revenue guidance (which was adopted by the Company in its interim financial statements for 2018).

An entity should only remeasure liability-classified awards that have not been settled by the date of adoption and equity-classified awards for which a measurement date has not been established through a cumulative-effect adjustment to retained earnings as of the beginning of the fiscal year of adoption. Upon transition, the entity is required to measure these nonemployee awards at fair value as of the adoption date.

The Company is evaluating the impact of ASU 2018-07 on its financial statements.
4.

In February 2016, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update No. 2016-02 (Topic 842) “Leases”. Topic 842 supersedes the lease requirements in Accounting Standards Codification (ASC) Topic 840, “Leases”. Under Topic 842, lessees are required to recognize assets and liabilities on the balance sheet for most leases and provide enhanced disclosures. ASU No. 2016-02 is effective for interim and annual reporting periods beginning after December 15, 2018. In July 2018, the FASB issued amendments in ASU 2018-11, which provide a transition election to not restate comparative periods for the effects of applying the new standard. This transition election permits entities to change the date of initial application to the beginning of the earliest comparative period presented, or retrospectively at the beginning of the period of adoption through a cumulative-effect adjustment.

The Company is currently evaluating the impact that the adoption of ASU 2016-02 will have on its financial statements and related disclosures.
5.

Commencing January 1, 2018, the Company adopted ASU 2016-18, Statement of Cash Flows (Topic 230):

“Restricted Cash” (ASU 2016-18), which requires companies to include amounts generally described as restricted cash and restricted cash equivalents in cash and cash equivalents when reconciling beginning-of-period and end-of-period total amounts shown on the statement of cash flows. The amendments in this update are effective for public business entities for fiscal years beginning after December 15, 2017, and interim periods within those fiscal years.
This guidance did not have a material impact on the Company’s consolidated financial statements.

ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURE ABOUT MARKET RISK

Not required for smaller reporting companies.

24 

ITEM 8. CONSOLIDATED FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

INDEX TO CONSOLIDATED FINANCIAL STATEMENTSViewbix Inc.

Index to Consolidated Financial Statements

Report of Independent Registered Public Accounting Firm (PCAOB ID No. 1197)28F-2
Consolidated Financial Statements 
Consolidated Balance sheets as of December 31, 2018 and December 31, 2017Sheets30F-4
Consolidated Statements of Comprehensive loss for the years ended December 31, 2018 and 2017Loss31F-5
Consolidated Statements of changesChanges in stockholders’ deficit for the years ended December 31, 2018 and 2017Stockholders’ Deficit32F-6
Consolidated Statements of cash flows for the years ended December 31, 2018 and 2017Cash Flows33F-7 - F-8
Notes to Consolidated Financial Statements34F-9

F-1

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

TO THE BOARD OF DIRECTORS AND STOCKHOLDERS OFTo the Stockholders and Board of Directors of Viewbix Inc.

Virtual Crypto Technologies Inc (Formerly Emerald Medical Applications Corp)

Opinion on the Consolidated Financial Statements

We have audited the accompanying consolidated balance sheetsheets of Virtual Crypto Technologies Inc (Formerly Emerald Medical Applications Corp.)Viewbix Inc. and its subsidiary (the “Company”) as of December 31, 20182021 and 2020 and the related consolidated statements of comprehensive loss, stockholders’stockholder’s deficit and cash flows for each of the yeartwo years in the period ended December 31, 2018,2021, and the related notes (collectively referred to as the “consolidated financial“financial statements”). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2018,2021 and 2020, and the results of its operations and its cash flows for each of the yeartwo years in the period ended December 31, 2018,2021, in conformity with accounting principles generally accepted in the United States of America.

The consolidated financial statements of the Company for the year ended December 31, 2017, before the effects of the retrospective adjustments for the discontinued operations discussed in Note 1C to the financial statements, were audited by other auditors whose report, dated April 17, 2018, expressed an unqualified opinion on those statements with an explanatory paragraph regarding the Company’s ability to continue as a going concern. We also have audited the retrospective adjustments to the 2017 consolidated financial statements for the operations discontinued in 2018, as discussed in Note 1C to the financial statements. In our opinion, such retrospective adjustments are appropriate and have been properly applied. However, we were not engaged to audit, review, or apply any procedures to the 2017 consolidated financial statements of the Company other than with respect to the retrospective adjustments, and accordingly, we do not express an opinion or any other form of assurance on the 2017 consolidated financial statements taken as a whole.

Going Concern

The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 11.E to the consolidated financial statements, the Company’ has not yet generated material revenues from its operations to fund its activities and is therefore dependent upon external sources for financing its operations. As of December 31, 2018, the Company has incurred accumulatedCompany’s substantial net losses, shareholder’s deficit of $41,626,905, stockholder’s deficit of $416,476 and negative operating cash flows. These factor among others, as discussed in Note 1 to the consolidated financial statementsflows from operations raise substantial doubt about the Company’sits ability to continue as a going concern. Management’s plans concerning these matters are also described in Note 11.E to the consolidated financial statements. The consolidated financial statements do not include any adjustments that might result from the outcome of'of’ these uncertainties.uncertainties

Basis for Opinion

These consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audit.audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audit, we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.

Our audit included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audit provides a reasonable basis for our opinion.

Halperin Ilanit.

Certified Public Accountants (Isr.)

Tel Aviv, Israel

March 28, 2019

We have served as the Company’s auditor since 2018

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

TO THE BOARD OF DIRECTORS AND STOCKHOLDERS OF

Virtual Crypto Technologies Inc (Formerly Emerald Medical Applications Corp.)

Opinion on the Financial Statements

We have audited, before the effects of the retrospective adjustments for the discontinued operations discussed in Note 1C to the consolidated financial statements, the accompanying consolidated balance sheet of Virtual Crypto Technologies Inc (Formerly Emerald Medical Applications Corp.) and its subsidiary (the “Company”) as of December 31, 2017 and the related consolidated statements of comprehensive loss, shareholders’ deficit and cash flows for the year ended December 31, 2017, and the related notes (collectively referred to as the “financial statements”) (the 2017 financial statements before the effects of the retrospective adjustments discussed in Note 1C to the financial statements are not presented herein). In our opinion, the 2017 financial statements before the effects of the retrospective adjustments for the discontinued operations discussed in Note 1C to the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2017, and the results of its operations and its cash flows for the year ended December 31, 2017, in conformity with accounting principles generally accepted in the United States of America. We were not engaged to audit, review, or apply any procedures to the retrospective adjustments for the discontinued operations discussed in Note 1C to the consolidated financial statements, and accordingly, we do not express an opinion or any other form of assurance about whether such retrospective adjustments are appropriate and have been properly applied. Those retrospective adjustments were audited by other auditors.

Going Concern

The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 1 to the consolidated financial statements, the Company’s lack of revenues and substantial operating losses raise substantial doubt about its ability to continue as a going concern. Management’s plans concerning these matters are also described in Note 1 to the consolidated financial statements. The consolidated financial statements do not include any adjustments that might result from the outcome of' these uncertainties.

Basis for Opinion

These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our auditaudits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audit,audits, we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.

Our auditaudits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our auditaudits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audit providesaudits provide a reasonable basis for our opinion.

Critical Audit Matter

The critical audit matter communicated below is a matter arising from the current-period audit of the financial statements that was communicated or required to be communicated to the audit committee and that (1) relates to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of a critical audit matter does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing separate opinions on the critical audit matter or on the accounts or disclosures to which it relates.

F-2

Payable to Parent Company - Valuation of Fair Value of Debt Recognized upon Modification – Refer to Note 4 to the consolidated financial statements

Critical Audit Matter Description

The Company entered into an agreement with its parent company, Gix Internet Ltd., (the “Parent Company”), effective as of December 31, 2021, for the modification of the balance payable to the Parent Company, in the amount of $2,299,956, from a current payable balance into a loan.

The Company accounted for the modification as an extinguishment of the balance payable to the Parent Company and the issuance of a new debt. Accordingly, the loan was recorded at its fair value of $2,115,853 as of December 31, 2021. The difference of $184,103 between the fair value of the loan and the carrying value of the payable to the Parent Company was recorded in the Company’s consolidated statement of changes in stockholders’ deficit as a deemed contribution to the Company by the Parent Company. The Company determined the fair value of the loan using the discounted cash flow model. This valuation involves management judgement in determining the discount rate.

We identified the valuation of the loan at fair value as a critical audit matter because of the magnitude of the loan balance, the judgment involved in determining the discount rate and due to the increased extent of audit effort in relation to our audit as a whole, including the need to involve our fair value specialists.

How the Critical Audit Matter Was Addressed in the Audit

Our audit procedures related to the valuation of the fair value of the loan included the following, among others:

With the assistance of our fair value specialists, we evaluated the Company’s valuation methodologies, assumptions and fair value results.

With the assistance of our fair value specialists, we developed an independent estimate of the discount rate and the resulting fair value and compared our estimate to the Company’s estimate.

 

/S/ Brightman Almagor Zohar & Co.

Certified Public Accountants

Member ofA Firm in the Deloitte Touche Tohmatsu LimitedGlobal Network

Tel Aviv, Israel

AprilMarch 17, 20182022

We began servinghave served as the Company’s auditor in 2016. In 2018, we became the predecessor auditor.since 2019

Virtual Crypto Technologies Inc (Formerly Emerald Medical Applications Corp)

F-3

Viewbix Inc.

Consolidated Balance Sheets

  December 31, 2018  December 31,
2017
 
Assets        
Current assets:        
Cash and cash equivalents $499,919  $2,959 
Marketable securities  17,242   - 
Other current assets  41,516   12,222 
Total current assets  558,677   15,181 
         
Restricted cash  -   59 
Property and Equipment, net  -   14,290 
Total assets $558,677  $29,530 
         
Liabilities and Stockholders’ Deficit        
Current liabilities:        
Accounts payable and accrued liabilities $13,115  $123,719 
Accounts payable - related party  -   - 
Employee payable  7,064   - 
Short term portion of convertible notes (Note 3)  485,449   352,447 
Liabilities held for sale (Note 1C)  469,525   535,775 
Total current liabilities  975,153   1,011,941 
         
Convertible notes (Note 3)  -   606,165 
Total liabilities  975,153   1,618,106 
         
Stockholders’ deficit (Note 4)        
Preferred stock, $0.0001 par value; 10,000,000 shares authorized; none and 529 issued at December 31, 2018 and December 31, 2017, respectively.  -   (*)
Common stock, $0.0001 par value; 490,000,000 shares authorized; 110,748,391 and 22,543,008 shares issued and outstanding at December 31, 2018 and December 31, 2017, respectively.  11,075   2,255 
Accumulated other comprehensive income  (19,337)  (19,337)
Additional paid-in capital  41,218,691   14,968,925 
Receipt on account of shares  -   80,000 
Accumulated deficit  (41,626,905)  (16,620,419)
Total stockholders’ deficit  (416,476)  (1,588,576)
Total liabilities and stockholders’ deficit $558,677  $29,530 

U.S. dollars in thousands (except share and per share data)

(*) less than $1

    

As of

December 31,

  

As of

December 31

 
  Note 2021  2020 
ASSETS          
           
CURRENT ASSETS          
Cash and cash equivalents   $74  $148 
Trade receivables    8   15 
Other accounts receivable    30   20 
Prepaid expenses    44   42 
           
Total current assets   $156  $225 
           
Total assets   $156  $225 
           
LIABILITIES, TEMPORARY EQUITY AND STOCKHOLDERS’ DEFICIT          
           
CURRENT LIABILITIES          
Trade payables   $9  $22 
Other accounts payable and accrued liabilities 3  242   177 
Parent company 4  2,116   2,054 
Short term loan 5  69   50 
           
Total current liabilities   $2,436  $2,303 
           
STOCKHOLDERS’ DEFICIT 6        
           
Share Capital          
Common stock, $0.0001 par value; 490,000,000 shares authorized; 34,753,669 shares issued and outstanding at December 31, 2021 and at December 31, 2020    3   3 
Additional paid-in capital 4,5  13,257   13,073 
Accumulated deficit    (15,540)  (15,154)
           
Total stockholders’ deficit   $(2,280) $(2,078)
           
Total liabilities, temporary equity and stockholders’ deficit   $156  $225 

The accompanying notes are an integral part of these consolidated financial statements.

30F-4
 

Virtual Crypto Technologies Inc (Formerly Emerald Medical Applications Corp)Viewbix Inc.

Consolidated Statements of Comprehensive Loss

U.S. dollars in thousands (except share and per share data)

  Year ended  Year ended 
  December 31, 2018  December 31, 2017 
       
Revenues (Note 1D) $100,000  $- 
         
Expenses:        
Research and development  (790,413)  - 
General and administrative (Note 6)  (1,773,839)  (557,300)
Total operating expenses  (2,564,252)  (557,300)
         
Operation Loss  (2,464,252)  (557,300)
         
Finance expense:        
Finance expense, net (Note 7)  (22,542,234)  (307,516)
         
Net loss from continuing operations available to shareholders of the company $(25,006,486) $(864,816)
Net loss from discontinued operations available to shareholders of the company) Note 1C)  -   (709,090)
Net loss from continuing operations attributable to shareholders of the company $(25,006,486) $(1,573,906)
Net loss attributable to shareholders of preferred stock  -   39,491 
Net loss from continuing operations $(25,006,486) $(1,534,415)
Basic and diluted net loss per share        
From continuing operations  (0.41)  (0.04)
From discontinued operations  -   (0.03)
Weighted average shares outstanding - basic and diluted  61,165,674   21,780,899 
  Note Year ended December 31,
2021
  Year ended December 31,
2020
 
         
Revenues 7  41   96 
Cost of revenues    -   5 
Gross profit    41   91 
Expenses:          
Research and development 8  64   108 
Sales and marketing 9  2   8 
General and administrative 10  304   437 
Other expenses    25   - 
Gain from sale of a subsidiary    -   (8)
Total operating expenses    395   545 
Loss from operations    (354)  (454)
Finance income 11  1   20 
Finance expense 11  (31)  (7)
Loss Before taxes on income    (384)  (441)
Taxes on income 12  2   2 
Net Loss    (386)  (443)
Basic and diluted net loss per share:    (0.011)  (0.014)
Weighted average shares outstanding - basic and diluted 13  34,753,669   31,201,669 

The accompanying notes are an integral part of these consolidated financial statements.

Virtual Crypto Technologies Inc (Formerly Emerald Medical Applications Corp)

F-5

Viewbix Inc.

Consolidated Statements of Changes in Stockholders’ Deficit

  Common  Preferred  Additional Paid-in  Receipt on
Account of
  Other
Comprehensive
  Accumulated  Total
stockholders’
 
  Shares  Amount  Stock  Amount  Capital  Shares  Income  Deficit  deficit 
Balance as of January 1, 2017  19,931,478  $1,994   -  $-  $  13,826,957  $-  $(19,337) $  (15,046,513) $(1,236,899)
Common stock issued for cash  1,315,563   132   -   -   526,081   -   -   -   526,213 
Cashless exercise of Warrants  1,096,395   110   -   -   (110)  -   -   -   - 
Conversion of Convertible Note to shares  74,572   7   -   -   10,393   -   -   -   10,400 
Issuance of Ordinary Shares  125,000   12   -   -   (12)  -   -   -   - 
Issuance of Preferred Stock          529   (*)  529,000   -   -   -   529,000 
Receipt on Account of Shares          -   -   -   80,000   -   -   80,000 
Share based compensation  -   -   -   -   76,616   -   -   -   76,616 
Net loss for the year  -   -   -   -   -   -   -   (1,573,906)  (1,573,906)
Balance as of December 31, 2017  22,543,008  $2,255   529  $-  $14,968,925  $80,000  $(19,337) $(16,620,419) $(1,588,576)
Common stock and warrants issued for cash  27,697,855   2,770   -   -   1,938,180   -   -   -   1,940,950 
Common stock issued for services  4,329,999   433           1,003,866               1,004,299 
Warrants issued for services  -   -   -   -   146,376   -   -   -   146,376 
Exercise of stock options  62,500   6   -   -   57   -   -   -   63 
Issuance of new convertible note with a beneficial conversion feature  -   -   -   -   100,000   -   -   -   100,000 
Change in the terms of Convertible Note  -   -   -   -   22,581,508   -   -   -   22,581,508 
Partial conversion of convertible note to shares  55,543,600   5,554   -   -   549,836   -   -   -   555,390 
Cancellation of Preferred Shares  -   -   (529)  -   (150,000)  -   -   -   (150,000)
Issuance of Shares in respect of proceeds received during 2017  571,429   57   -   -   79,943   (80,000)  -   -   - 
Net loss for the year  -   -   -   -   -   -   -   (25,006,486)  (25,006,486)
Balance as of December 31, 2018  110,748,391  $11,075   -  $-  $41,218,691  $-  $(19,337) $(41,626,905) $(416,476)

U.S. dollars in thousands (except share and per share data)

(*) less than $1

                
  Ordinary shares  

Additional

paid-in

  Accumulated  

Total

shareholders’

 
  Number  Amount  capital  deficit  deficit 
                
Balance as of January 1, 2021  34,753,669   3   13,073   (15,154)    (2,078)
                     
Financing provided by the Parent Company (see note 4)  -   -   184       184 
Issuance of shares                    
Issuance of shares, shares                    
Net loss for the period  -   -   -   (386)  (386)
Balance as of December 31, 2021  34,753,669   3   13,257   (15,540)  (2,280)

  Ordinary shares  

Additional

paid-in

  Accumulated  

Total

shareholders’

 
  Number  Amount  capital  deficit  deficit 
                
Balance as of January 1, 2020  31,201,669   3   13,015   (14,711)     (1,693)
Balance  31,201,669   3   13,015   (14,711)  (1,693)
Issuance of shares  3,552,000   -(*)  58   -   58 
Net loss for the period  -   -   -   (443)  (443)
Balance as of December 31, 2020  34,753,669   3   13,073   (15,154)  (2,078)
Balance  34,753,669   3   13,073   (15,154)  (2,078)

(*)Represents an amount less than $1.

The accompanying notes are an integral part of these consolidated financial statements.

Virtual Crypto Technologies Inc (Formerly Emerald Medical Applications Corp)

F-6

Viewbix Inc.

Consolidated Statements of Cash Flows

U.S. dollars in thousands (except share and per share data)

  Year ended  Year ended 
  December 31, 2018  December 31,
2017
 
Operating Activities:        
Net loss $(25,006,486) $(1,573,906)
Depreciation  14,290   17,513 
Amortization of debt discount  1,040,838   350,208 
Loss from marketable securities  32,758     
Shares and Warrants issued for services  1,150,675    
Share based compensation      

76,616

 
Finance loss arising from change in terms of convertible notes  21,472,897   - 
Change in derivative liability  -   (336,272)
settlement with debt and warrant holders  -   659,960 
Non cash finance, general and administrative expenses arising from        
Decrease in liabilities held for sale  (66,250)  - 
Decrease in deferred revenues  (50,000)  - 
Increase (decrease) in accounts payable and accrued liabilities  (103,051)  189,461 
Decrease in amounts due from related party  -   (40,339)
Decrease in accrued interest  -   35,078 
Increase in other receivables  (29,724)  (2,866)
Net cash used in operating activities  (1,544,053)  (630,015)
         
Investing Activities:        
Decrease in restricted cash  -   11,866 
Net cash provided by investing activities  -   11,866 
         
Financing Activities:        
Issuance of common stock (net of issuance expenses)   1,940,950   526,342 
Issuance of short-term convertible notes  100,000   - 
Receipt on account of stock      80,000 
Exercise of options  63     
Net cash provided by financing activities  2,041,013   606,342 
         
Net increase (decrease) in cash  496,960   (2,527)
Cash and cash equivalents - beginning of period  2,959   4,486 
Cash and cash equivalents - end of period $499,919  $1,959 
         
Non-cash transactions:        
Deferred revenues against Marketable securities $50,000) $- 
Common stock issued in respect of proceeds received during 2017 $80,000  $- 
pursuant to convertible note $555,390  $- 
Issuance of Preference Shares in connection with settlement with debt and warrant holders $-  $529,000 
Settlement agreement with debt and warrant holders accounted for as extinguishment and re issuance of debt:        
Extinguishment of convertible note  -   659,960 
Re issuance of convertible note  -   470,200 
  2021  2020 
  

For the year ended

December 31

 
  2021  2020 
    
Cash flows from operating activities        
         
Net loss for the period  (386)  (443)
         
Adjustments to reconcile net loss to net cash used in operating activities:        
Gain from sale of a subsidiary  -   (8)
Depreciation  -   5 
Changes in operating assets and liabilities:        
Decrease (Increase) in trade receivables and prepaid expenses  5   (40)
Decrease (Increase) in other accounts receivable  (10)  100 
Increase (decrease) in trade payables  52   (55)
Increase in payable to parent company  246   443 
Increase (decrease) in other accounts payables and accrued liabilities  19   (55)
         
Net cash used by operating activities  (74)  (53)
         
Cash flows from investing activities        
Cash received from the sale of a subsidiary  -   13 
         
Net cash used in investing activities  -   13 
         
Cash flows from financing activities        
         
Issuance of shares  -   49 
Short term loan received  -   50 
         
Net cash provided by financing activities  -   99 
         
Increase (decrease) in cash and cash equivalents and restricted cash  (74)  59 
         
Cash and cash equivalents and restricted cash at the beginning of the period  148   89 
         
Cash and cash equivalents and restricted cash at the end of the period $74  $148 
         

F-7

Viewbix Inc.

Condensed Consolidated Statements of Cash Flows

U.S. dollars in thousands (except share and per share data)

(Unaudited)

SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:

As of

December 31
2021

Modification of parent company payable into a loan (see note 4)

2,116

As of
February 12, 2020
Current assets excluding cash and cash equivalents6
Current liabilities(1)
Gain from sale of a subsidiary8
Cash received from the sale of a subsidiary13

The accompanying notes are an integral part of these consolidated financial statements.

F-8

Viewbix Inc.

Notes to Consolidated Financial Statements

U.S. dollars in thousands (except share and per share data)

NOTE 1. GENEREL

A.Organizational Background

Viewbix Inc. (formerly known as Virtual Crypto Technologies, Inc (FormerlyInc.) (the “Company”) was incorporated in the State of Ohio in 1989 under a predecessor name, Zaxis International, Inc. (“Zaxis”). On August 25, 1995, Zaxis merged with a subsidiary of The InFerGene Company, a Delaware corporation, which entity changed its name to Zaxis International, Inc. and the Company was reincorporated in Delaware under the name of Zaxis International, Inc. In 2015 the Company changes its name to Emerald Medical Applications Corp)Corp.

On January 17, 2018, the Company formed a new wholly-owned subsidiary under the laws of the State of Israel, Virtual Crypto Technologies Ltd. (“VCT Israel”), to develop and market software and hardware products facilitating and supporting the purchase and/or sale of cryptocurrencies. Effective as of March 7, 2018, the Company’s name was changed from Emerald Medical Applications Corp. to Virtual Crypto Technologies, Inc. to reflect its new operations and business focus.

VCT Israel ceased its business operation prior to consummation of the Recapitalization Transaction. On January 27, 2020, VCT Israel was sold to a third party for NIS 50,000 ($14,459).

On February 7, 2019, the Company entered into a share exchange agreement (the “Share Exchange Agreement” or the “Recapitalization Transaction”) with Gix Internet Ltd., an company organized under the laws of the State of Israel (“Gix”), pursuant to which, Gix assigned, transferred and delivered its 99.83% holdings in Viewbix Ltd., a company organized under the laws of the State of Israel (“Viewbix Israel”), to the Company in exchange for shares of restricted common stock of the Company, which resulted in Viewbix Israel becoming a subsidiary of the Company. In connection with the Share Exchange Agreement, effective as of August 7, 2019, the Company’s name was changed from Virtual Crypto Technologies, Inc. to Viewbix Inc.

On January 1, 2020, the Company announced certain cost reduction measures due the fact the Company not achieved certain revenues goals.

On December 5, 2021, the Company entered into a certain Agreement and Plan of Merger (the “Merger Agreement” or the “Gix Merger”) with Gix Media Ltd., an Israeli company and the majority-owned subsidiary of Gix (“Gix Media”) and Vmedia Merger Sub Ltd., an Israeli company and wholly-owned subsidiary of the Company (“Merger Sub”), pursuant to which, following the Gix Merger and upon satisfaction of the closing conditions listed in the Merger Agreement, Merger Sub will merge with and into Gix Media, with Gix Media being the surviving entity and wholly-owned subsidiary of the Company. As of the reporting date, the closing conditions of the Merger Agreement have not been fulfilled yet the Gix Merger has not been consummated.

The Company and its subsidiaries are collectively referred to as the “Company”. The Company has developed an interactive video platform based on Software as a Service (“SaaS”) business model with interactive elements, and the ability to collect and analyze information about each interactive action performed during the viewing of the video clip. The interactive elements and information gathered, allowing the advertiser to analyze user viewing habits and optimize real-time throughout the campaign while increasing the effectiveness of online and live video advertising.

F-9

Viewbix Inc.

Notes to Consolidated Financial Statements

U.S. dollars in thousands (except share and per share data)

Note 1. General

NOTE. 1GENERAL (Cont.):

A.B.Virtual Crypto Technologies, Inc., f/k/a Emerald Medical Applications Corp. (the “Company(, was incorporated in the State of Ohio in 1989 under a predecessor name, Zaxis International, Inc. (“Zaxis”). On August 25, 1995, Zaxis merged with a subsidiary of The InFerGene Company, a Delaware corporation, which entity changed its name to Zaxis International, Inc. and the Company was reincorporated in Delaware under the name of Zaxis International, Inc. On December 30, 2014, Zaxis entered into an agreement with Emerald Medical Applications Ltd., a private limited liability company organized under the laws of the State of Israel

Emerald Medical Applications Ltd., the Company’s wholly-owned subsidiary (“Emerald Israel”).

On March 16, 2015, Zaxis and Emerald Israel executed the Share Exchange Agreement, which closed on July 14, 2015 (the “Share Exchange Agreement”) and Emerald Israel became the Company’s wholly-owned subsidiary. Emerald Israel was engaged in the business of developing Emerald Israel’s DermaCompare technology and the development, sale and service of imaging solutions utilizing its DermaCompare software for use in derma imaging and analytics for the detection of skin cancer. On January 29, 2018, the Company ceased the DermaCompare operations of its former subsidiary.

DuringOn May 2, 2018, the fourth quarterDistrict Court of 2015,Lod, Israel issued a winding-up order for Emerald Israel and appointed an Israeli attorney as special executor for Emerald Israel.

C.Stock Subscription Agreement and Loan Agreement

On December 18, 2020, the Company entered into a Stock Subscription Agreement (the “Subscription”) with certain investors (the “Investors”) in connection with the Share Exchangesale and issuance of an aggregate of 3,000,000 shares of Common Stock, at a purchase price of $0.01 per share, and for an aggregate purchase price of $30,000. In addition, and on the same date, the company entered into a Loan Agreement (the “Loan”) with the Company changed its nameInvestors, pursuant to Emerald Medical Applications Corp.which the Investors lent an aggregate of $69,000 (the “Principal Amount”). In accordance with the terms of the Loan, the company repaid the interest on the Principal Amount (8% compounded annually) to the Investors in the form of an issuance of an aggregate of 552,000 shares of Common Stock, at a price per share of $0.01. The shares of Common Stock were issued to the Investors pursuant to Regulation S of the Securities Act of 1933, as amended.

B.D.On January 4, 2018, the Company and Emerald Israel entered into an agreementMerger with Alpha Capital Ansalt and Chi Squared Inc. (collectively, the “Preferred Shareholders”Gix Media Ltd.

On December 5, 2021, the Company entered into the Merger Agreement with Gix Media and Merger Sub, pursuant to which, following the Gix Merger, and upon satisfaction of additional closing conditions, Merger Sub will merge with and into Gix Media, with Gix Media being the surviving entity and wholly-owned subsidiary of the Company. As of the reporting date, the closing conditions of the Merger Agreement have not been fulfilled yet and the Gix Merger has not been consummated (see Note 15).

F-10

Viewbix Inc.

Notes to Consolidated Financial Statements

U.S. dollars in thousands (except share and per share data)

NOTE. 1GENERAL (Cont.), pursuant to which the Preferred Shareholders agreed to cancel their shares of Series A Preferred Convertible Stock in return for the receipt of up to $250,000 of proceeds from the liquidation of Emerald Israel, to the extent that such liquidation yields net positive proceeds (“Excess Net Assets”).

E.Going Concern

 

Management’s best estimate of the potential value of the Excess Net Assets at the date of the cancellation of the shares of Series A Preferred Convertible Stock was $150,000 and therefore, theThe Company recorded a charge to Additional Paid-in Capitalhas incurred $386 in the Statement of Changes in Stockholders’ Deficit with a corresponding credit to liabilities. Management’s best estimate of the potential value of the Excess Net Assets as of December 31, 2018, was nil. Accordingly, the Company recorded a finance income of $150,000 in its Consolidated Statements of Comprehensive Loss a result of the reversal of the relating liability.

As such, as of December 31, 2018, there were no shares of Series A Preferred Convertible Stock outstanding.

C.

On January 29, 2018, the Company ceased the DermaCompare operations of Emerald Israel and on May 2, 2018, the District Court of Lod, Israel issued a winding-up order for Emerald Israel and nominated an Israeli advocate (attorney) as a special executor for Emerald Israel. Following the cessation of the DermaCompare operations, the Company classified to discontinued operations its 2017 results of operation and balances relating to the DermaCompare operation.

Liabilities held for sale:

  December 31, 2018  December 31, 2017 
Accounts payable and accrued liabilities  287,070   321,934 
Accounts payable - related party  76,004   82,331 
Employee payable  75,955   98,476 
Short term portion of convertible notes  30,496   33,034 
Total  469,525   535,775 

D.On January 17, 2018, the Company formed a new wholly-owned subsidiary in Israel, Virtual Crypto Technologies Ltd. (the “New Subsidiary” or “Virtual Crypto Israel”), to develop and market software and hardware products facilitating, allowing and supporting purchase and/or sale of cryptocurrencies through ATMs, tablets, personal computers and/or mobile devices.

On January 24, 2018, Virtual Crypto Israel had entered into a binding term sheet (the “Chiron Term Sheet”) with Chiron Refineries Ltd. (“Chiron”), a public company listed on the Tel-Aviv Stock Exchange (TASE: CHR). Pursuant to the Chiron Term Sheet: (i) Virtual Crypto Israel agreed to appoint a wholly-owned subsidiary of Chiron, to be organized under the laws of the Turkish Republic of Northern Cyprus (the “Distributor”), as the exclusive distributor of Virtual Crypto Israel’s Products in Turkey, including the territory of Turkish Republic of Northern Cyprus (collectively, the “Territory”); and (ii) the Distributor shall have the right to appoint sub-distributors within the Territory. The appointment of the Distributor was subject to the payment by the distributor to Virtual Crypto Israel of $250,000 as an appointment fee, of which $150,000 was to be deemed an advance payment by the distributor made on account of future purchases of the Company’s Products.

Virtual Crypto Israel further granted the Distributor an option, exercisable by the Distributor within 12 months from the date on which the ATM Product, including the related software and hardware, was fully tested and ready for installation and operation, to be appointed as an exclusive distributor of the Products for the Federal Republic of Nigeria. If the option was exercised, the Distributor was required to pay Virtual Crypto Israel an appointment fee not more than $250,000. In November 2018, Chiron reported that it had encountered financial difficulties and as such the Company will no longer pursue the transactions contemplated by the Chiron Term Sheet.

To date, $100,000 was paid by the Distributor to Virtual Crypto Israel, which has been recognized as revenuesnet loss for the year ended December 31, 2018.

E.Going Concern:

The Company2021 and 443 in net loss for the year ended December 31,2020, has incurred significant operating losses$2,280 stockholders’ deficit as of December 31, 2021 and $2,078 in total stockholders’ deficit as of December 31, 2020 and $74 in negative cash flows from operating activities in relation to its operations since inception. While the Company raised approximately $1.9 million infor the year ended December 31, 20182021 and 53 in negative cash flows from operations for the year ended December 31, 2020. Since January 2020, the Company has significantly reduced its operations and expenses of Viewbix Israel. Management expects the Company to continue to generate substantial operating losses and to continue to fund theits operations primarily through utilization of its New Subsidiary, the Company will require additional capital resources in order to support the commercialization of the New Subsidiary’s technology and operations and maintain its research and development activities related to the New Subsidiary’s technology. The Company is addressing its liquidity needs by seeking additional funding from public and/or private sources. There are no assurances, however, that the Company will be able to obtain an adequate level ofcurrent financial resources that are required for the Company’s short and long-term requirements, or at all thesethrough additional raises of capital.

Such conditions raise substantial doubtdoubts about the Company’s ability to continue as a going concern. The consolidatedManagement’s plan includes raising funds from outside potential investors. However, there is no assurance such funding will be available to the Company or that it will be obtained on terms favorable to the Company or will provide the Company with sufficient funds to meet its objectives. These financial statements do not include any adjustments relating to reflect the possible future effects on recoverability and classification of assets, carrying amounts or the amountsamount and classification of liabilities that may result frombe required should the outcome of this uncertainty.Company be unable to continue as a going concern.

Note

F-11

Viewbix Inc.

Notes to Consolidated Financial Statements

U.S. dollars in thousands (except share and per share data)

NOTE. 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

The consolidated financial statements were prepared in accordance withsignificant accounting principles generally accepted in the United States of America (US GAAP).

Use of estimatespolicies used in the preparation of consolidated financial statements

This Management’s Discussion and Analysis of Financial Condition and Results of Operations discuss our financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). In connection with the preparation of our financial statements, we are required to make assumptions and estimates about future events, and apply judgments that affect the reported amounts of assets, liabilities, revenue, expenses and the related disclosures. We base our assumptions, estimates and judgments on historical experience, current trends and other factors that management believes to be relevant at the time our consolidated financial statements are prepared. On a regular basis, management reviews the accounting policies, assumptions, estimates and judgments to ensure that our financial statements are presented fairly and in accordance with U.S. GAAP. However, because future events and their effects cannot be determined with certainty, actual results could differ from our assumptions and estimates, and such differences could be material. As applicable to the consolidated financial statements included elsewhere in this report, the most significant estimates and assumptions relate to (i) the going concern assumptions, (ii) measurement of Convertible Note.as follows:

Functional currency

The functional currency of the Company and its subsidiary is the US dollar, which is the currency of the primary economic environment in which it operates. In accordance with ASC 830, “Foreign Currency Matters” (ASC 830), balances denominated in or linked to foreign currency are stated on the basis of the exchange rates prevailing at the applicable balance sheet date. For foreign currency transactions included in the statement of operations, the exchange rates applicable on the relevant transaction dates are used. Gains or losses arising from changes in the exchange rates used in the translation of such transactions are carried as financing income or expenses.

Principles of consolidation

The consolidated financial statements include the accounts of the Company and its subsidiary. All intercompany balances and transactions have been eliminated in consolidation.

Cash and cash equivalents

The GroupCompany considers all short-term investments, which are highly liquid investments with original maturities of three months or less at the date of purchase, to be cash equivalents.

Marketable Securities

The Company accounts for investments in marketable securities in accordance with ASC Topic 320-10,“Investments - Debt and Equity Securities” (“ASC Topic 320-10”). Management determines the appropriate classification of its investments in marketable securities at the time of purchase and reassesses such determination at each balance sheet date. The investments in marketable securities covered by ASC Topic 320-10 that were held by the Company during the reported periods were designated by management as trading securities. Trading securities are stated at market value. The changes in market value are charged to financing income or expenses. Trading losses for the years 2018 and 2017 amounted to approximately $ 40,160 and nil respectively.

Property and equipment

 

1. Property and equipment are stated at cost, net of accumulated depreciation. Depreciation is calculated using the straight-line method over the estimated useful lives of the assets. When an asset is retired or otherwise disposed of, the related carrying value and accumulated depreciation are removed from the respective accounts and the net difference less any amount realized from disposition is reflected in the statements of operations.

2. Rates of depreciation:

%
Computers33
Furniture and office equipment7-15

Impairment of long-lived assets

The Group’s long-lived assets are reviewed for impairment in accordance with ASC 360, “Property, Plant and Equipment”, whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to the future undiscounted cash flows expected to be generated by the asset. If such asset is considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the asset exceeds its fair value. To date the Group did not incur any material impairment losses.

Accounting For Obligations And Instruments Potentially To Be Settled In The Company’s Own Stock:

We account for obligations and instruments potentially to be settled in the Company’s stock in accordance with FASB ASC 815, Accounting for Derivative Financial Instruments. This guidance addresses the initial balance sheet classification and measurement of contracts that are indexed to, and potentially settled in, the Company’s own stock.

Fair Value of Financial Instruments:

FASB ASC 825, “Financial Instruments,” requires entities to disclose the fair value of financial instruments both

The carrying values of Company’s financial assets and liabilities, recognized and not recognized on the balance sheet, for which it is practicable to estimate fair value. FASB ASC 825 defines fair value of a financial instrument as the amount at which the instrument could be exchanged in a current transaction between willing parties. At December 31, 2018 and 2017, the carrying value of certain financial instruments (cashincluding cash and cash equivalents, restricted cash, other current assets, trade payables, other accounts payable and accrued expenses and employee payable.) approximatesfinancing provided by the Parent Company approximate their fair value due to the short-term naturematurity of the instruments or interest rates, which are comparable with current rates.these instruments.

The Company measures its derivative warrant liabilities at fair value at each period. The Company adopted the FASB standard related to fair value measurement at inception. The standard defines fair value, establishes a framework for measuring fair value and expands disclosure of fair value measurements. The standard applies under other accounting pronouncements that require or permit fair value measurements and, accordingly, does not require any new fair value measurements. The standard clarifies that fair value is an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability.

As a basis for considering such assumptions, the standard established a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value as follows.

Level 1. Observable inputs such as quoted prices in active markets;

Level 2. Inputs, other than quoted prices in active markets, that are observable either directly or indirectly; and

Level 3. Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions.

37F-12
 

 

Viewbix Inc.

Notes to Consolidated Financial Statements

U.S. dollars in thousands (except share and per share data)

NOTE. 2 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Cont.)

Accounting For Convertible Debt Instruments

We account for convertible debt instruments, which do not meet the definition of a derivative financial instrument per FASB ASC 815, Accounting for Derivative Financial Instruments, in accordance with FASB ASC 470-20, Debt with Conversion and Other Options. This guidance addresses the allocation of proceeds from the issuance of convertible debt into its equity and debt components. Discount on the debt component resulting from allocation of proceeds to the equity component is amortized in the profit and loss statement as finance expense.

Allocation of proceeds into equity and debt components of convertible notes issued together with other detachable financial instruments is performed, in relation to the proceeds allocated to the convertible notes, based on the relative fair value of such convertible notes and the other detachable financial instruments issued.

Share-based compensation

The Company applies ASC 718-10, “Share-Based Payment,” which requires the measurement and recognition of compensation expenses for all share-based payment awards made to employees and directors (including employee stock options under the Company’s stock plans) based on estimated fair values.

ASC 718-10 requires companies to estimate the fair value of equity-based payment awards on the date of grant. The value of the portion of the award that is ultimately expected to vest is recognized as an expense over the requisite service periods in the Company’s statement of operations.

The Company recognizes compensation expenses for the value of non-employee awards based on the straight-line method over the requisite service period of each award, net of estimated forfeitures.

The Company estimates the fair value of stock options granted as equity awards using a Black-Scholes options pricing model. The option-pricing model requires a number of assumptions, of which the most significant are share price, expected volatility and the expected option term (the time from the grant date until the options are exercised or expire). Expected volatility is estimated based on volatility of similar companies in the technology sector. The Company has historically not paid dividends and has no foreseeable plans to issue dividends. The risk-free interest rate is based on the yield from governmental zero-coupon bonds with an equivalent term. The expected option term is calculated for options granted to employees and directors using the “simplified” method. Grants to non-employees are based on the contractual term. Changes in the determination of each of the inputs can affect the fair value of the options granted and the results of operations of the Company.

Earnings per Common Share

Basic netEarnings or loss per share (“EPS”) is the amount of earnings attributable to each share of common stock. For convenience, the term is used to refer to either earnings or loss per share. EPS is computed pursuant to ASC 260-10-45. Pursuant to ASC 260-10-45-10 through 260-10-45-16 Basic EPS is computed by dividing net loss, as adjustedincome available to includecommon stockholders (the numerator) by the weighted averageweighted-average number of common shares outstanding (the denominator) during the year. Common shares and preferred shares contingently issuable for little or no cash are included in basic net loss per share on an as issued basis.

Diluted net loss per share isperiod. Income available to common stockholders shall be computed by dividingdeducting both the dividends declared in the period on preferred stock (whether or not paid) from income from continuing operations (if that amount appears in the income statement) and also from net loss, as adjustedincome. The computation of diluted EPS is similar to include preferred shares dividend participation rightsthe computation of preferred shares outstanding duringbasic EPS except that the year as well as of preferred shares that would have been outstanding if all potentially dilutive preferred shares had been issued, by the weighted average number of common shares outstanding during the year, plusdenominator is increased to include the number of additional common shares that would have been outstanding if all potentiallythe dilutive potential common shares had been issued usingduring the treasury stock method, in accordance with ASC 260-10 “Earnings per Share”.

All outstandingperiod to reflect the potential dilution that could occur from common shares issuable through contingent shares issuance arrangement, stock options and warrants have been excluded from the calculation of the diluted loss per share for the years ended December 31, 2018 and December 31, 2017, since all such securities have an anti-dilutive effect.or warrants.

Revenue recognition

The Company follows paragraph 605-10-S99applies the provisions of the FASBAccounting Standards Codification for revenue recognition. (or “ASC”) 606, Revenue from Contracts with Customers (“ASC 606”).

The Company will recognizegenerates revenues primarily by granting customers the right to access software products through the Company’s cloud-based SaaS subscription offerings. Under a SaaS subscription agreement, the customer receives a right to access the software for a specified period of time in an environment hosted, supported, and maintained by the Company. SaaS subscription services are a single performance obligation satisfied over time, and associated revenue when it is realized or realizable and earned. The Company considers revenue realized or realizable and earned when allgenerally recognized ratably over the following criteria are met: (i) persuasive evidence of an arrangement exists, (ii)contract term once the product has been shipped or the services have been renderedsoftware is made available to the customer, (iii)customer. The SaaS subscription offerings are typically sold with one year subscription terms, generally invoiced in advance of each annual subscription period, and are non-cancelable during the sales price is fixed or determinable, and (iv) collectability is reasonably assured.committed subscription term.

38

 

Research and development expenses net::

Research and development expenses are charged to the statement of operations as incurred.

Income Taxes:Taxes:

We have adopted FASBThe Company accounts for income taxes in accordance with ASC 740, Accounting for Income Taxes. Pursuant to“Income Taxes”, and (“ASC 740”). ASC 740 we are required to computeprescribes the use of the asset and liability method whereby deferred tax asset benefits for net operating losses carried forward. The potential benefits of net operating losses have not been recognized in these consolidated financial statements because the Company cannot be assured it is more likely than not it will utilize the net operating losses carried forward in future years.

We must make certain estimates and judgments in determining income tax expense for consolidated financial statements purposes. These estimates and judgments occur in the calculation of certain tax assets and liabilities, which arise from differences in the timing of recognition of revenue and expense for tax and consolidated financial statements purposes.

Deferred tax assets and liabilitiesliability account balances are determined based on the differences between the financial reporting and the tax basisbases of assets and liabilities and for carry forward tax losses. Deferred taxes are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. ASC 740 provides for the recognition ofThe Company records a valuation allowance, if necessary, to reduce deferred tax assets to their estimated realizable value if realization of such assetsit is more likely than not to occur. Realization of our net deferred tax assets is dependent upon our generating sufficient taxable income in future years in appropriate tax jurisdictions to realize benefit from the reversal of temporary differences and from net operating loss,more-likely-than-not that some portion or NOL, carryforwards. We have determined it more likely than not that these timing differences will not materialize and have provided a valuation allowance against substantially all of our net deferred tax asset. Management will continue to evaluate the realizability of the deferred tax asset and its related valuation allowance. If our assessment of the deferred tax assets or the corresponding valuation allowance were to change, we would record the related adjustment to income during the period in which we make the determination. Our tax rate may also vary based on our results and the mix of income or loss in domestic and foreign tax jurisdictions in which we operate.will not be realized.

In addition, the calculation of our tax liabilities involves dealing with uncertainties in the application of complex tax regulations. We recognize liabilities for anticipated tax audit issues in the U.S. and other tax jurisdictions based on our estimate of whether, and to the extent to which, additional taxes will be due. If we ultimately determine that payment of these amounts is unnecessary, we will reverse the liability and recognize a tax benefit during the period in which we determine that the liability is no longer necessary. We will record an additional charge in our provision for taxes in the period in which we determine that the recorded tax liability is less than we expect the ultimate assessment to be.

ASC 740 which requiresprescribes a recognition of estimated income taxes payable or refundable on income tax returnsthreshold and measurement attribute for the current yearfinancial statement recognition and for the estimated future tax effect attributable to temporary differences and carry-forwards. Measurement of deferred income tax is based on enacted tax laws including tax rates, with the measurement of deferred income tax assets being reduced by available tax benefits not expected to be realized.

Uncertain Tax Positions:

When tax returns are filed, it is highly certain that some positions taken would be sustained upon examination by the taxing authorities, while others are subject to uncertainty about the merits of the position taken or the amount of the position that would be ultimately sustained. In accordance with the guidance of FASB ASC 740-10, Accounting for Uncertain Income Tax Positions, the benefit of a tax position taken or expected to be taken in a tax return. The first step is recognizedto evaluate the tax position taken or expected to be taken in a tax return. This is done by determining if the consolidated financial statements in the period during which, based on allweight of available evidence management believesindicates that it is more likely than notmore-likely-than-not that, on an evaluation of the technical merits, the tax position will be sustained upon examination,on audit, including the resolution of any related appeals or litigation processes, if any. Tax positions taken are not offset or aggregated with other positions. Tax positions that meetprocesses. The second step is to measure the more-likely-than-not recognition threshold are measuredtax benefit as the largest amount of tax benefit that is more than 50 percent50% likely of beingto be realized upon settlement with the applicable taxing authority. ultimate settlement.

F-13

Viewbix Inc.

Notes to Consolidated Financial Statements

U.S. dollars in thousands (except share and per share data)

Note 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Cont.)

Contingencies:

The portion of the benefits associated with tax positions taken that exceeds the amount measured as described above should be reflected as a liability for unrecognized tax benefits in the accompanying consolidated balance sheets along with any associated interest and penalties that would be payable to the taxing authorities upon examination.

Contingencies

The GroupCompany records accruals for loss contingencies arising from claims, litigation and other sources when it is probable that a liability has been incurred and the amount can be reasonably estimated. These accruals are adjusted periodically as assessments change or additional information becomes available. Legal costs incurred in connection with loss contingencies are expensed as incurred.

Accounting for Income Taxes

In December 2019, the Financial Accounting Standards Board issued Accounting Standards Update No. ASU 2019-12, “Simplifying the Accounting for Income Taxes”. This ASU amends Accounting Standards Codification (“ASC”) 740 by removing certain exceptions to the general principles, clarifying and amending existing guidance. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2020. The Company adopted this standard in the first quarter of 2021. The adoption of this ASU did not impact our financial statements or the related disclosures.

Recently issued accounting pronouncements

Financial Instruments – Credit Losses

In June 2016, the FASB issued ASU 2016-13, “Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments” (“ASU 2016-13”). ASU 2016-13 replaces the current incurred loss model guidance with a new method that reflects expected credit losses. Under this guidance, an entity would recognize an allowance for credit losses equal to its estimate of expected credit losses on financial assets measured at amortized cost. In November 2019, the FASB extended the effective date of ASU 2016-13 for smaller reporting companies. As a result, ASU 2016-13 is effective for fiscal years, and interim periods within those years, beginning after December 15, 2022, with early adoption permitted. The standard is not expected to have a significant impact on the Company’s consolidated financial statements.

Convertible instruments

In August 2020, the FASB issued ASU 2020-06, “Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity” (“ASU 2020-06”). ASU 2020-06 simplifies the accounting for convertible instruments by removing certain separation models in Accounting Standards Codification (“ASC”) 470-20, “Debt—Debt with Conversion and Other Options,” (“ASC 470-20”) for convertible instruments. Under ASU 2020-06, the embedded conversion features no longer are separated from the host contract for convertible instruments with conversion features that are not required to be accounted for as derivatives under ASC 815, “Derivatives and Hedging,” or that do not result in substantial premiums accounted for as paid-in capital. For smaller reporting companies, ASU 2020-06 is effective for fiscal years, and interim periods within those years, beginning after December 15, 2023, with early adoption permitted for fiscal years beginning after December 15, 2020. The Company is currently assessing the impact of this update on the Company’s consolidated financial statements.

F-14

Viewbix Inc.

Notes to Consolidated Financial Statements

U.S. dollars in thousands (except share and per share data)

Note 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Cont.)

Business Combination

On October 28, 2021, the FASB issued ASU 2021-08, which amends ASC 805 to “require acquiring entities to apply Topic 606 to recognize and measure contract assets and contract liabilities in a business combination.” Under current GAAP, an acquirer generally recognizes such items at fair value on the acquisition date. According to the FASB, this Update is intended “to improve the accounting for acquired revenue contracts with customers in a business combination by addressing diversity in practice and inconsistency related to the following:

1.Accounting Standard Update 2014-09, “Revenue from Contracts with Customers”Recognition of an acquired contract liability
 

Commencing January 1, 2018,

Payment terms and their effect on subsequent revenue recognized by the Company adopted Accounting Standard Update 2014-09, Revenue from Contracts with Customers (Topic 606) (“ASU 2014-09”).

ASU 2014-09 outlines a single comprehensive model to use in accounting for revenue arising from contracts with customers and supersedes most current revenue recognition guidance, including industry-specific guidance. ASU 2014-09 also requires entities to disclose sufficient information, both quantitative and qualitative, to enable users of financial statements to understand the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers.

An entity should apply the amendments in ASU 2014-09 using one of the following two methods:

1. Retrospectively to each prior reporting period presented with a possibility to elect certain practical expedients, or,

2. Retrospectively with the cumulative effect of initially applying ASU 2014-09 recognized at the date of initial application. If an entity elects the latter transition method, it also should provide certain additional disclosures.

During 2016, the FASB issued several Accounting Standard Updates (“ASUs”) that focus on certain implementation issues of the new revenue recognition guidance including Narrow-Scope Improvements, Practical Expedients and technical corrections.
In accordance with an amendment to ASU 2014-09, introduced by Accounting Standard 2015-14, “Revenue from contracts with Customers – Deferral of the Effective Date”, for a public entity, the amendments in ASU 2014-09 became effective for annual reporting periods beginning after December 15, 2017, including interim periods within that reporting period (the first quarter of fiscal year 2018 for the Company).
The adoption of ASU 2014-09 did not have a significant impact on its consolidated financial statements.acquirer.

ASU 2021-08 06 is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. We are currently assessing the impact of this update on the Company’s consolidated financial statements.

Warrants

In May 2021, the Financial Accountings Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2021-04, “Earnings Per Share (Topic 260), Debt—Modifications and Extinguishments (Subtopic 470-50), Compensation—Stock Compensation (Topic 718), and Derivatives and Hedging— Contracts in Entity’s Own Equity (Subtopic 815- 40): Issuer’s Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options” (“ASU 2021-04”). The guidance is effective for the Company on January 1, 2022. The Company is currently evaluating the impact of adopting this standard

2.Note 3.Accounting Standard Update (ASU) No. 2017-11, “Earnings Per Share”OTHER ACCOUNTS PAYABLE AND ACCRUED LIABILITIES
In July 2017, the FASB issued ASU No. 2017-11, Earnings Per Share (Topic 260); Distinguishing Liabilities from Equity (Topic 480); Derivatives and Hedging (Topic 815): (Part I) Accounting for Certain Financial Instruments with Down Round Features, (Part II) Replacement of the Indefinite Deferral for Mandatorily Redeemable Financial Instruments of Certain Nonpublic Entities and Certain Mandatorily Redeemable Noncontrolling Interests with a Scope Exception (“ASU 2017-11”).
Among others, Part I of ASU 2017-11 simplifies the accounting for certain financial instruments with down round features, which is a provision in an equity-linked financial instrument (or embedded feature) that provides a downward adjustment of the current exercise price based on the price of future equity offerings. Current accounting guidance creates cost and complexity for organizations that issue financial instruments with down round features by requiring, on an ongoing basis, fair value measurement of the entire instrument or conversion option.

Composition:

SCHEDULE OF OTHER ACCOUNTS PAYABLE AND ACCRUED LIABILITIES

  As of
December 30
  As of
December 31
 
  2021  2020 
       
Other payables and deferred revenues $47  $47 
Accrued liabilities  195   130 
Total other accounts payables $242  $177 

F-15
 

Viewbix Inc.

Notes to Consolidated Financial Statements

U.S. dollars in thousands (except share and per share data)

ASU 2017-11 require companies to disregard the down round feature when assessing whether the instrument is indexed to its own stock, for purposes of determining liability or equity classification. Companies that provide earnings per share (EPS) data will adjust their basic EPS calculation for the effectNote 4.RELATED PARTY TRANSACTIONS.

Balances:

SCHEDULE OF RELATED PARTY TRANSACTIONS

  December 31,  December 31, 
  2021  2020 
         
Gix – Company Payable $2,116  $2,054 

As part of the agreement with Gix, the parties agreed to have the Company’s operations outsourced to Gix from the agreement date and until the acquisition is consummated. The following term were included in the agreement pursuant to the above:

(a)From May 2018 all of the feature when triggered (i.e., whenCompany’s employees will become employees of Gix.
(b)Between the exercise priceperiods of May 2018 to October 2018, Gix will pay the full expenses of the employees as well as other related equity-linked financial instrument is adjusted downward because of the down round feature) and will also recognize the effect of the trigger within equity.expenses.
(c)ASU 2017-11 also addresses navigational concerns withinFrom November 2018 until to the FASB Accounting Standards Codification related to an indefinite deferral available to private companies.
The provisions ofClosing Date, the new ASU related to down rounds are effective for public business entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018 (fiscal 2019 for the Company). Early adoption is permitted for all entities.
The adoption of ASU 2017-11 did not have a significant impact on its consolidated financial statements

3.Accounting Standard Update 2018-07, Compensation—Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting

In June 2018, the FASB issued Accounting Standard Update 2018-07, Compensation—Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting (ASU 2018-07). ASU 2018-07 aligns the measurement and classification guidance for share-based payments to nonemployees with the guidance for share-based payments to employees with certain exceptions.

Consistent with the accounting requirement for employee share-based payment awards, nonemployee share-based payment awards within the scope of Topic 718 will be measured at grant-date fair value of the equity instruments that an entity is obligated to issue when the goods has been delivered or the service has been rendered and any other conditions necessary to earn the right to benefittransferred from the instruments have been satisfied. Equity-classified nonemployee share-based payment awardsCompany to Gix will be measured at the grant date.
With respect to awards with performance conditions, ASU 2018-07 concludes that, consistent with the accounting for employee share-based payment awards, an entity will consider the probabilitydedicate half of satisfying performance conditions when nonemployee share-based payment awards contain such conditions.
ASU 2018-07 also requires that the classification of equity classified nonemployee share-based payment awards will continue to be subject to the requirements of Topic 718 unless the award was modified after the goods has been delivered, the service has been rendered, any other conditions necessary to earn the right to benefit from the instruments have been satisfied, and the nonemployee is no longer providing goods or services. This eliminates the requirement to reassess classification of such awards upon vesting.
In addition, ASU 2018-07 includes certain Non-public Entity-Specific Amendments.
ASU 2018-07 is effective for Public entities in annual periods beginning after 15 December 2018, and interim periods within those years (first quarter of 2019 for the Company). Early adoption is permitted, including in an interim period, but not before an entity adopts the new revenue guidance (which was adopted by the Company in its interim financial statements for 2018).
An entity should only remeasure liability-classified awards that have not been settled by the date of adoption and equity-classified awards for which a measurement date has not been established through a cumulative-effect adjustment to retained earnings as of the beginning of the fiscal year of adoption. Upon transition, the entity is required to measure these nonemployee awards at fair value as of the adoption date.
The Company is evaluating the impact of ASU 2018-07 on its financial statements.
4.

In February 2016, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update No. 2016-02 (Topic 842) “Leases”. Topic 842 supersedes the lease requirements in Accounting Standards Codification (ASC) Topic 840, “Leases”. Under Topic 842, lessees are required to recognize assets and liabilities on the balance sheet for most leases and provide enhanced disclosures. ASU No. 2016-02 is effective for interim and annual reporting periods beginning after December 15, 2018. In July 2018, the FASB issued amendments in ASU 2018-11, which provide a transition election to not restate comparative periods for the effects of applying the new standard. This transition election permits entities to change the date of initial application to the beginning of the earliest comparative period presented, or retrospectively at the beginning of the period of adoption through a cumulative-effect adjustment.

The Company is currently evaluating the impact that the adoption of ASU 2016-02 will have on its financial statements and related disclosures.

5.

Commencing January 1, 2018, the Company adopted ASU 2016-18, Statement of Cash Flows (Topic 230):

“Restricted Cash” (ASU 2016-18), which requires companies to include amounts generally described as restricted cash and restricted cash equivalents in cash and cash equivalents when reconciling beginning-of-period and end-of-period total amounts shown on the statement of cash flows. The amendments in this update are effective for public business entities for fiscal years beginning after December 15, 2017, and interim periods within those fiscal years.

This guidance did not have a material impact on the Company’s consolidated financial statements.

Note 3 - Convertible Notes

A.On August 7, 2017, the Company entered into the settlement agreement with Alpha and Chi Squared Capital Inc. as a result of the fact that Alpha and Chi Squared had taken the position that certain defaults may have occurred as a result of actions and/or inactions by the Company with respecttheir time to the Company’s obligations under convertible notes (the “Notes”) issued during 2016, whichoperations and correspondingly 50% of the Company did not deemcosts to be defaults (the “Settlement Agreement”).
Pursuant to the Settlement Agreement, the Notes, which had originally provided for a maturity date of June 19, 2017 and were in the original principal amounts of $400,000 and $40,000, respectively, were extended until June 19, 2019, in consideration for which the Company agreed to an increase in the principal amounts to $551,600 and $55,160, respectively, both of which retain the adjusted conversion price of $0.14, calculated in accordance with the terms of the original Notes. Such conversion price is subject adjustments in the event of future financing at a price of less than $0.14 per share. As a further part of the settlement, the Company agreed to issue Alpha and Chi Squared a total of 528.82 newly authorized shares of Series A Convertible Preferred Stock having a stated value and liquidation preference of $1,000 per share, and are convertible into a total of 3,778,647 shares based upon a conversion price of $0.14 per share, subject to adjustment in the event of a future financing such that the amount of ordinary shares to be issued pursuant to conversion of Series A Convertible Preferred Stock will represent the value of $1,000, per 1 Series A Convertible Preferred Stock, based on a conversion price which is identical to the ordinary share price at which securities are offered in such future financing. The Series A Convertible Preferred Stock shall be entitled to receive dividends on the same basis as Ordinary Shares and shall have no voting rights.
As part of the Settlement Agreement, the Company extended the Alpha Chi Option to July 15, 2018.
The settlement was accounted for as extinguishment of the pre-settlement notes and re issuance of the Notes and Series A Convertible Preferred Stock. As a result of the Settlement Agreement, the Company recorded a charge to general and administrative expenses in the Statement of Operation Losses of $440,684 representing the penalties and liquidation damages portion of the above-mentioned provision, and $219,276 was charged to finance expenses in the Statement of Operating Losses. The Series A Convertible Preferred Stock were recorded in shareholders’ equity at their fair value at the effective date of the settlement. As the Company concluded the conversion feature embedded in the amended notes is not a beneficial conversion feature pursuant to the provisions of ASC 470-20 (“Debt with Conversion and Other Options”), the post amendment carrying amount of the convertible notes, which was based on the fair value of the convertible notes at the effective date of the settlement, was recorded in liabilities in its entirely.
The Company accounts for options to purchase convertible notes and warrants (refer to the Alpha Chi Option above) as derivative liabilities that are measured at their far value at each period end, in accordance with ASC 815 (“Derivatives and Hedging”).
The Company uses directly observable inputs as well as significant unobservable inputs in the valuation of these derivative liabilities. The inputs used in the valuation are risk free interest rate, expected volatility, expect option term, expected dividend yield and Company specific discount rate.
On January 24, 2018, Alpha Anstalt Capital (“Alpha”), Chi Squared Capital (“Chi”), Firstfire Global Opportunities Fund LTC, Goldmed Ltd, IlanMalca and Maz Partners, former holders of the Company’s convertible notes, sold their convertible notes previously issuedincurred by the Company in the aggregate amount of $958,611 (the “January 2018 Convertible Notes”) to certain new third-party accredited investors (the “New Investors”) and, in connection therewith, the Company and the New Investors agreed to: (i) amend the conversion price of the January 2018 Convertible Notes from $0.014 to $0.01; (ii) cancel the Class A warrants and Class B warrants issued together with the January 2018 Convertible Notes (see Note 4 Stockholders’ Equity for accounting treatment of the cancelled warrants); (iii) amend the interest rate from 8% to 1% per annum under the January 2018 Convertible Notes; (iv) extend the repayment/maturity date on the January 2018 Convertible Notes to January 23, 2019 (see Subsequent Events Note 10 ); and (iv) cancel the options granted to Alpha and Chi in July 2016 (the “Alpha-Chi Options”).
The change in terms of the January 2018 Convertible Notes, including the cancellation of the above-referenced warrants, was accounted for as an extinguishment of the convertible notes and the issuance of new convertible notes. The Company recorded a finance expense in the amount of $21,622,897 in the Statement of Comprehensive Loss and an increase to Additional Paid-in Capital in the Statement of Stockholders’ Deficit of $22.6 million as a result of the transaction.
The Company further concluded that the post-amended January 2018 Convertible Notes contain a -beneficial conversion feature equal to the par value of the January 2018 Convertible Notes ($958,611) and accordingly, recorded a discount on the January 2018 Convertible Notes, to be amortized to finance expense in the Statement of Comprehensive Loss over the term of the January 2018 Convertible Notes.
On January 24, 2018, $73,000 of the January 2018 Convertible Notes was converted, at the adjusted conversion price of $0.01 per share, into 7,300,000 shares of the Company’s common stock and on March 19, 2018, a further $9,218 of the January 2018 Convertible Notes were converted, at the adjusted conversion price of $0.01 per share, into 921,800 shares of the Company’s common stock and on December 9, 2018, $465,172 of the January 2018 Convertible Notes was converted, at the adjusted conversion price of $0.01 per share, into 465,172,000 shares of the Company’s common stock.

  December 31, 2018  December 31, 2017 
       
Principle $958,611  $890,766 
Conversion of convertible notes to shares  (547,390)  - 
Accrued interest  -   67,846 
Discount  (13,938)  - 
Total  397,283   958,612 
B.In January 2018, the Company received from certain third-party accredited investors $100,000 in consideration for the issuance of convertible promissory notes (the “$100,000 Convertible Notes”) as follows: (i) interest at the rate of 1% per annum; (ii) a conversion price of $0.01 per share of common stock; and (iii) repayable through to January 15, 2019, without penalty. The beneficial conversion feature was valued at $100,000, which resulted in a $100,000 discount recorded as a reduction of debt and an increase to additional paid in capital in the Statement of Stockholders’ Deficit. The discount is amortized to finance expenses in the consolidated statements of Comprehensive Loss over the term of the $100,000 Convertible Notes.
On January 23, 2018, $3,000 of the $100,000 Convertible Notes was converted at $0.01 per share into 300,000 shares, based upon the $100,000 Notes conversion price of $0.01 per share of common stock and On December 14 2018, $5,004 of the $100,000 Convertible Notes was converted, at the conversion price of $0.01 per share, into 504,600 shares of the Company’s common stock.

  December 31, 2018  December 31, 2017 
       
Principle $100,000  $         - 
Conversion of convertible notes to shares  (8,004)  - 
Discount  (3,830)  - 
Total  88,166   - 

Note 4 - Stockholders’ Equity.

A.Shares of common stock confer upon their holders the right to receive notice to participate and vote in general meetings of shareholders of the Company, the right to receive dividends, if declared, and the right to receive a distribution of any surplus of assets upon liquidation of the Company.
B.Preferred shares confer upon their holders the right to receive dividends when paid to holders of common stock of the Company on an as-converted basis, and the right to receive a distribution of any surplus of assets upon liquidation of the Company before any distribution or payment shall be made to the holders of any common stock.
C.Issuances of Common Stock and Warrants during 2018 and 2017
1.On February 24, 2017, Publicis Groupe 90 (“Publicis 90”) invested 500,000 Euros or approximately U$526,000 and the Registrant accepted a Reg S Subscription Agreement from Publicis 90 in consideration for the issuance to Publicis 90 of 1,315,563 restricted shares of the Registrant’s common stock at a subscription price of $0.40 per share. The issuance was made in reliance upon the exemptions provided in Section 4(2) of the Securities Act of 1933, as amended (the “Act”) and Regulation S promulgated by the SEC under the Act.
2.On April 25, 2017, a holder of a convertible note in the principal amount of $100,000 issued in July 2016, converted $10,400 into 74,572, shares based on an adjusted conversion price of $0.14. The conversion price was adjusted on March 22, 2017 pursuant to the provisions of the 2016 Secured Convertible Note Agreement.
3.On June 12, 2017, certain warrant holders holding 1,100,000 Class A Warrants and 1,100,000 Class B Warrants, elected to exercise certain warrants on a cashless basis. In accordance with the 2016 Secured Convertible Note Agreement the Class A warrants and Class B warrants were increased to 5,665,626 each, based on an adjusted share price of $0.14 per share and 3,451,490 Class B Warrants were converted to 1,096,395 shares at $0.14 per share. The exercise price and number of shares issued were adjusted on March 22, 2017.
4.On June 12, 2017, the Company completed the issuance of 125,000 shares of the Company’s common stock to Alpha pursuant to the Company’s agreement with Alpha in the prior year.
5.In July and August 2017, the Company received $80,000Gix in respect of 571,429 unitsthese employees are to two accredited investors for $0.14 per unit. Each unit consist (i) 571,429 shares at a price of $0.14 per share, (ii) 571,429 Class H warrants exercisable for a one-year period in exercise price of $0.14, and (iii) 571,429 Class I warrants exercisable for a two-year period. As of December 31, 2017, the Company had not issued the shares or the warrantsbe charged to the accredited investors as such, the proceeds were recorded as Receipts on Account of shares in the Company’s shareholders equity statement.
On February 8, 2018, the Company issued 571,429 units to two accredited investors in consideration for subscription proceeds of $80,000 which proceeds were received in August 2017.
6.Between January 2018 and April 2018, the Company received the aggregate amount of $1,940,950 in subscription proceeds from certain “accredited investors” in consideration for the issuance of 27,697,855 units (the “Units”) at an offering price of $0.07 per Unit (the “$0.07 Unit Offering”), each consisting of: (i) one (1) share of the Company’s common stock (the “Shares”); (ii) one (1) common stock purchase warrant exercisable for a period of twelve months to purchase one additional Share at an exercise price of $0.14 per Share (the “Class F Warrants”); and (iii) one (1) common stock purchase warrant exercisable for a period of twelve months to purchase one additional Share at an exercise price of $0.28 per Share (the “Class G Warrants”).
7.On January 26, 2018, the Company signed a two-year consulting agreement with Maz Partners, pursuant to which it will to provide investment and corporate finance advice to the Company in consideration for 200,000 Class H Warrants. Each Class H Warrant is exercisable through to January 2020 to purchase one (1) Share at an exercise price of $0.14 per Share. The fair value of these Class H Warrants at the issuance date was $39,845 and was charged to General and administration expenses in the Statement of Comprehensive Loss with a corresponding credit to Additional Paid-in Capital in the Statement of Changes in Stockholders’ Deficit. The fair value was estimated using the Black-Scholes option pricing model and the following weighted average assumptions: share price - $0.24; exercise price - $0.14; expected life - 24 months; annualized volatility - 170.7%; dividend yield - 0%; risk free rate – 0.7%, were charged to General and administration expenses in the Statement of Comprehensive Loss with a corresponding credit to Additional Paid-in Capital in the Statement of Changes in Stockholders’ Deficit.
8.On March 9, 2018, the Company signed a consulting agreement with Ayin, Nun, Chaf, Yeuzt Ltd, pursuant to which it will to provide professional legal advice to the Company in consideration for 550,000 Class H Warrants. Each Class H Warrant is exercisable through to March 2020 to purchase one (1) Share at an exercise price of $0.14 per Share. The fair value of these Class H Warrants at the issuance date was $134,566. The fair value was estimated using the Black-Scholes option pricing model and the following weighted average assumptions: share price - $0.26; exercise price - $0.14; expected life - 24 months; annualized volatility - 244.8%; dividend yield - 0%; risk free rate – 2.4%. $106,531 were charged to General and administration expenses in the Statement of Comprehensive Loss with a corresponding credit to Additional Paid-in Capital in the Statement of Changes in Stockholders’ Deficit.
9.On March 12, 2018, the Company issued a total of 3,629,999 restricted Shares to certain consultants, who were accredited investors, in connection with services rendered during the first quarter of 2018, which Shares were valued at $892,300, based on the closing Share price on the day prior to the issuance date. The above-mentioned amount was recorded as a charge to the Company’s Statement of Comprehensive Loss, with a corresponding credit to Additional Paid in Capital in the Company’s Consolidated Statement of Changes in Stockholders’ Deficit.
10.On March 20, 2018, the Company issued a total of 62,500 restricted Shares in consideration for the exercise of a stock option at an exercise price of $0.01 per Share, which options were granted in connection with services rendered in October 2016. The Company recorded the proceeds on the exercise of the stock option in Additional Paid-in Capital in its Consolidated Statement of Changes in Stockholders’ Deficit.
11.On April 20, 2018, the Company issued a total of 700,000 restricted Shares to certain consultants, who were accredited investors, in connection with services rendered during the second quarter of 2018, which Shares were valued at $112,000, based on the closing share price on the day prior to each of the issuances. The above-mentioned amount was recorded as a charge to the Company’s Statement of Comprehensive Loss, with a corresponding credit to Additional Paid in Capital in the Company’s Statement of Changes in Stockholders’ Equity.
12.As described in Note 3 above, the Company issued a total of 55,543,600 Shares in connection with the conversion of convertible note in amount of $555,390.
13.The following table summarizes information of outstanding warrants issued to investors and consultants in exchange for their services as of December 31, 2018 and 2017:Company.

December 31, 2018

  Warrants  Warrant Term Exercise Price  Exercisable 
Investors – Class F Warrants  27,697,855  January 2019 -April 2019 $0.14   27,697,855 
Investors – Class G Warrants  27,697,855  January 2019 -April 2019 $0.28   27,697,855 
Investors - Class H Warrants  1,321,429  January 2019 -March 2020 $0.14   1,321,429 
Investors - Class I Warrants  571,429  January 2020 $0.14   571,429 

December 31, 2017

  Warrants  Warrant Term  Exercise Price  Exercisable 
Investors - Class A Warrants  6,334,626  1 year  $0.14-0.80   6,334,626 
Investors - Class B Warrants  5,400,478  5 years  $0.14   5,400,478 
Alimi Ahmed - Class E Warrants (1)  900,000   (1) $0.0001   900,000 

D.Recent Option Grants
During the fiscal year ended December 31, 2017, the Company had outstanding awards for stock options under its 2017 Stock Incentive Plan (the “Plan”).
The Plan, which was approved by the Board of Directors on December 1, 2017 and provides for the grant of up to 2 million shares to eligible participants bearing such terms and conditions, including but not limited to vesting provisions, exercise price(s) and other terms as the Board of Directors may reasonably determine from time to time, expires on November 30, 2023. Options granted under the Plan may be exercised on a cash or cashless basis, and the number of shares eligible for grant under the Plan may be increased, and the option exercise price(s) and vesting terms may the adjusted by, the Board of Directors, subject to provisions of the Plan and applicable laws and rules. Any options under the Plans that are canceled or forfeited before expiration become available for future grants. The Board of Directors of the Company administers the Company’s stock incentive compensation and equity-based plans.
A summary of the Company’s activity related to options to employees, executives, directors and consultants and related information is as follows:

  For the year ended December 31, 2018  For the year ended December 31, 2017 
  Amount of options  Weighted average exercise price  Aggregate intrinsic value  Amount of options  Weighted average exercise price  Aggregate intrinsic value 
     $  $     $  $ 
Outstanding at beginning of year  62,500   0.01            4,193,397   0.11     
Granted  -   -       -   -          
Exercised  (62,500)  0.01       -   -     
Cancelled  -   -   -   (4,130,397)  (0.11)    
                         
Outstanding at the end of period  -   -   -   62,500   0.01     
Vested and expected-to-vest at end of period  -   -   -   62,500   0.01   - 

The aggregate intrinsic value inFrom the table above representsclosing date, the total intrinsic value (the difference between the fair market valueactual of the Company’s common shares on December 31, 2017 andexpenses incurred by Gix that related to the exercise price, multipliedCompany will be charged to the Company.

No amounts were paid by the number of in-the-money stock options on those dates) that would have been received by the stock option holders had all stock option holders exercised their stock options on those dates.Company to Gix during 2021 and 2020.

The stock options outstandingCompany entered into an agreement with Gix, its parent company, pursuant to which, effective as of December 31, 2017, have been separated2021, the parent company payable was modified into exercise prices, as follows:

Exercise

price

  

Stock options

outstanding as of

December 31,

  

Weighted average remaining contractual

life – years as of

December 31,

  

Stock options

exercisable as of

December 31,

 
   2017  2017  2017 
           
 0.01   62,500   8.25   62,500 
 0.01   62,500   8.25   62,500 

Compensation expense recordeda loan, which may be increased from time to time, upon the written mutual consent of the Company and Gix (the “Gix Loan”) .The Gix Loan bears interest at a rate equivalent to the minimal interest rate recognized and attributed by the Israel Tax Authority and will be repaid, together with the accrued interest, in one payment until December 31, 2022, unless extended upon mutual consent of the Company and Gix Internet.

The Company accounted for the modification as an extinguishment of the parent company payable and the issuance of a new debt. The loan was recorded at its fair value of $2,115,853 as of the modification date, with the difference of $184,103 between the fair value of the loan and the carrying value of the payable to the Parent Company recorded in the Company’s Consolidated Statement of Changes in Stockholders’ Deficit as a deemed contribution to the Company by the Parent Company, with a corresponding discount on the loan, to be amortized as finance expense in the Company’s Consolidated Statements of Comprehensive Loss over the term of the loan.

F-16

Viewbix Inc.

Notes to Consolidated Financial Statements

U.S. dollars in thousands (except share and per share data)

Note 5.SHORT TERM LOAN AND ISSUES OF SHARES

On December 18, 2020, the company entered into a Loan Agreement (the “Loan”) and Stock Subscription Agreement with certain Investors as described in note 1c, pursuant to which the Investors lent an aggregate amount of $69,000 (the “Principal Amount”). In accordance with the terms of the Loan, the company prepaid the interest on the Principal Amount of 8% compounded annually to the Investors as an issuance of 552,000 shares of Common Stock, at a price per share of $0.01. Under the Stock Subscription Agreement, the Investors transferred an amount of $30,587 to the company as consideration for the issued shares.

The Company allocated the total proceeds in respect of its stock-based employee compensation awards in accordance with ASC 718-10 for the year ended December 31, 2018shares issued and 2017the Loan extended based on theirrelative fair values. As a result of the allocation, a discount of $19 was nilrecorded on the loan. The discount is amortized over the term of the loan as finance expense.

The allocation of the proceeds to the fair value distribution of the liability and $76,616, respectively and are included in General and Administrative expenses inequity components on the Statementstransactions date was as follows:

SCHEDULE OF FAIR VALUE DISTRIBUTION OF LIABILITY AND EQUITY COMPONENTS

Instrument Fair Value  % of total fair  

Allocated

amount

 
Loan  55,200   49.45   49,246 
Shares  54,000   50.55   50,340 
Total  109,200   100   99,586 

The composition of Operationsshort term loan balance as of the transaction is as follows:

SCHEDULE OF COMPOSITION OF SHORT TERM LOAN

Note 5 - Commitments and Contingencies

A.The Company received grants to fund research and development projects from the State of Israel according to guidelines and procedures of the Office of the Chief Scientist of the Ministry of Industry and Trade. According to the agreement, the Company is obligated to pay royalties on the sale of products developed with the participation of the Chief Scientist. The royalty rate is 3.5% of sales and the total royalties will not exceed the amount of the grants received. As of December 31, 2018, total grants received amounted approximately $222 thousands.
The obligation to pay royalties is contingent upon the successful outcome of the Company’s research and development projects and the attainment of sales. The Company has no obligation to pay royalties, if sales are not generated, and if the research and development project fails.
B.In April 2017, a lawsuit was filed with the Tel Aviv court by Emerald’s former CEO and founder, claiming certain damages to the total amount of $100,000, under the assertion of wrongful dismissal by the Company. The Company believes these claims to be unsubstantiated and wholly without merit and intends to defend itself against these claims. The Company believes that there is a less than 50% chance of his claim being successful. Accordingly, no provision was recorded in regards to this claim.
C.In December 2017, a liquidation request was filed with the Tel Aviv court by a group of former Company’s employees under the assertion of delay of pay and insolvency. On December 20, 2017, a hearing discussion took place according to which the court decision that the Company shall settle its pension debts to the former employees within 21 days and settle its severance debts to them in 60 days, otherwise a winding-up order could be given. The amounts being claimed by the former employees are less than $96,000 and are included in current liabilities.
D.On January 29, 2018, the Company transferred the ordinary shares of its former Israeli subsidiary, Emerald Israel, to Attorney Eviatar Knoller, Esq., with offices at 20 Lincoln, Tel Aviv-Jaffa 6713412, as trustee (the “Trustee”). The purpose of the transfer of the management shares to the Trustee, pursuant to resolution of the Registrant’s Board of Directors, was to enable the Trustee to liquidate the management shares and/or the assets of Emerald Israel to satisfy its debts and satisfy its financial obligations to former employees. As a result, the former employees of Emerald Israel commenced an action in a court of competent jurisdiction in Israel to liquidate Emerald Israel and use any assets to satisfy the debts owed to the former employees.
E.On April 24, 2018, Emerald Israel reported to the District Court regarding the failure in contracting a buyer for its DermaCompare technology at fair market price and therefore that Emerald Israel was no longer opposed to the requested Liquidation Warrant. On May 1, 2018, the Official Receiver submitted its response to the District Court, stating that according to such announcement of Emerald Israel, it did not oppose the requested Liquidation Warrant either. Based on both the Company’s and the Official Receiver’s position, on May 2, 2018, the District Court issued a Winding-up Order and temporarily nominated Adv. Hanit Nov (attorney) as a Special Executor to Emerald Israel, who is still in the process of winding up Emerald Israel in terms of the court order.

Note 6 - General and administrative expenses.

  Year ended December 31, 
  2018  2017 
       
Professional fees  559,880   480,684 
Common stock and warrants issued for services  1,150,675   76,616 
Other  63,284   - 
   1,773,839   557,300 

48
   
Principal amount69
Discount on Short term loan(19)
Short term loan, Net50

F-17

Viewbix Inc.

Notes to Consolidated Financial Statements

U.S. dollars in thousands (except share and per share data)

Note 7 - FINANCING6. STOCKHOLDERS’ DEFICIT.

Ordinary Shares:

Ordinary shares confer the right to: (i) participate in the general meetings, to one vote per share for any purpose, to an equal part, on share basis, (ii) in distribution of dividends and (iii) to equally participate, on share basis, in distribution of excess of assets and funds from the Company and they shall not confer other privileges unless stated hereunder or in the Companies Law otherwise. Some investors have standard anti-dilutive rights, registration rights, and information and representation rights.

On December 18, 2020, the company entered into a Stock Subscription Agreement (the “Subscription”) with certain investors (the “Investors”) in connection with the sale and issuance of an aggregate of 3,000,000 shares of Common Stock, at a purchase price of $0.01 per share, and for an aggregate purchase price of $30,000. In accordance with the terms of the Loan, the company repaid the interest on the Principal Amount 8% compounded annually to the Investors in the form of an issuance of an aggregate of 552,000 shares of Common Stock, at a price per share of $0.01. The shares of Common Stock were issued to the Investors pursuant to Regulation S of the Securities Act of 1933, as amended. For more details, please see note 1c.

Warrants

The following table summarizes information of outstanding warrants as of December 31, 2021:

SUMMARY OF OUTSTANDING WARRANTS

  Warrants  Warrant Term Exercise Price  Exercisable 
            
Class J Warrants  3,649,318  July 2029  0.48   3,649,318 
Class K Warrants  3,649,318  July 2029  0.80   3,649,318 

Additionally, in connection with the Share Exchange Agreement, upon the earlier of: (a) the launch of a live video product to an American consumer in the United States by Viewbix Israel, or (b) the launch of an interactive television product to an American consumer in the United States by Viewbix Israel, the Company will issue to Gix an additional 1,642,193 shares of restricted common stock of the Company. All of the Company’s warrants meet the US GAAP criteria for equity classification. During 2020, 50,000 class H warrants , 38,095 class I warrants and 142,857 Class G warrants expired.

F-18

Viewbix Inc.

Notes to Consolidated Financial Statements

U.S. dollars in thousands (except share and per share data)

Note 7. REVENUES.

SCHEDULE OF REVENUES

  Year ended December 31, 
  2021  2020 
Individual Subscriptions  10   13 
Enterprise Subscriptions  31   83 
   41   96 

Note 8. RESEARCH AND DEVELOPMENT EXPENSES NET.

SCHEDULE OF RESEARCH AND DEVELOPMENT EXPENSES

  Year ended December 31, 
  2021  2020 
       
Salaries and related expense  -   55 
Subcontractors  64   53 
   64   108 

Note 9. SALES AND MARKTING EXPENSES.

SCHEDULE OF SALES AND MARKETING EXPENSES

  Year ended December 31, 
  2021  2020 
       
Salaries and related expense  -   7 
Others  2   1 
   2   8 

Note 10. GENERAL AND ADMINISTRATIVE EXPENSES.

SCHEDULE OF GENERAL AND ADMINISTRATIVE EXPENSES

  2021  2020 
  Year ended December 31, 
  2021  2020 
       
Wages, salaries and related expenses  140   214 
Professional fees  150   176 
Depreciation  -   5 
Other  14   42 
General and administrative expenses  304   437 

 

  Year ended December 31, 
  2018  2017 
       
Finance loss arising from change in terms of convertible notes (Note 3)  21,622,897   - 
Amortization of debt discount  1,040,838     
Losses from marketable securities  32,758   - 
Cancellation of Preferred Shares  (150,000)    
Other  (4,259)  307,516 
         
   22,542,234   307,516 
F-19

Viewbix Inc.

Notes to Consolidated Financial Statements

U.S. dollars in thousands (except share and per share data)

Note 8 - Income Taxes.11. FINANCIAL EXPENSES (INCOME), NET.

SCHEDULE OF FINANCIAL (EXPENSES) INCOME, NET

  Year ended December 31, 
  2021  2020 
       
Bank fees  3   1 
Exchange rate differences  (1)  (14)
Interest expenses  28   - 
   30   (13)

Note 12. INCOME TAXES.

The Company is subject to income taxes under the Israeli and U.S. tax laws:laws

CorporateTax rates applicable to the income of the Company:

Viewbix Inc. is taxed according to U.S. tax rates

The Company is subjectlaws. On December 22, 2017, the U.S. enacted the Tax Cuts and Jobs Act (the “Act”), which among other provisions, reduced the U.S. corporate tax rate from 35% to 21%, effective January 1, 2018.Viewbix Israel and Israeli subsidiaries are taxed according to Israeli corporate, 24% in 2017 and 23% from 2018.tax laws. The maximum statutory federalIsraeli corporate tax rate is 23% in the USyears 2021, 2020 and onwards.

Deferred income taxes:

Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of the Company’s deferred tax assets are as follows:

SCHEDULE OF DEFERRED INCOME TAXES

  2021  2020 
  As of
December 31
  As of
December 31
 
  2021  2020 
       
Deferred R&D expenses $167  $114 
Operating loss carryforward  33,055   32,256 
Differences between tax basis and carrying values of loans
(see notes 4 and 5)
 $(184) $(18)
Total $33,038  $32,352 
         
Net deferred tax asset before valuation allowance $7,230  $7,072 
Valuation allowance  (7,230)  (7,072)
Net deferred tax asset $-  $- 

F-20

Viewbix Inc.

Notes to Consolidated Financial Statements

U.S. dollars in 2017thousands (except share and 2018 is 35%. The Company is not subject to current federal taxes, as it has incurred losses in 2017 and 2018.per share data)

Note 12. INCOME TAXES. (Cont.)

As of December 31, 2018,2021, the Company generated nethas provided valuation allowances of $3,909 in respect of deferred tax assets resulting from tax loss carryforward and other temporary differences. Management currently believes that because the Company has a history of losses, it is more likely than not that the deferred tax regarding the loss carryforward and other temporary differences will not be realized in the foreseeable future.

Available carryforward tax losses:

As of December 31, 2021, Viewbix Israel incurred operating losses in Israel of approximately $960,000,$14,624 which may be carried forward and offset against taxable income in the future for an indefinite period.

As of December 31, 2018,2021 the Company generated net operating losses for tax in the U.S. of approximately $300,000. $18,615Net operating losses in the United StatesU.S. are available through 2035. Utilization of U.S. net operating losses may be subject to substantial annual limitation due to the “change in ownership” provisions of the Internal Revenue Code of 1986 and similar state provisions. The annual limitation may result in the expiration of net operating losses before utilization.

Loss from continuing operations, before taxes on income, consists of the following:

SCHEDULE OF LOSS (INCOME) FROM CONTINUING OPERATIONS, BEFORE TAXES ON INCOME

  For the year ended December 31 
  2021  2020 
       
USA $164  $65 
Israel  220   376 
  $384  $441 

NOTE 13. LOSS PER SHARE-BASIC AND DILUTED

Composition:

SCHEDULE OF LOSS PER SHARE-BASIC AND DILUTED

  For the year ended December 31 
  2021  2020 
Net loss attributable to ordinary stockholders  386   443 
         
Weighted-average ordinary shares  34,753,669   31,201,669 
         
Loss per share-basic and diluted  0.011   0.014 

F-21

Viewbix Inc.

Notes to Consolidated Financial Statements

U.S. dollars in thousands (except share and per share data)

NOTE 14. COVID-19 PANDEMIC IMPLICATIONS..

The COVID-19 pandemic which originated in China in late 2019, has resulted in a widespread health crisis that has adversely affected businesses, economies and financial markets worldwide, placed constraints on the operations of businesses, decreased consumer mobility and activity, and caused significant economic volatility in the United States, Israel and international capital markets. The COVID-19 pandemic has caused an economic recession, high unemployment rates and other disruptions, both in the United States, Israel and the rest of the world. The Company is stillactively monitoring the pandemic and is taking any necessary measures to respond to the situation in its development stage andcooperation with the various stakeholders. Due to the uncertainty surrounding the COVID-19 pandemic, the Company will continue to assess the situation, including government-imposed restrictions, market by market. The COVID-19 pandemic has not yet generated revenues, therefore,currently adversely affected our business, however, it is more likely than not possible at this time to estimate the full impact that sufficient taxable income will not be available for the tax lossesCOVID-19 pandemic, the continued spread of COVID-19, and any additional measures taken by governments, health officials or by the Company in response to be utilized insuch spread, could have on the future. Therefore, a valuation allowance was recordedCompany’s business, results of operations and financial condition.

NOTE 15. SUBSEQUENT EVENTS.

Loan Agreement

In January 2022, the Investors under the Loan Agreement expressed their intention to reduceconvert the deferred tax assetsPrincipal Amount to its recoverable amounts.the Company’s shares of Common Stock, and accordingly, the Company agreed to extend the repayment date (see note 5).

  As of
December 31, 2018
  As of
December 31, 2017
 
Net loss carry-forward $19,604,852  $18,344,852 
         
Total deferred tax assets  44,185,284   3,916,297 
Valuation allowance  (4,185,284)  (3,916,297)
         
Net deferred tax assets $-  $- 

Gix Merger

On December 22, 2017, the Tax Cuts and Jobs Act (the “Tax Act”) was signed into law in the United States. The Tax Act, among other provisions, introduces changes in the U.S corporate tax rate, business related deductions and credits, and has international tax consequences for companies that operate globally. Most of the changes introduced in the Tax Act are effective beginning on January 1, 2018. As a result of the tax act the maximum statutory federal tax rate was reduced to 21% starting on January 1, 2018. The other effects of the Tax Act provisions are still being identified and evaluated by the Company.

Note 9 - Related Party Transactions.

Other than transactions and balances related to cash and share based compensation to officers and directors and other than the issues of convertible debt and warrants to Alpha (see note 3), and payments in respect of consulting fees to certain shareholders with beneficial holdings of greater that 5% of $148,910 and $ nill during the years ended December 31, 2018 and 2017,5, 2021, the Company did not have any transactionsentered into the Merger Agreement with Gix Media and balances with related parties and executive officers during the years ended December 2018 and 2017.

Note 10. Subsequent Events.

On January 1, 2019, the January 2018 Convertible Notes were extended through to January 31, 2020 and the $100,000 Convertible Notes were extended through to January 14, 2020.

On February 7, 2019, Virtual Crypto Technologies, Inc. (the “Company”) entered a share exchange agreement (the “Agreement”) with Algomizer Ltd., an Israeli Corporation (“Algomizer”),Merger Sub, pursuant to which, Algomizerfollowing the Gix Merger, and upon satisfaction of additional closing conditions, Merger Sub will assign, transfermerge with and deliver its 99.83% holdings in Viewbix Ltd., an Israeli Corporation,into Gix Media, with Gix Media being the surviving entity and wholly-owned subsidiary of the Company. As of the reporting date, the closing conditions of the Merger Agreement have not been fulfilled yet.

Subject to the Companyterms and conditions of the Merger Agreement, at the Merger Effective Date (as defined in exchange forthe Merger Agreement) all outstanding ordinary shares of restricted common stockGix Media, having no par value (the “Gix Media Shares”) will be converted into shares of Common Stock, such that immediately following the Gix Merger, holders of Gix Media Shares will hold 90% of the Company representing 65% of the issued and outstanding shareCompany’s capital of the Companystock on a fully diluted basis on the closing date, excluding VCT warrants to purchase shares of common stock, which will expire in 2020basis. The Merger Agreement contains customary representations, warranties and with an exercise price representing a valuation for VCT equal to $30,000,000 (“Fully Diluted Share Capital”). In addition, upon the earlier of: (a) the launch of a live video product to an American consumer in the U.Scovenants made by Viewbix Ltd., or (b) the launch of an interactive television product to an American consumer in the U.S Viewbix Ltd., the Company will issue Algomizer additional shares of restricted common stockeach of the Company, representing 5%Gix Media and Merger Sub.

On December 21, 2021, the shareholders of each of Gix Media and Merger Sub approved the Merger Agreement. Consummation of the Fully Diluted Share Capital.

Furthermore, on theGix Merger is subject to certain additional closing date, the Company will issue Algomizer:conditions, including, among other things, (i) warrants to purchase shares of restricted common stock of the Company with an exercise price representing a valuation for the Company of $15,000,000 on Fully Diluted Share Capital basis, which will represent 10% of the Fully Diluted Share Capital immediately following the closing for a period of ten years, and (ii) warrants to purchase shares of restricted common stock of the Company with an exercise price representing a valuation for the Company of $25,000,000 on Fully Diluted Share Capital basis, which will represent 10% of the Fully Diluted Share Capital immediately following the closing for a period of ten years.

The closing of the Agreement is condition upon the Company filing an amendment to its certificate of incorporation to change the Company’s name to ViewBix“Gix Media, Inc., effecting a reverse split(ii) obtaining approval from certain third parties, including the approval of the Company’sBank Leumi due to certain liens registered in its favor against ordinary shares of common stock at a ratio of 15:1,Gix Media; (iii) conversion of the Company’s outstanding debenturesconvertible instruments into restricted common stockshares of Common Stock and (iv) obtaining a tax pre-ruling from the Israeli Tax Authority relating to the AgreementAgreement.

F-22

Viewbix Inc.

Notes to be obtained by Algomizer. Consolidated Financial Statements

U.S. dollars in thousands (except share and per share data)

NOTE 15. SUBSEQUENT EVENTS. (Cont.)

Reverse Stock Split

In addition,connection with the closing is subject to and conditioned uponGix Merger, on February 13, 2022, the approvalrequisite majority of the shareholdersCompany’s stockholders approved certain amendments to the Company’s certificate of the Company.

On February 26, 2019, the Majority Consenting Stockholders approved the Stockholder Consent, approving the Reverse Stock Split Certificate of Amendment in orderincorporation, including, but not limited to affect(i) a name change from “Viewbix Inc.” to “Gix Media, Inc.”, (ii) a reverse stock split of the Corporation’s CommonCompany’s common Stock onat a 1-for-15 basis.The Company will effect such reverse stock split once all approvals for such actions are obtained.

ratio of 1-for-28 (the “Planned Reverse Split”), (iii) a staggered board structure, and (iv) certain other provisions therein. Pursuant to the Planned Reverse Stock Split, each fifteen (15)twenty-eight (28) shares of Common Stockthe Company’s common stock will be automatically converted, without any further action by the stockholders, into one share of Common Stock.the Company’s common stock. No fractional shares of Common Stock will be issued as the result of the Reverse Stock Split.reverse stock split. Instead, each Stockholderstockholder will be entitled to receive one share of Common Stockcommon stock in lieu of the fractional share that would have resulted from the reverse stock split.

The Company intends to effect the foregoing amended and restated certificate of incorporation upon the closing of the Gix Merger, thus, as of the reporting date the Planned Reverse Stock Split.Split has not been effected.

F-23

ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

None.

ITEM 9A. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

Under the supervision and with the participation of our management, including our Chief Executive Officer and our Chief Financial Officer, we carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act. Based on that evaluation, our Chief Executive Officer and our Chief Financial Officer have concluded that, at December 31, 2018, such disclosure controls and procedures were effective.

Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is accumulated and communicated to management, including our Chief Executive Officer and Chief Financial Officer, or persons performing similar functions, as appropriate, to allow timely decisions regarding required disclosure.

Our management, including our principal executive officer and principal financial officer, evaluated the effectiveness of our disclosure controls and procedures pursuant to Rules 13a-15(e) and 15d-15(e) under the Exchange Act as of December 31, 2021, the end of the period covered by this Annual Report on Form 10-K. Based on such evaluation, due to the material weakness discussed below, our principal executive officer and principal financial officer concluded that our disclosure controls and procedures were not effective at a reasonable assurance level as of December 31, 2021.

25 

 

Management’s Annual Report on Internal Control Overover Financial Reporting

As required by the SEC rules and regulations, our managementManagement is responsible for establishing and maintaining adequate internal control over financial reporting. Ourreporting as defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act. The Company’s internal control over financial reporting is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of our consolidated financial statements for external reporting purposes in accordance with U.S. GAAP. Our internal control over financial reporting includes those policies and procedures that:

(1)pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of our company;
(2)provide reasonable assurance that transactions are recorded as necessary to permit preparation of consolidated financial statements in accordance with accounting principles generally accepted in the United States of America, and that our receipts and expenditures are being made only in accordance with authorizations of our management and directors; and
(3)provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on the consolidated financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect errors or misstatements in our consolidated financial statements.misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree orof compliance with the policies or procedures may deteriorate.

Management assessedevaluated the design and operating effectiveness of our internal control over financial reporting at December 31, 2018. In making these assessments, management used thebased on criteria set forthestablished in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 Framework)(“COSO 2013”). Based on our assessments and those criteria,this evaluation, management determinedconcluded that we maintained effectiveour internal control over financial reporting atas of December 31, 2018.2021 was not effective due to the material weakness described below.

In connection with the preparation of our consolidated financial statements as of and for the year ended December 31, 2021 and December 31, 2020, we have identified a material weakness in our internal control over financial reporting. The material weakness was identified in the period-end financial reporting process, and is associated with our history as a private company and a material weakness is a deficiency or combination of deficiencies in our internal control over financial reporting such that there is a reasonable possibility that a material misstatement of our consolidated financial statements would not be prevented or detected on a timely basis. This deficiency could result in additional misstatements to our consolidated financial statements that would be material and would not be prevented or detected on a timely basis.

We are evaluating and implementing additional procedures in order to remediate this material weakness, however, we cannot assure you that these or other measures will fully remediate the material weakness in a timely manner.

Attestation Report of the Registered Public Accounting Firm

This annual report on Form 10-K does not include an attestation report of the Company’s registered public accounting firm regarding internal control over financial reporting. Management’s report was not subject to attestation by the Company’s registered public accounting firm pursuant to rules of the SEC that permit the Company, as a non-accelerated filer, to provide only management’s report in this annual report on Form 10-K.

Changes in Internal Control Over Financial Reporting

There were no changes in our internal control over financial reporting or in other factors identified in connection with the evaluation required by paragraph (d) of Exchange Act Rules 13a-15 or 15d-15 that occurred during the fourth quarter ended December 31, 20182021 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

ITEM 9B. OTHER INFORMATION

None.

5126 
 

PART III

ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

Our directors were elected to serve until the next annual meeting of shareholders and until his respective successors will have been elected and will have qualified. The following table sets forth the name, age and position held with respect to our present executive officers and directors:

NameAgeTitle
Alon DayanAmihay Hadad4244CEODirector, Chief Executive Officer and DirectorChief Financial Officer
Eyal Ben-AmiAlon Dayan4244Director
Gadi Levin46CFO

Alon Dayan, age 42, Director:Amihay HadadOn March 14, 2018, the Registrant has served as our chief executive officer since February 20, 2020, chief financial officer since July 25, 2019, and was appointed Mr. Alon Dayan as a member of our board of directors on January 1, 2020. From 2011 until 2018, Mr. Hadad served as the Registrant’s Boardchief financial officer of Directors. OnYedioth Internet. As of January 30, 2020, Mr. Hadad serves as the chief executive officer of Gix Internet, a controlling stockholder of the Company, in addition to his existing role as Gix Internet’s chief financial officer. Mr. Hadad holds both a B.A. and an MBA from the College of Management Academic Studies in Rishon LeZion, Israel, and an M.A. in law from Bar-Ilan University, Israel. Mr. Hadad is also a certified public accountant in Israel.

Alon Dayan has served as a member of our board of directors since March 14, 2018, and from January 24, 2018 Mr. Dayan was appointeduntil July 25, 2019, he served as CEO of the Registrant’s wholly-owned Israeli subsidiary, Virtual Crypto Technologies Ltd. with responsibilities for the development, production, manufacture and sale of the Subsidiary’s planned ATM for the purchase and sale of crypto currencies. Mr. Dayan’s background includes business and technical experience and success in new technologies.

our chief executive officer. From July 2014 to the present, Mr. Dayan has served as the CEOchief executive officer and founder of L1 Systems Ltd(www.L1-systems.com)Ltd., an Israeli based company engaged in the business of providing the public and private sectors with advanced security solutions including: (i) development, production and sale of a new technology for secured wide band cellular communication; (ii)telecommunications and cyber large-scale system integration; (iii)identifying potential business partners and system integration companies for companies in Israel, Latin America, Eastern Europe, and Spain.solutions. Since July 2013, Mr. Dayan has served as CEOchief executive officer and was the founder of Polaris Star, (www.polaris-sys.com), an Israeli-based company which is engaged in providing advanced cyber security telecommunication for utilities world-wide, including the United States, Israel, India, Japan, Singapore, Italy, Mexico and Brazil.

From 2006 to July 2013,world-wide. Mr. Dayan served as Regional Director-Sales and Business Development, for Elbit Systems Ltd (NASDAQ: ESLT), an Israeli-based companyand a leading manufacturer of electronic defense materials with approximately 5,000 employees.

In 2003, Mr. Dayan receivedearned hisB.Tech. degree in electronic engineering from Ariel University Israel, which is part of Bar-Ilan University.

Eyal Ben-Ami, age 42, Director. On January 19, 2018, the Registrant’s Board of Directors appointed Mr. Eyal Ben-Ami as a member of the Board. From 2008 to the present, Mr. Ben-Ami has served as the Director of Employee Benefits at the IDB Bank of Israel, founded in 1935 and one of Israel’s three largest banks. IDB Bank hasmore than 260 branches, a staff of approximately 5,700, assets of approximately US$50 billion and international operations with branches in Israel and the United States. From 1993 through 2007, Mr. Ben-Ami was a professional soccer player and a member of Hapoel Tel-Aviv FC, a professional Israeli soccer team, and a member of Israel’s National Soccer Team.

Mr. Gadi Levin, age 45, Chief Financial Officer. On April 18, 2017, the Board of Directors appointed Mr. Levin to serve a CFO of the Registrant. Mr. Levin has over 15 years of experience working with public US, Canadian and multi-jurisdictional public companies. Mr. Levin currently serves as Chief Financial Officer of Briacell Therapeutics Corp (OTCQB: BCTXF, TSX-V: BRIA.V). Previously, Mr. Levin served as Chief Financial Officer of DarioHeath Corp (NASDAQ: DRIO), a mHealth company operating in the field diabetes management. Mr. Levin also served as the Vice President of Finance and Chief Financial Officer for two Israeli investment firms specializing in private equity, hedge funds and real estate. Mr. Levin began his CPA career at the accounting firm, Arthur Andersen, where he worked for nine years, specializing in U.S. listed companies involved in IPO’s working with US GAAP and IFRS. Mr. Levin has a Bachelor of Commerce degree in Accounting and Information Systems from the University of the Cape Town, South Africa, and a post graduate diploma in Accounting from the University of South Africa. He received his Chartered Accountant designation in South Africa and has an MBA from Bar Ilan University in Israel.

We do not compensate our directors. We do not have any standing committees at this time.

Involvement in Certain Legal Proceedings

Our director, officers or affiliates have not, within the past five years, filed any bankruptcy petition, been convicted in or been the subject of any pending criminal proceedings, or is any such person the subject or any order, judgment or decree involving the violation of any state or federal securities laws.

Family Relationships

There are no family relationships between or among any of our directors or executive officers.

Compliance with Section 16(a) Compliance.

Section 16(a) of the Securities and Exchange Act of 1934 requires that directors and executive officers, and persons who own beneficially more than ten percent (10%) of the Registrant’s Common Stock, to file reports of ownership and changes of ownership with the Securities and Exchange Commission. Copies of all filed reports are required to be furnished to the Registrant pursuant to Section 16(a). Based solely on the reports received by the Registrant and on written representations from reporting persons, the Registrant believes that all of theThe Registrant’s officers directors, and owners of more than ten percent of the outstanding shares of our common stock complied with Section 16(a) of the Exchange Act for the year ended December 31, 2008, except as follows: our CEO, CFO and directors have conducted lateare current in their filings of their respective Forms 3are required under Section 16(a).

NASDAQ Rule 4200. The NASDAQ Rule 4200, which sets forth several tests to determine whether a director of a listed company is independent. Rule 4200 provides that a director would not be considered independent if the director or an immediate family member accepted any compensation from the listed company in excess of $120,000 during any period of 12 consecutive months within the three years preceding the determination of independence (excluding compensation for board or board committee service, compensation paid to an immediate family member as a non-executive employee, benefits paid under a tax-qualified retirement plan and non-discretionary compensation).

Director Independence. In determining whether or

The Company does not our directors are consideredcurrently have any independent the Company used the definition of independence as defined in NASDAQ Rule 4200. We therefore believe that only Eyal Ben-Ami and Alon Dayan are deemed to be independent directors.

Directors’ Term of Office.

Our directors are elected tofor a term of one year and serve until the next annual meeting of shareholders and until their respective successors will have beensuch director’s successor is duly elected and will have qualified. Each executive officer serves at the pleasure of the board.

27 

 

Audit Committee and Financial Expert, Compensation Committee, Nominations Committee.

We do not have any of the above mentioned standing committees because our corporate financial affairs and corporate governance are simple in nature at this stage of development and each financial transaction is approved by our sole officerofficers or director.board of directors.

Potential Conflicts of Interest.Interest.

Since we do not have an audit or compensation committee comprised of independent Directors,directors, the functions that would have been performed by such committees are performed by our Boardboard of Directors.directors. Thus, there is a potential conflict of interest in that our Directorsdirectors have the authority to determine issues concerning management compensation, in essence their own, and audit issues that may affect management decisions. We are not aware of any other conflicts of interest with any of our Executivesexecutives or Directors.directors.

Board’s Role in Risk Oversight. The Board assesses

Our board of directors assess on an ongoing basis the risks faced by the Company. These risks include financial, technological, competitive, and operational risks. In addition, since the Company does not have an Audit Committee,audit committee, the Boardboard of directors is also responsible for the assessment and oversight of the Company’s financial risk exposures.

Involvement in Certain Legal Proceedings.

We are not aware of any material legal proceedings that have occurred within the past ten years concerning any Directordirector or control person which involved a criminal conviction, a pending criminal proceeding, a pending or concluded administrative or civil proceeding limiting one’s participation in the securities or banking industries, or a finding of securities or commodities law violations.

ITEM 11. EXECUTIVE COMPENSATION

Any compensation received by our officers, directors, and management personnel will be determined from time to time by our Board of Directors. Our officers, directors, and management personnel will be reimbursed for any out-of-pocket expenses incurred on our behalf.

ForThe following table sets out the threecompensation paid for the fiscal years ended December 31, 2018, 20172021 and 2016, we did not pay any compensation2020 as applicable, to our executive officers, nor did any other person receive a total annual salary and bonus exceeding $100,000.the following Named Executive Officer:

New Service Agreements

Mr. Amihay Hadad, our current Chief Executive Officer and Chief Financial Officer.

The table is in U.S. dollars
Name and principal position
 Year  Salary  Bonus  Stock Awards  Option Awards  All Other Compensation  Total 
Mr. Amihay Hadad  2021   83,326   -   -   -   -   83,326 
Current Chief Executive Officer, Chief Financial Officer  2020   47,072(1)  -   -   -   -   47,072 

(1)Mr. Amihay Hadad’s salary for the fiscal year-ended December 31, 2020 was paid beginning April 2020 and onwards.

The Registrant entered into separate service agreements with Gadi Levin, CFO and Eyal Ben-Ami, a Director, respectively. The Registrant’s service agreements provide as follows: (i) the agreement with Gadi Levin for serving as CFO of the Registrant and its new Israeli subsidiary provides for monthly cash compensation of $7,500, reduced to $3,750 from October 1, 2018; and (ii) the agreement with Eyal Ben-Ami for serving as a Director provides for the payment of monthly cash compensation of $1,250, payable quarterly on the first day of each fiscal quarter.

Director’s Compensation

Other than with respect to the service agreement with Mr. Ben-Ami, a director referenced above, ourOur directors are not entitled to receive compensation for service rendered to us or for meeting(s) attended except for reimbursement of out-of-pocket expenses. There is no formal or informal arrangements or agreements to compensate employee directors for service provided as a director; however, compensation for new non-employee directors is determined on an ad hoc basis by the existing members of the board of directors at the time a director is elected.

28 

Compensation Policies and Practices as They Relate to the Company’s Risk Management

We believe that our compensation policies and practices for all employees, including executive officers, do not create risks that are reasonably likely to have a material adverse effect on us.

Employment Contracts

We do not have any formal employment agreement with any of our officers. Any future compensation will be determined by the Board of Directors, and, as appropriate, an employment agreement will be executed. We do not currently have plans to pay any compensation until such time as the Company maintains a positive cash flow.

Outstanding Equity Awards

There were no equity awards outstanding as of the end the year ended December 31, 2018.2021.

Option Grants

During the year ended December 31, 2018,2021, the Boardboard of Directorsdirectors did not authorize the issuance of stock options to executive officers and directors to purchase shares of common stock.Common Stock.

Aggregated Option Exercises and Fiscal Year-End Option Value

There were no stock options exercised during the year ending December 31, 20182021 by our executive officers.

Long-Term Incentive Plan (“LTIP”) Awards

There were no awards made to a named executive officerofficers in the last completed fiscal year under any LTIP.

Indebtedness of Management

No officer, director or security holder known to us to own of record or beneficially more than 5% of our Common Stockcommon stock or any member of the immediate family or sharing the household (other than a tenant or employee) of any of the foregoing persons is indebted to us in the years 20182021 and 2017.2020.

ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

The following table depictsbelow provides information regarding the beneficial ownership of our common stockCommon Stock as of March 28, 2019. The information providesDecember 31, 2021, of (i) each of our current directors, (ii) each of the ownership information for:Named Executive Officers, (iii) all of our current directors and officers as a group, and (iv) each person or entity known byto us to be the beneficial owner ofwho owns more than 5% of our common stock; eachstock.

The percentage of our directors; each of our executive officers; and our executive officers and directors as a group.

Name of Beneficial OwnerCommon Stock Beneficially
Owned (1)
Percentage of Common Stock Owned (1)
Gadi Levin, CFO-0.00%
Moshav Azriel 108
Lev Hasharon, Israel
Eyal Ben-Ami, Director-0.00%
22 Ma’agal Shalom Street
Rishon Lezion, Israel
Alon Dayan, Director-0.00%
Shir Hashirim 39
Elakana, Israel

Kfir Silberman, Individually and as
control person of L.I.A. Pure Capital Ltd.

20 Raoul Wallenberg St.,

Tel Aviv 6971916, Israel

  9,680,991   8.74%
         

Lavi Karasny , Individually and as
control person of Capitalink Ltd.,

10 Pa’amoni Street

Tel Aviv 6291806, Israel

  9,353,064   8.45%
         

Amir Uziel, Individually and as
control person of Amir Uziel Economic Consultant Ltd.

5 Shira Street

Rishon Lezion 7580237, Israel

  9,100,000   8.22%
         

Nir Reinhold , Individually and as
control person of Buffalo Investments Ltd.
Moshav Avigdor

Israel 8380000

  10,300,000   9.3%
         

Itschak Shrem, Individually and as
control person of Attribute Ltd.

13 Hatikva Street

Ramat Hasharon 472169, Israel

  9,153,064   8.27%

(1) Applicable percentage ownershipCommon Stock beneficially owned is based on 110,749,64334,753,669 shares of common stockCommon Stock outstanding as of March 28, 2019. Beneficial ownership is determined in accordance with the rulesDecember 31, 2021. The number and percentage of the Securities and Exchange Commission and generally includes votingshares of Common Stock beneficially owned by a person or investment power with respect to securities. Sharesentity also include shares of common stockCommon Stock issuable upon exercise of warrants that are currently exercisable or will become exercisable within 60 days of March 28, 2019December 31, 2021. However, these shares are not deemed to be beneficially owned by the person holding such securitiesoutstanding for the purpose of computing the percentage of ownership of such person but are not treated as outstanding for the purpose of computing the percentage ownershipshares beneficially owned of any other person.person or entity.

Name and Address of Beneficial Owner Title of Class Amount and Nature
of Beneficial
Ownership(1)
  Percent of Class 
Gix Internet Ltd. Common Stock  27,579,721(2)  79.36%
L.I.A. Pure Capital Ltd. Common Stock  1,831,427(3)  5.27%
           
Executive Officers and Directors          
Amihay Hadad Common Stock  -   - 
Alon Dayan Common Stock  50,000   * 
Directors and officers as a group (2 individuals)    50,000   * 

* Less than 1%

29 

(1)Beneficial ownership is determined in accordance with the rules of the SEC and generally includes voting or investment power with respect to securities. Each of the beneficial owners named in the table have, to our knowledge, direct ownership of and sole voting and investment power with respect to the shares of Common Stock beneficially owned by them.
(2)Includes (i) 20,281,085 of shares of Common Stock, (ii) warrants to purchase up to 3,649,318 shares of restricted Common Stock with an exercise price of $0.48 per share, and (iii) warrants to purchase up to 3,649,318 shares of restricted Common Stock with an exercise price of $0.8 per share, which are currently exercisable or will become exercisable within 60 days of December 31, 2021.
(3)The number of shares shown as beneficially owned by this stockholder is based on its Schedule 13G filed on February 14, 2022.

ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS AND DIRECTORS INDEPENDENCE

Certain Related Party Transactions

IndebtednessOn December 18, 2020, L.I.A. Pure Capital Ltd. (“Pure Capital”), together with other Investors, entered into the Stock Subscription Agreement, pursuant to which Pure Capital was issued 1,000,000 shares of ManagementCommon Stock in exchange for an investment of $10,000, at a purchase price of US$0.01 per share. Additionally, Pure Capital, together with other Investors, entered into the Loan Agreement, pursuant to which Pure Capital lent $23,000 and we repaid the interest on that amount in the form of an issuance of 184,000 shares of Common Stock to Pure Capital, at a price per share of $0.01. The shares of Common Stock were issued to the Investors pursuant to Regulation S of the Securities Act of 1933, as amended.

DuringOn February 13, 2022, the year endedCompany entered into a loan agreement with Gix Internet, its Parent Company. Pursuant to the loan agreement, the Parent Company payables in the amount of $2,299,938 were modified to a loan (the “Gix Loan”). The loan agreement also allows the Gix Loan to be increased from time to time, upon the written mutual consent of the Company and Gix Internet. The Gix Loan bears interest, commencing on December 31, 20182021, at a rate equivalent to the minimal interest rate recognized and 2017, we paid $148,910attributed by the Israel Tax Authority, as such may be adjusted from time to time, and $ nil, respectively,shall be repaid, together with the accrued interest, in respect of consulting fees, to certain shareholders who beneficially own more than 5% of our Common Stock.

No officer, director or security holder known to us to own of record or beneficially more than 5% of our Common Stock or any memberone payment until December 31, 2022, unless extended upon mutual consent of the immediate family or sharing the household (other than a tenant or employee) of any of the foregoing persons is indebted to us in the years 2018Company and 2017.Gix Internet.

ITEM 14. PRINCIPAL ACCOUNTING FEES AND SERVICES

Independent Public Accountants

The Registrant’s Board of Directors has appointed Halperin IlanitBrightman Almagor Zohar & Co. as independent public accountant for the fiscal years ended December 31, 2018.2021.

Principal Accounting Fees

The following table presents the fees for professional audit services rendered by Halperin. Ilanit for the audit of the Registrant’s annual consolidated financial statements for the year ended December 31, 2018 and(a) Brightman Almagor Zohar & Co. for the audit of the Registrant’s annual consolidated financial statements for the yearyears ended December 31, 2017. Fees2021 and December 31, 2020 and (b) the aggregate fees billed for other services rendered by Halperin Ilanitin each of the last two fiscal years as pertaining to, among others, tax compliance, tax advice and Brightman Almagor Zohar & Co. during those periods.tax planning conferred to the Registrant.

  Year Ended  Year Ended 
  December 31, 2018  December 31, 2017 
Audit fees (1) $14,500  $43,000 
Audit-related fees (2)      
Tax fees (3)      
All other fees      

  Year Ended  Year Ended 
  December 31,
2021
  December 31,
2020
 
Audit fees (1)  50,000   50,000 
Tax -related fees (2)  -   2,948 

(1)At 2018 Audit fees consist of audit and review services, and at 2017 the Audit fees consist of audit and review services and the consents and review of documents filed with the SEC.
(2)Audit-related
(2)Tax fees consist of, assistance and discussion concerning financial accounting and reporting standards andamong other accounting issues.
(3)Tax fees consist ofitems, preparation of federal and state tax returns, review of quarterly estimated tax payments, andIsraeli tax rulings, consultation concerning tax compliance issues.issues, and services rendered for purposes of a tax ruling filed with government agencies and institutions in connection with the Recapitalization Transaction.

30 

PART IV

ITEM 15. EXHIBITS AND CONSOLIDARED FINANCIAL STATEMENT SCHEDULES

(a) The following documents are filed as exhibits to this report on Form 10-K or incorporated by reference herein. Any document incorporated by reference is identified by a parenthetical reference to the SEC filing that included such document.

Exhibit No. Description

Exhibit No.Exhibit Description
3.1Certificate of Incorporation (incorporated by reference to the Registrant'sRegistrant’s registration statement on Form S-1 filed with the SEC on August 5, 2015).
3.1(a)3.2Certificate of Amendment to the Certificate of Incorporation (incorporated by reference to Exhibit 3.1 to the Registrant'sRegistrant’s Current Report on Form 8-K filed with the SEC on July 25, 2019)
3.3Bylaws (incorporated by reference to the Registrant’s registration statement on Form S-1 filed with the SEC on August 5, 2015).
3.1(b)4.1CertificateDescription of Amendment to the Certificate of IncorporationRegistrant’s Securities (incorporated by reference to the Registrant's registration statementRegistrant’s annual report on Form S-1,10-K filed for the fiscal year ended December 31, 2019 with the SEC on August 5, 2015).March 20, 2020)
3.24.2Bylaws, attachedForm of Warrant by and between the Company and Gix Media Ltd., dated July 25, 2019 (incorporated by reference to Exhibit 4.1 to the Registrant’s Form S-1 as filed with the SECCurrent Report on August 5, 2015.
10.1Share Exchange Agreement between the Registrant and Algomizer Ltd., dated February 7, 2019, filed as an exhibit to the Registrant’s Form 8-K filed with the SEC on February 7, 2019.July 25, 2019)
10.210.12017 Employee Incentive Plan (incorporated by reference to the Registrant'sRegistrant’s annual report on Form 10-K for the fiscal year ended December 31, 2017, filed with the SEC on April 17, 2018).
31.110.2CertificationForm of CEO pursuantStock Subscription Agreement between the Company and the investors set forth therein (incorporated by reference to Rule 13a-14(a) or 15d-14(a)Exhibit 10.1 to the Registrant’s Current Report on Form 8-K filed on December 21, 2020)
10.3Form of Loan Agreement between the Company and the investors set forth therein (incorporated by reference to Exhibit 10.2 to the Registrant’s Current Report on Form 8-K filed on December 21, 2020)
10.4Agreement and Plan of Merger, dated December 5, 2021 (incorporated by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K filed with the SEC on December 6, 2021)
21.1*Subsidiaries of the Exchange Act pursuant to Registrant
31.1*Section 302 ofCertification under the Sarbanes-Oxley Act of 2002.*2002 of the Principal Executive Officer and Principal Financial Officer
31.232.1*Section 906 Certification of CFO pursuant to Rule 13a-14(a) or 15d-14(a) of the Exchange Act pursuant to Section 302 ofunder the Sarbanes-Oxley Act of 2002.*2002 of the Principal Executive Officer and Principal Financial Officer
32.1101.INS*Certification of CEO pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.*XBRL Instance Document
32.2101.SCH*Certification of CFO pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.*XBRL Taxonomy Extension Schema Document
101.CAL*XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF*XBRL Taxonomy Extension Definition Linkbase Document
101.LAB*XBRL Taxonomy Extension Label Linkbase Document
101.PRE*XBRL Taxonomy Extension Presentation Linkbase Document

*Filed herewith.
**Furnished herewith.

* Filed herewith

5631 
 

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned.

VIRTUAL CRYPTO TECHNOLOGIES, INC.

By:VIEWBIX INC.
Date: March 17, 2022By:/s/ Alon DayanAmihay Hadad
Alon Dayan, Amihay Hadad
Chief Executive Officer
(Principal Executive Officer)
Date: March 29, 2019
By:/s/ Gadi Levin
Gadi Levin, Chief Financial Officer
(Principal Financial and Principal Accounting Officer)
Date: March 29, 2019

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below on this 17th day of March 2022 by the following persons on behalf of the registrant and in the capacities and onindicated, including a majority of the dates indicated.directors.

By:SignatureTitle
/s/ Amihay HadadChief Executive Officer
Amihay Hadad(Principal Executive Officer)
/s/ Amihay HadadChief Financial Officer and Director
Amihay Hadad(Principal Financial and Accounting Officer)
/s/ Amihay HadadDirector
Amihay Hadad
/s/ Alon DayanDirector
Alon Dayan Chief Executive Officer

Date: March 29, 2019

32